{
  "name": "Alfonso Iorio",
  "first_name": "Alfonso",
  "last_name": "Iorio",
  "middle_names": "",
  "title": "Professor, Health Research Methods, Evidence, and Impact",
  "photo_url": "https://experts.mcmaster.ca/harvestedImages/fullImages/3105.jpg",
  "email": "iorioa@mcmaster.ca",
  "websites": [],
  "linkedin": "",
  "twitter": "",
  "websites_json": "[]",
  "primary_website": "",
  "overview": "",
  "affiliations_json": "[{\"organizations\": \"Faculty of Health Sciences > McMaster University\"}, {\"position\": \"Member\", \"organizations\": \"McMaster Centre for Transfusion Research (MCTR) > Faculty of Health Sciences\"}, {\"position\": \"Member\", \"organizations\": \"Michael G. DeGroote Cochrane Canada Centre at McMaster > Faculty of Health Sciences\"}, {\"position\": \"Professor\", \"organizations\": \"Health Research Methods, Evidence, and Impact > Faculty of Health Sciences\"}, {\"position\": \"Joint Appointment\", \"organizations\": \"Medicine > Faculty of Health Sciences\"}, {\"position\": \"Director\", \"organizations\": \"Health Information Research Unit (HIRU) > Faculty of Health Sciences\"}]",
  "all_affiliations": "Faculty of Health Sciences > McMaster University ; Member, McMaster Centre for Transfusion Research (MCTR) > Faculty of Health Sciences ; Member, Michael G. DeGroote Cochrane Canada Centre at McMaster > Faculty of Health Sciences ; Professor, Health Research Methods, Evidence, and Impact > Faculty of Health Sciences ; Joint Appointment, Medicine > Faculty of Health Sciences ; Director, Health Information Research Unit (HIRU) > Faculty of Health Sciences",
  "all_organizations": "Faculty of Health Sciences > McMaster University ; McMaster Centre for Transfusion Research (MCTR) > Faculty of Health Sciences ; Michael G. DeGroote Cochrane Canada Centre at McMaster > Faculty of Health Sciences ; Health Research Methods, Evidence, and Impact > Faculty of Health Sciences ; Medicine > Faculty of Health Sciences ; Health Information Research Unit (HIRU) > Faculty of Health Sciences",
  "primary_affiliation": "Faculty of Health Sciences > McMaster University",
  "primary_position": "",
  "research_areas": "",
  "research_areas_json": "[]",
  "education_json": "[]",
  "all_degrees": "",
  "all_degrees_only": "",
  "all_institutions": "",
  "highest_degree": "",
  "degree_institution": "",
  "total_publications": 756,
  "journal_articles_count": 478,
  "book_chapters_count": 1,
  "conference_papers_count": 258,
  "recent_publications_count": 209,
  "publications_json": "{\"journal_articles\": [{\"title\": \"A Hemophilia Joint Health Score-Based Model for the Economic Evaluation of Hemophilia A Prophylaxis Interventions.\", \"url\": \"https://experts.mcmaster.ca/display/publication3562694\", \"journal\": \"PharmacoEconomics (Auckland)\", \"year\": \"2025\", \"doi\": \"10.1007/s40273-025-01484-1\"}, {\"title\": \"Developing a Two-Sided Decision Box to Facilitate Shared Decision-Making for Switching From Conventional to Pharmacokinetic-Tailored Prophylaxis in Haemophilia.\", \"url\": \"https://experts.mcmaster.ca/display/publication3607068\", \"journal\": \"Haemophilia\", \"year\": \"2025\", \"doi\": \"10.1111/hae.70072\"}, {\"title\": \"2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura.\", \"url\": \"https://experts.mcmaster.ca/display/publication3596642\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2025\", \"doi\": \"10.1016/j.jtha.2025.06.002\"}, {\"title\": \"Core GRADE 7: principles for moving from evidence to recommendations and decisions\", \"url\": \"https://experts.mcmaster.ca/display/publication3590750\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-083867\"}, {\"title\": \"Benchmarking domain-specific pretrained language models to identify the best model for methodological rigor in clinical studies.\", \"url\": \"https://experts.mcmaster.ca/display/publication3570978\", \"journal\": \"Journal of Biomedical Informatics\", \"year\": \"2025\", \"doi\": \"10.1016/j.jbi.2025.104825\"}, {\"title\": \"Core GRADE 6: presenting the evidence in summary of findings tables.\", \"url\": \"https://experts.mcmaster.ca/display/publication3587715\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-083866\"}, {\"title\": \"Core GRADE 5: rating certainty of evidence\\u2014assessing indirectness\", \"url\": \"https://experts.mcmaster.ca/display/publication3584132\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-083865\"}, {\"title\": \"Rating certainty when the target threshold is the null and the point estimate is close to the null.\", \"url\": \"https://experts.mcmaster.ca/display/publication3554782\", \"journal\": \"BMJ Evidence-Based Medicine\", \"year\": \"2025\", \"doi\": \"10.1136/bmjebm-2024-113077\"}, {\"title\": \"Core GRADE 4: rating certainty of evidence\\u2014risk of bias, publication bias, and reasons for rating up certainty\", \"url\": \"https://experts.mcmaster.ca/display/publication3582028\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-083864\"}, {\"title\": \"A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A.\", \"url\": \"https://experts.mcmaster.ca/display/publication3582044\", \"journal\": \"Haemophilia\", \"year\": \"2025\", \"doi\": \"10.1111/hae.70061\"}, {\"title\": \"Core GRADE 3: rating certainty of evidence\\u2014assessing inconsistency\", \"url\": \"https://experts.mcmaster.ca/display/publication3579501\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-081905\"}, {\"title\": \"Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling.\", \"url\": \"https://experts.mcmaster.ca/display/publication3558104\", \"journal\": \"Haemophilia\", \"year\": \"2025\", \"doi\": \"10.1111/hae.70021\"}, {\"title\": \"What You May Have Missed in 2024: Navigating New Medical Evidence.\", \"url\": \"https://experts.mcmaster.ca/display/publication3562693\", \"journal\": \"ACP journal club\", \"year\": \"2025\", \"doi\": \"10.7326/ANNALS-25-01164\"}, {\"title\": \"Core GRADE 2: choosing the target of certainty rating and assessing imprecision.\", \"url\": \"https://experts.mcmaster.ca/display/publication3576756\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-081904\"}, {\"title\": \"Core GRADE 1: overview of the Core GRADE approach.\", \"url\": \"https://experts.mcmaster.ca/display/publication3574383\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-081903\"}, {\"title\": \"Why Core GRADE is needed: introduction to a new series in The BMJ.\", \"url\": \"https://experts.mcmaster.ca/display/publication3569000\", \"journal\": \"The BMJ\", \"year\": \"2025\", \"doi\": \"10.1136/bmj-2024-081902\"}, {\"title\": \"Policies on artificial intelligence chatbots among academic publishers: a cross-sectional audit.\", \"url\": \"https://experts.mcmaster.ca/display/publication3546878\", \"journal\": \"Research Integrity and Peer Review\", \"year\": \"2025\", \"doi\": \"10.1186/s41073-025-00158-y\"}, {\"title\": \"Attitudes and perceptions of medical researchers towards the use of artificial intelligence chatbots in the scientific process: an international cross-sectional survey.\", \"url\": \"https://experts.mcmaster.ca/display/publication3489774\", \"journal\": \"The Lancet Digital Health\", \"year\": \"2025\", \"doi\": \"10.1016/S2589-7500(24)00202-4\"}, {\"title\": \"RWD150 First Patient Enrolled in Pilot Phase of the Economics and Patient Outcomes in China in Hemophilia (EPOCH) Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3520196\", \"journal\": \"Value in Health\", \"year\": \"2024\", \"doi\": \"10.1016/j.jval.2024.10.3708\"}, {\"title\": \"From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation\", \"url\": \"https://experts.mcmaster.ca/display/publication3506476\", \"journal\": \"Blood\", \"year\": \"2024\", \"doi\": \"10.1182/blood-2024-198579\"}, {\"title\": \"A mixed-methods survey and focus group study to understand researcher and clinician preferences for a Journal transparency Tool.\", \"url\": \"https://experts.mcmaster.ca/display/publication3486229\", \"journal\": \"Scientific Reports\", \"year\": \"2024\", \"doi\": \"10.1038/s41598-024-77790-z\"}, {\"title\": \"Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.\", \"url\": \"https://experts.mcmaster.ca/display/publication3474659\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2024\", \"doi\": \"10.1056/NEJMoa2302982\"}, {\"title\": \"Thrombophilia testing: does practice follow guidelines?\", \"url\": \"https://experts.mcmaster.ca/display/publication3474660\", \"journal\": \"Blood Advances\", \"year\": \"2024\", \"doi\": \"10.1182/bloodadvances.2024013478\"}, {\"title\": \"Boosting efficiency in a clinical literature surveillance system with LightGBM.\", \"url\": \"https://experts.mcmaster.ca/display/publication3472557\", \"journal\": \"PLOS Digital Health\", \"year\": \"2024\", \"doi\": \"10.1371/journal.pdig.0000299\"}, {\"title\": \"The McMaster Health Information Research Unit: Over a Quarter-Century of Health Informatics Supporting Evidence-Based Medicine\", \"url\": \"https://experts.mcmaster.ca/display/publication3450481\", \"journal\": \"Journal of Medical Internet Research\", \"year\": \"2024\", \"doi\": \"10.2196/58764\"}, {\"title\": \"Kinetic Modeling for BT200 to Predict the Level of Plasma-Derived Coagulation Factor VIII in Humans\", \"url\": \"https://experts.mcmaster.ca/display/publication3452076\", \"journal\": \"AAPS PharmSciTech\", \"year\": \"2024\", \"doi\": \"10.1208/s12248-024-00952-4\"}, {\"title\": \"Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS\\u2010Hemo platform\", \"url\": \"https://experts.mcmaster.ca/display/publication3429329\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.15027\"}, {\"title\": \"Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi\\u2010country severe WAPPS\\u2010Hemo haemophilia patients\", \"url\": \"https://experts.mcmaster.ca/display/publication3429328\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.15032\"}, {\"title\": \"Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication3450418\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2024\", \"doi\": \"10.1016/j.jtha.2024.07.002\"}, {\"title\": \"GRADE concept paper 8: judging the certainty of discrimination performance estimates of prognostic models in a body of validation studies\", \"url\": \"https://experts.mcmaster.ca/display/publication3413027\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2024\", \"doi\": \"10.1016/j.jclinepi.2024.111344\"}, {\"title\": \"Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate\", \"url\": \"https://experts.mcmaster.ca/display/publication3447909\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2024\", \"doi\": \"10.1016/j.jtha.2024.06.015\"}, {\"title\": \"Scoping review of the recommendations and guidance for improving the quality of rare disease registries\", \"url\": \"https://experts.mcmaster.ca/display/publication3428521\", \"journal\": \"Orphanet Journal of Rare Diseases\", \"year\": \"2024\", \"doi\": \"10.1186/s13023-024-03193-y\"}, {\"title\": \"Health utilities in adults with hemophilia A: A retrospective cohort study\", \"url\": \"https://experts.mcmaster.ca/display/publication3410784\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.14979\"}, {\"title\": \"Protocol for the development of the Chatbot Assessment Reporting Tool (CHART) for clinical advice\", \"url\": \"https://experts.mcmaster.ca/display/publication3450342\", \"journal\": \"BMJ Open\", \"year\": \"2024\", \"doi\": \"10.1136/bmjopen-2023-081155\"}, {\"title\": \"What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence\", \"url\": \"https://experts.mcmaster.ca/display/publication3414586\", \"journal\": \"ACP journal club\", \"year\": \"2024\", \"doi\": \"10.7326/m24-0832\"}, {\"title\": \"Lower-dose emicizumab prophylaxis: can less be more?\", \"url\": \"https://experts.mcmaster.ca/display/publication3410430\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2024\", \"doi\": \"10.1016/j.jtha.2024.01.018\"}, {\"title\": \"Canadian clinical experience on switching from standard half\\u2010life recombinant factor VIII (rFVIII), octocog alfa, to extended half\\u2010life rFVIII, damoctocog alfa pegol, in persons with haemophilia A \\u2265 12 years followed in a Comprehensive Hemophilia Care Program in Canada\", \"url\": \"https://experts.mcmaster.ca/display/publication3401766\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.14960\"}, {\"title\": \"GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists\", \"url\": \"https://experts.mcmaster.ca/display/publication3383056\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2024\", \"doi\": \"10.1016/j.jclinepi.2023.111241\"}, {\"title\": \"Publisher preferences for a journal transparency tool: A modified three-round Delphi study.\", \"url\": \"https://experts.mcmaster.ca/display/publication3557719\", \"journal\": \"F1000Prime Reports\", \"year\": \"2024\", \"doi\": \"10.12688/f1000research.154408.2\"}, {\"title\": \"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing\", \"url\": \"https://experts.mcmaster.ca/display/publication3234482\", \"journal\": \"Blood Advances\", \"year\": \"2023\", \"doi\": \"10.1182/bloodadvances.2023010177\"}, {\"title\": \"Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada\", \"url\": \"https://experts.mcmaster.ca/display/publication3320151\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.102265\"}, {\"title\": \"The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients\", \"url\": \"https://experts.mcmaster.ca/display/publication3384977\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.102264\"}, {\"title\": \"Impact of strategies to mitigate misinformation in diverse settings and populations: a protocol for a living evidence synthesis\", \"url\": \"https://experts.mcmaster.ca/display/publication3300566\", \"journal\": \"BMJ Open\", \"year\": \"2023\", \"doi\": \"10.1136/bmjopen-2023-076672\"}, {\"title\": \"Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study\", \"url\": \"https://experts.mcmaster.ca/display/publication3307056\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.102228\"}, {\"title\": \"OC 06.5 Use of Emicizumab for the Treatment of Acquired Hemophilia A: A Systematic Review\", \"url\": \"https://experts.mcmaster.ca/display/publication3461835\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.100462\"}, {\"title\": \"OC 20.5 The WFH Gene Therapy Registry: A Collaborative Approach Towards a Global Resource for the Long-Term Follow-up of People with Hemophilia Treated with Gene Therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication3461836\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.100445\"}, {\"title\": \"OC 24.1 Effect of the Type of F9 Mutation on the Pharmacokinetic Profile of Patients with Hemophilia B Treated with Extended Half-Life FIX Concentrates\", \"url\": \"https://experts.mcmaster.ca/display/publication3461837\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.100443\"}, {\"title\": \"OC 24.2 Estimated Factor VIII Activity Levels at the Time of Bleeding Events in Individuals with Hemophilia a Without Inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication3461839\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.100436\"}, {\"title\": \"OC 24.4 Effect of F8 Mutations and Von Willebrand Factor on Pharmacokinetics of FVIII Concentrates in Severe Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication3461838\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.100438\"}, {\"title\": \"PB0175 Impact of Reagent on the Estimation of Eloctate and Adynovate Pharmacokinetic (PK) Parameters?\", \"url\": \"https://experts.mcmaster.ca/display/publication3461834\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.101061\"}, {\"title\": \"PB0191 myGTR: A Patient Engagement Tool from the World Federation of Hemophilia Gene Therapy Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication3461831\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.101212\"}, {\"title\": \"PB0644 Evaluation of the Burden of Bone Fractures in People Living with Hemophilia: A Registry-Based Case-Control Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3461832\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.101184\"}, {\"title\": \"PB0661 Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Canadian Patients with Hemophilia A: Interim Results from the HEM-POWR Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3461833\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.101178\"}, {\"title\": \"PB0827 WFH World Bleeding Disorders Registry Launches the First Global Data Collection on People with von Willebrand Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication3461828\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.101579\"}, {\"title\": \"PB0837 Analysis of the Change in Diagnosis of von Willebrand Disease by Region and Economic Status\", \"url\": \"https://experts.mcmaster.ca/display/publication3461829\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.101562\"}, {\"title\": \"PB1392 Late Diagnosis of Two Adult Siblings with Bernard Soulier Syndrome (BSS)\", \"url\": \"https://experts.mcmaster.ca/display/publication3461830\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.101516\"}, {\"title\": \"Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness\", \"url\": \"https://experts.mcmaster.ca/display/publication3291906\", \"journal\": \"Vaccine\", \"year\": \"2023\", \"doi\": \"10.1016/j.vaccine.2023.09.012\"}, {\"title\": \"Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review\", \"url\": \"https://experts.mcmaster.ca/display/publication3247183\", \"journal\": \"Haemophilia\", \"year\": \"2023\", \"doi\": \"10.1111/hae.14803\"}, {\"title\": \"Reported prevalence of von Willebrand disease worldwide in relation to income classification\", \"url\": \"https://experts.mcmaster.ca/display/publication3251275\", \"journal\": \"Haemophilia\", \"year\": \"2023\", \"doi\": \"10.1111/hae.14810\"}, {\"title\": \"Von Willebrand Disease: Gaining a global perspective\", \"url\": \"https://experts.mcmaster.ca/display/publication3238619\", \"journal\": \"Haemophilia\", \"year\": \"2023\", \"doi\": \"10.1111/hae.14804\"}, {\"title\": \"Deep learning to refine the identification of high-quality clinical research articles from the biomedical literature: Performance evaluation\", \"url\": \"https://experts.mcmaster.ca/display/publication3236692\", \"journal\": \"Journal of Biomedical Informatics\", \"year\": \"2023\", \"doi\": \"10.1016/j.jbi.2023.104384\"}, {\"title\": \"GRADE guidance 36: updates to GRADE's approach to addressing inconsistency\", \"url\": \"https://experts.mcmaster.ca/display/publication2951096\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2023\", \"doi\": \"10.1016/j.jclinepi.2023.03.003\"}, {\"title\": \"Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance\", \"url\": \"https://experts.mcmaster.ca/display/publication2184076\", \"journal\": \"BMJ Evidence-Based Medicine\", \"year\": \"2023\", \"doi\": \"10.1136/bmjebm-2022-111962\"}, {\"title\": \"The von Willebrand factor\\u2013binding aptamer rondaptivon pegol as a treatment for severe and\\u00a0nonsevere hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication2431117\", \"journal\": \"Blood\", \"year\": \"2023\", \"doi\": \"10.1182/blood.2022016571\"}, {\"title\": \"Cost\\u2010utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada\", \"url\": \"https://experts.mcmaster.ca/display/publication2632548\", \"journal\": \"Haemophilia\", \"year\": \"2023\", \"doi\": \"10.1111/hae.14723\"}, {\"title\": \"Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication3068251\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2023.100106\"}, {\"title\": \"Prevalence of selected bleeding and thrombotic events in\\u00a0persons with hemophilia versus the general population: A\\u00a0scoping review\", \"url\": \"https://experts.mcmaster.ca/display/publication2952021\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2023\", \"doi\": \"10.1016/j.rpth.2022.100007\"}, {\"title\": \"Prophylaxis use of clotting factor replacement products in people with non\\u2010severe haemophilia: A review of the literature\", \"url\": \"https://experts.mcmaster.ca/display/publication2440132\", \"journal\": \"Haemophilia\", \"year\": \"2023\", \"doi\": \"10.1111/hae.14676\"}, {\"title\": \"Recommendations and guidelines for creating scholarly biomedical journals: A scoping review\", \"url\": \"https://experts.mcmaster.ca/display/publication3067556\", \"journal\": \"PLoS ONE\", \"year\": \"2023\", \"doi\": \"10.1371/journal.pone.0282168\"}, {\"title\": \"Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia\", \"url\": \"https://experts.mcmaster.ca/display/publication2430999\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2022\", \"doi\": \"10.1111/jth.15885\"}, {\"title\": \"Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal\", \"url\": \"https://experts.mcmaster.ca/display/publication2184075\", \"journal\": \"BMJ Evidence-Based Medicine\", \"year\": \"2022\", \"doi\": \"10.1136/bmjebm-2021-111866\"}, {\"title\": \"Switching from standard to extended half\\u2010life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics\", \"url\": \"https://experts.mcmaster.ca/display/publication2424750\", \"journal\": \"Haemophilia\", \"year\": \"2022\", \"doi\": \"10.1111/hae.14649\"}, {\"title\": \"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach\", \"url\": \"https://experts.mcmaster.ca/display/publication2428181\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2022\", \"doi\": \"10.1016/j.jclinepi.2022.07.014\"}, {\"title\": \"GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions\", \"url\": \"https://experts.mcmaster.ca/display/publication2435789\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2022\", \"doi\": \"10.1016/j.jclinepi.2022.07.015\"}, {\"title\": \"Overall prognosis of preschool autism spectrum disorder diagnoses\", \"url\": \"https://experts.mcmaster.ca/display/publication2441907\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2022\", \"doi\": \"10.1002/14651858.cd012749.pub2\"}, {\"title\": \"A personalized limited sampling approach to better estimate terminal half\\u2010life of FVIII concentrates\", \"url\": \"https://experts.mcmaster.ca/display/publication2294458\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2022\", \"doi\": \"10.1111/jth.15803\"}, {\"title\": \"A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map\", \"url\": \"https://experts.mcmaster.ca/display/publication2192610\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2022\", \"doi\": \"10.1016/j.jclinepi.2022.04.012\"}, {\"title\": \"An evaluation of the COVID-19 recommendation map identified diverging clinical and public health guidance\", \"url\": \"https://experts.mcmaster.ca/display/publication2188998\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2022\", \"doi\": \"10.1016/j.jclinepi.2022.03.008\"}, {\"title\": \"EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication2716673\", \"journal\": \"Value in Health\", \"year\": \"2022\", \"doi\": \"10.1016/j.jval.2022.04.724\"}, {\"title\": \"von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient\\u2010derived endothelial colony\\u2010forming cells\", \"url\": \"https://experts.mcmaster.ca/display/publication2188703\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2022\", \"doi\": \"10.1111/jth.15740\"}, {\"title\": \"Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature\", \"url\": \"https://experts.mcmaster.ca/display/publication2182254\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2022\", \"doi\": \"10.1111/jth.15723\"}, {\"title\": \"Emicizumab state\\u2010of\\u2010the\\u2010art update\", \"url\": \"https://experts.mcmaster.ca/display/publication2188827\", \"journal\": \"Haemophilia\", \"year\": \"2022\", \"doi\": \"10.1111/hae.14524\"}, {\"title\": \"Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19\", \"url\": \"https://experts.mcmaster.ca/display/publication2188857\", \"journal\": \"Vaccine\", \"year\": \"2022\", \"doi\": \"10.1016/j.vaccine.2022.04.005\"}, {\"title\": \"Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication2182322\", \"journal\": \"HemaSphere\", \"year\": \"2022\", \"doi\": \"10.1097/hs9.0000000000000694\"}, {\"title\": \"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study\", \"url\": \"https://experts.mcmaster.ca/display/publication2172480\", \"journal\": \"JMIR Human Factors\", \"year\": \"2022\", \"doi\": \"10.2196/30797\"}, {\"title\": \"GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies\", \"url\": \"https://experts.mcmaster.ca/display/publication2157243\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2022\", \"doi\": \"10.1016/j.jclinepi.2021.11.024\"}, {\"title\": \"New methods facilitated the process of prioritizing questions and health outcomes in guideline development\", \"url\": \"https://experts.mcmaster.ca/display/publication2157242\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2022\", \"doi\": \"10.1016/j.jclinepi.2021.11.031\"}, {\"title\": \"Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real\\u2010world, multicenter, retrospective study\", \"url\": \"https://experts.mcmaster.ca/display/publication2180875\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2022\", \"doi\": \"10.1002/rth2.12661\"}, {\"title\": \"Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication2158375\", \"journal\": \"European Journal of Haematology\", \"year\": \"2022\", \"doi\": \"10.1111/ejh.13731\"}, {\"title\": \"Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature\", \"url\": \"https://experts.mcmaster.ca/display/publication2163956\", \"journal\": \"Journal of Medical Internet Research\", \"year\": \"2022\", \"doi\": \"10.2196/30791\"}, {\"title\": \"A taxonomy and framework for identifying and developing actionable statements in guidelines suggests avoiding informal recommendations\", \"url\": \"https://experts.mcmaster.ca/display/publication2142168\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2022\", \"doi\": \"10.1016/j.jclinepi.2021.09.028\"}, {\"title\": \"POSC37 Economic Cost of Treatment in Canada: A Multi-Centre, Retrospective Study\", \"url\": \"https://experts.mcmaster.ca/display/publication2429733\", \"journal\": \"Value in Health\", \"year\": \"2022\", \"doi\": \"10.1016/j.jval.2021.11.442\"}, {\"title\": \"Sexual issues in people with haemophilia: Awareness and strategies for overcoming communication barriers\", \"url\": \"https://experts.mcmaster.ca/display/publication2146388\", \"journal\": \"Haemophilia\", \"year\": \"2022\", \"doi\": \"10.1111/hae.14447\"}, {\"title\": \"Knowledge translation strategies for sharing evidence-based health information with older adults and their caregivers: findings from a persona-scenario method\", \"url\": \"https://experts.mcmaster.ca/display/publication2149454\", \"journal\": \"BMC Geriatrics\", \"year\": \"2021\", \"doi\": \"10.1186/s12877-021-02588-x\"}, {\"title\": \"A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation\", \"url\": \"https://experts.mcmaster.ca/display/publication2149453\", \"journal\": \"JMIR Research Protocols\", \"year\": \"2021\", \"doi\": \"10.2196/29398\"}, {\"title\": \"How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines\", \"url\": \"https://experts.mcmaster.ca/display/publication2126643\", \"journal\": \"Blood Advances\", \"year\": \"2021\", \"doi\": \"10.1182/bloodadvances.2020003577\"}, {\"title\": \"Evaluation of the sexual health in people living with hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication2129783\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14410\"}, {\"title\": \"Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines\", \"url\": \"https://experts.mcmaster.ca/display/publication1969571\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2021\", \"doi\": \"10.1016/j.jclinepi.2021.04.016\"}, {\"title\": \"External qualification of the Web\\u2010Accessible Population Pharmacokinetic Service\\u2013Hemophilia (WAPPS\\u2010Hemo) models for octocog alfa using real patient data\", \"url\": \"https://experts.mcmaster.ca/display/publication2146886\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2021\", \"doi\": \"10.1002/rth2.12599\"}, {\"title\": \"The impact of extended half\\u2010life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B\", \"url\": \"https://experts.mcmaster.ca/display/publication2142105\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2021\", \"doi\": \"10.1002/rth2.12601\"}, {\"title\": \"Machine Learning Approaches to Retrieve High-Quality, Clinically Relevant Evidence From the Biomedical Literature: Systematic Review\", \"url\": \"https://experts.mcmaster.ca/display/publication2126644\", \"journal\": \"JMIR Medical Informatics\", \"year\": \"2021\", \"doi\": \"10.2196/30401\"}, {\"title\": \"Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time\", \"url\": \"https://experts.mcmaster.ca/display/publication1984959\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14364\"}, {\"title\": \"Factor product utilization and health outcomes in patients with haemophilia A and B on extended half\\u2010life concentrates: A Canadian observational study of real\\u2010world outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication1984960\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14369\"}, {\"title\": \"Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B\", \"url\": \"https://experts.mcmaster.ca/display/publication2126820\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2021\", \"doi\": \"10.1002/14651858.cd014201\"}, {\"title\": \"Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference\", \"url\": \"https://experts.mcmaster.ca/display/publication1970639\", \"journal\": \"Journal of Trauma and Acute Care Surgery\", \"year\": \"2021\", \"doi\": \"10.1097/ta.0000000000003300\"}, {\"title\": \"Terminal half\\u2010life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database\", \"url\": \"https://experts.mcmaster.ca/display/publication1970638\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2021\", \"doi\": \"10.1111/jth.15395\"}, {\"title\": \"Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1958635\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14268\"}, {\"title\": \"Comparison of single subject and population\\u2010based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1969089\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14329\"}, {\"title\": \"Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication2142041\", \"year\": \"2021\", \"doi\": \"10.2196/preprints.30791\"}, {\"title\": \"Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation\", \"url\": \"https://experts.mcmaster.ca/display/publication1910784\", \"journal\": \"European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy\", \"year\": \"2021\", \"doi\": \"10.1093/ehjcvp/pvaa052\"}, {\"title\": \"Patient\\u2010relevant health outcomes for hemophilia care: Development of an international standard outcomes set\", \"url\": \"https://experts.mcmaster.ca/display/publication1963914\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2021\", \"doi\": \"10.1002/rth2.12488\"}, {\"title\": \"Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study\", \"url\": \"https://experts.mcmaster.ca/display/publication1961033\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14292\"}, {\"title\": \"Optimizing a literature surveillance strategy to retrieve sound overall prognosis and risk assessment model papers\", \"url\": \"https://experts.mcmaster.ca/display/publication1957420\", \"journal\": \"Journal of the American Medical Informatics Association : JAMIA\", \"year\": \"2021\", \"doi\": \"10.1093/jamia/ocaa232\"}, {\"title\": \"Derivation of a Pharmacokinetic Model to Include a Plasma-Derived, von Willebrand Factor-Containing Factor VIII (Koate\\u00ae-DVI) Concentrate and its Low-Dose Use\", \"url\": \"https://experts.mcmaster.ca/display/publication2152493\", \"journal\": \"Clinical Medicine Insights: Blood Disorders\", \"year\": \"2021\", \"doi\": \"10.1177/26348535211062229\"}, {\"title\": \"GRADE Concept Paper 1: Validating the \\u201cF.A.C.E\\u201d instrument using stakeholder perceptions of feasibility, acceptability, cost, and equity in guideline implement\", \"url\": \"https://experts.mcmaster.ca/display/publication1943041\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2021\", \"doi\": \"10.1016/j.jclinepi.2020.11.018\"}, {\"title\": \"Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication1959646\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14247\"}, {\"title\": \"Extended half\\u2010life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products\", \"url\": \"https://experts.mcmaster.ca/display/publication1961440\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2021\", \"doi\": \"10.1002/rth2.12476\"}, {\"title\": \"Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000\\u201318: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database\", \"url\": \"https://experts.mcmaster.ca/display/publication1936479\", \"journal\": \"The Lancet Respiratory Medicine\", \"year\": \"2021\", \"doi\": \"10.1016/s2213-2600(20)30417-3\"}, {\"title\": \"Interventions to Influence Opioid Prescribing Practices for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1939077\", \"journal\": \"American Journal of Preventive Medicine\", \"year\": \"2021\", \"doi\": \"10.1016/j.amepre.2020.07.012\"}, {\"title\": \"Non\\u2010severe haemophilia: Is it benign? \\u2013 Insights from the PROBE study\", \"url\": \"https://experts.mcmaster.ca/display/publication1923964\", \"journal\": \"Haemophilia\", \"year\": \"2021\", \"doi\": \"10.1111/hae.14105\"}, {\"title\": \"A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients\", \"url\": \"https://experts.mcmaster.ca/display/publication1937724\", \"journal\": \"Thrombosis Research\", \"year\": \"2020\", \"doi\": \"10.1016/j.thromres.2020.10.024\"}, {\"title\": \"Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide\", \"url\": \"https://experts.mcmaster.ca/display/publication1895932\", \"journal\": \"BMC Medical Research Methodology\", \"year\": \"2020\", \"doi\": \"10.1186/s12874-020-00964-6\"}, {\"title\": \"Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults\", \"url\": \"https://experts.mcmaster.ca/display/publication1940446\", \"journal\": \"BMJ Open\", \"year\": \"2020\", \"doi\": \"10.1136/bmjopen-2020-040122\"}, {\"title\": \"Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company\", \"url\": \"https://experts.mcmaster.ca/display/publication1936087\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14144\"}, {\"title\": \"Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH\", \"url\": \"https://experts.mcmaster.ca/display/publication1937783\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2020\", \"doi\": \"10.1111/jth.15023\"}, {\"title\": \"Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1928352\", \"journal\": \"Annals of Hematology\", \"year\": \"2020\", \"doi\": \"10.1007/s00277-020-04280-3\"}, {\"title\": \"Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews\", \"url\": \"https://experts.mcmaster.ca/display/publication1934644\", \"journal\": \"Blood Advances\", \"year\": \"2020\", \"doi\": \"10.1182/bloodadvances.2020002482\"}, {\"title\": \"Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1927366\", \"journal\": \"The Lancet Haematology\", \"year\": \"2020\", \"doi\": \"10.1016/s2352-3026(20)30293-3\"}, {\"title\": \"Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura\", \"url\": \"https://experts.mcmaster.ca/display/publication1926003\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2020\", \"doi\": \"10.1111/jth.15009\"}, {\"title\": \"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura\", \"url\": \"https://experts.mcmaster.ca/display/publication1926001\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2020\", \"doi\": \"10.1111/jth.15006\"}, {\"title\": \"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura\", \"url\": \"https://experts.mcmaster.ca/display/publication1926002\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2020\", \"doi\": \"10.1111/jth.15010\"}, {\"title\": \"COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine\", \"url\": \"https://experts.mcmaster.ca/display/publication1813096\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2020\", \"doi\": \"10.1016/j.jclinepi.2020.04.016\"}, {\"title\": \"The World Federation of Hemophilia Annual Global Survey 1999\\u20102018\", \"url\": \"https://experts.mcmaster.ca/display/publication1914356\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14012\"}, {\"title\": \"World Federation of Hemophilia Gene Therapy Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication1910847\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.14015\"}, {\"title\": \"Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment\", \"url\": \"https://experts.mcmaster.ca/display/publication1915840\", \"journal\": \"Blood Advances\", \"year\": \"2020\", \"doi\": \"10.1182/bloodadvances.2020001937\"}, {\"title\": \"Context and Approach in Reporting Evaluations of Electronic Health Record\\u2013Based Implementation Projects\", \"url\": \"https://experts.mcmaster.ca/display/publication1914539\", \"journal\": \"ACP journal club\", \"year\": \"2020\", \"doi\": \"10.7326/m19-0874\"}, {\"title\": \"Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences\", \"url\": \"https://experts.mcmaster.ca/display/publication1910855\", \"journal\": \"Blood Advances\", \"year\": \"2020\", \"doi\": \"10.1182/bloodadvances.2020001768\"}, {\"title\": \"Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1695519\", \"journal\": \"Blood\", \"year\": \"2020\", \"doi\": \"10.1182/blood.2019003603\"}, {\"title\": \"Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS\\u2010Hemo project\", \"url\": \"https://experts.mcmaster.ca/display/publication1703986\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.13977\"}, {\"title\": \"Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach\", \"url\": \"https://experts.mcmaster.ca/display/publication1681631\", \"journal\": \"Clinical Pharmacokinetics\", \"year\": \"2020\", \"doi\": \"10.1007/s40262-019-00832-7\"}, {\"title\": \"GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks\", \"url\": \"https://experts.mcmaster.ca/display/publication1688441\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2020\", \"doi\": \"10.1016/j.jclinepi.2019.12.023\"}, {\"title\": \"Prescriber adherence to guidelines for chronic noncancer pain management with opioids: Systematic review and meta-analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication1689177\", \"journal\": \"Health Psychology\", \"year\": \"2020\", \"doi\": \"10.1037/hea0000830\"}, {\"title\": \"Translating Clinical Questions by Physicians Into Searchable Queries: Analytical Survey Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1813227\", \"journal\": \"JMIR Medical Education\", \"year\": \"2020\", \"doi\": \"10.2196/16777\"}, {\"title\": \"Psychological interventions for people with hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1699203\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2020\", \"doi\": \"10.1002/14651858.cd010215.pub2\"}, {\"title\": \"Multicentre pharmacokinetic evaluation of rFVIII\\u2010Fc (efmoroctocog alfa) in a real life and comparison with non\\u2010extended half\\u2010life FVIII concentrates\", \"url\": \"https://experts.mcmaster.ca/display/publication1697012\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.13946\"}, {\"title\": \"Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate\\u00ae): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup\", \"url\": \"https://experts.mcmaster.ca/display/publication1661992\", \"journal\": \"Clinical Pharmacokinetics\", \"year\": \"2020\", \"doi\": \"10.1007/s40262-019-00809-6\"}, {\"title\": \"Pharmacokinetic\\u2010tailored approach to hemophilia prophylaxis: Medical decision making and outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication1696362\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2020\", \"doi\": \"10.1002/rth2.12305\"}, {\"title\": \"Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest\", \"url\": \"https://experts.mcmaster.ca/display/publication1669971\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2020\", \"doi\": \"10.1016/j.jclinepi.2019.08.012\"}, {\"title\": \"Clinical application of Web Accessible Population Pharmacokinetic Service\\u2014Hemophilia (WAPPS\\u2010Hemo): Patterns of blood sampling and patient characteristics among clinician users\", \"url\": \"https://experts.mcmaster.ca/display/publication1681632\", \"journal\": \"Haemophilia\", \"year\": \"2020\", \"doi\": \"10.1111/hae.13882\"}, {\"title\": \"Predictors of treatment adherence in patients with chronic disease using the Multidimensional Adherence Model: unique considerations for patients with haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1973952\", \"journal\": \"The Journal of Haemophilia Practice\", \"year\": \"2020\", \"doi\": \"10.17225/jhp00152\"}, {\"title\": \"The eCOVID-19 living recommendations map and gateway to contextualisation\", \"url\": \"https://experts.mcmaster.ca/display/publication2187515\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2020\"}, {\"title\": \"Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1\", \"url\": \"https://experts.mcmaster.ca/display/publication1813481\", \"journal\": \"Frontiers in Immunology\", \"year\": \"2020\", \"doi\": \"10.3389/fimmu.2020.00620\"}, {\"title\": \"A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients\", \"url\": \"https://experts.mcmaster.ca/display/publication1678145\", \"journal\": \"Thrombosis Research\", \"year\": \"2019\", \"doi\": \"10.1016/j.thromres.2019.10.023\"}, {\"title\": \"Strategies for eliciting and synthesizing evidence for guidelines in rare diseases\", \"url\": \"https://experts.mcmaster.ca/display/publication1635403\", \"journal\": \"BMC Medical Research Methodology\", \"year\": \"2019\", \"doi\": \"10.1186/s12874-019-0713-0\"}, {\"title\": \"Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide\", \"url\": \"https://experts.mcmaster.ca/display/publication2951105\", \"year\": \"2019\", \"doi\": \"10.21203/rs.2.16277/v1\"}, {\"title\": \"Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males\", \"url\": \"https://experts.mcmaster.ca/display/publication1666149\", \"journal\": \"ACP journal club\", \"year\": \"2019\", \"doi\": \"10.7326/m19-1208\"}, {\"title\": \"Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients\", \"url\": \"https://experts.mcmaster.ca/display/publication1655187\", \"journal\": \"Journal of Pharmacokinetics and Pharmacodynamics\", \"year\": \"2019\", \"doi\": \"10.1007/s10928-019-09647-2\"}, {\"title\": \"Corrigendum\", \"url\": \"https://experts.mcmaster.ca/display/publication3278902\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1002/rth2.12258\"}, {\"title\": \"Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins\", \"url\": \"https://experts.mcmaster.ca/display/publication1659327\", \"journal\": \"Microporous and Mesoporous Materials\", \"year\": \"2019\", \"doi\": \"10.1016/j.micromeso.2019.06.005\"}, {\"title\": \"A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication1629929\", \"journal\": \"Blood Transfusion\", \"year\": \"2019\", \"doi\": \"10.2450/2019.0183-18\"}, {\"title\": \"Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1647169\", \"journal\": \"Annals of Hematology\", \"year\": \"2019\", \"doi\": \"10.1007/s00277-019-03747-2\"}, {\"title\": \"Home therapy for inherited bleeding disorders in South Africa: Results of a modified Delphi consensus process\", \"url\": \"https://experts.mcmaster.ca/display/publication1666128\", \"journal\": \"SAMJ - South African Medical Journal\", \"year\": \"2019\", \"doi\": \"10.7196/samj.2019.v109i9.13637\"}, {\"title\": \"[Population pharmacokinetics of two recombinant human coagulation factor \\u2167 preparations in patients with hemophilia A].\", \"url\": \"https://experts.mcmaster.ca/display/publication1666148\", \"journal\": \"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\", \"year\": \"2019\", \"doi\": \"10.3760/cma.j.issn.0253-2727.2019.08.009\"}, {\"title\": \"Emicizumab and thrombosis: The story so far\", \"url\": \"https://experts.mcmaster.ca/display/publication1659325\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1111/jth.14556\"}, {\"title\": \"Comparative pharmacokinetics of two extended half\\u2010life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?\", \"url\": \"https://experts.mcmaster.ca/display/publication1640175\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1111/jth.14469\"}, {\"title\": \"Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review\", \"url\": \"https://experts.mcmaster.ca/display/publication1652668\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1002/rth2.12204\"}, {\"title\": \"The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods\", \"url\": \"https://experts.mcmaster.ca/display/publication1644760\", \"journal\": \"ACP journal club\", \"year\": \"2019\", \"doi\": \"10.7326/m18-3290\"}, {\"title\": \"Defining certainty of net benefit: a GRADE concept paper\", \"url\": \"https://experts.mcmaster.ca/display/publication1644704\", \"journal\": \"BMJ Open\", \"year\": \"2019\", \"doi\": \"10.1136/bmjopen-2018-027445\"}, {\"title\": \"The association between platelet transfusions and mortality in patients with critical illness\", \"url\": \"https://experts.mcmaster.ca/display/publication1635948\", \"journal\": \"Transfusion\", \"year\": \"2019\", \"doi\": \"10.1111/trf.15277\"}, {\"title\": \"An evidence rating service provided valid correlates of the clinical importance of medical articles and journals\", \"url\": \"https://experts.mcmaster.ca/display/publication1626298\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2019\", \"doi\": \"10.1016/j.jclinepi.2019.01.010\"}, {\"title\": \"Exploring regional variations in the cross\\u2010cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study\", \"url\": \"https://experts.mcmaster.ca/display/publication1634148\", \"journal\": \"Haemophilia\", \"year\": \"2019\", \"doi\": \"10.1111/hae.13703\"}, {\"title\": \"Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians\", \"url\": \"https://experts.mcmaster.ca/display/publication1637355\", \"journal\": \"ACP journal club\", \"year\": \"2019\", \"doi\": \"10.7326/m18-2147\"}, {\"title\": \"Hemophilia trials in the twenty\\u2010first century: Defining patient important outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication1639469\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1002/rth2.12195\"}, {\"title\": \"Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1626297\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1055/s-0039-1677700\"}, {\"title\": \"Switching patients in the age of long-acting recombinant products?\", \"url\": \"https://experts.mcmaster.ca/display/publication1626302\", \"journal\": \"Expert Review of Hematology\", \"year\": \"2019\", \"doi\": \"10.1080/17474086.2018.1564032\"}, {\"title\": \"Joint Bleeding Tendencies in Adult Patients With Hemophilia: It\\u2019s Not All Pharmacokinetics\", \"url\": \"https://experts.mcmaster.ca/display/publication1652661\", \"journal\": \"Clinical and Applied Thrombosis/Hemostasis\", \"year\": \"2019\", \"doi\": \"10.1177/1076029619862052\"}, {\"title\": \"PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies\", \"url\": \"https://experts.mcmaster.ca/display/publication1619765\", \"journal\": \"ACP journal club\", \"year\": \"2019\", \"doi\": \"10.7326/m18-1376\"}, {\"title\": \"Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population?\", \"url\": \"https://experts.mcmaster.ca/display/publication1623217\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2019\", \"doi\": \"10.1002/rth2.12172\"}, {\"title\": \"Test\\u2010retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains\", \"url\": \"https://experts.mcmaster.ca/display/publication1612046\", \"journal\": \"Haemophilia\", \"year\": \"2019\", \"doi\": \"10.1111/hae.13649\"}, {\"title\": \"Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication1608513\", \"journal\": \"Systematic Reviews\", \"year\": \"2018\", \"doi\": \"10.1186/s13643-018-0858-7\"}, {\"title\": \"The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1505309\", \"journal\": \"Pilot and Feasibility Studies\", \"year\": \"2018\", \"doi\": \"10.1186/s40814-018-0253-0\"}, {\"title\": \"The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1586628\", \"journal\": \"Thrombosis Research\", \"year\": \"2018\", \"doi\": \"10.1016/j.thromres.2018.08.004\"}, {\"title\": \"Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age\\u2010matched controls\", \"url\": \"https://experts.mcmaster.ca/display/publication1586461\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13595\"}, {\"title\": \"Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire\", \"url\": \"https://experts.mcmaster.ca/display/publication1584362\", \"journal\": \"BMJ Open\", \"year\": \"2018\", \"doi\": \"10.1136/bmjopen-2018-021900\"}, {\"title\": \"Core outcome set for gene therapy in haemophilia: Results of the coreHEMmultistakeholder project\", \"url\": \"https://experts.mcmaster.ca/display/publication1534544\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13504\"}, {\"title\": \"Focusing in on use of pharmacokinetic profiles in routine hemophilia care\", \"url\": \"https://experts.mcmaster.ca/display/publication1572639\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2018\", \"doi\": \"10.1002/rth2.12118\"}, {\"title\": \"Haemophilia clinical care and research needs: Assessing priorities\", \"url\": \"https://experts.mcmaster.ca/display/publication1570430\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13544\"}, {\"title\": \"Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations\", \"url\": \"https://experts.mcmaster.ca/display/publication1580738\", \"journal\": \"Research and Practice in Thrombosis and Haemostasis\", \"year\": \"2018\", \"doi\": \"10.1002/rth2.12106\"}, {\"title\": \"Pharmacokinetics and the transition to extended half\\u2010life factor concentrates: communication from the SSC of the ISTH\", \"url\": \"https://experts.mcmaster.ca/display/publication1534560\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2018\", \"doi\": \"10.1111/jth.14153\"}, {\"title\": \"A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1560121\", \"journal\": \"Journal of Medical Internet Research\", \"year\": \"2018\", \"doi\": \"10.2196/10281\"}, {\"title\": \"Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication1553139\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13489\"}, {\"title\": \"Point\\u2010of\\u2010care ultrasonography in haemophilia care: Training and competency for muscular haematomas\", \"url\": \"https://experts.mcmaster.ca/display/publication1505307\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13417\"}, {\"title\": \"World bleeding disorders registry: The pilot study\", \"url\": \"https://experts.mcmaster.ca/display/publication1496730\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13431\"}, {\"title\": \"Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.\", \"url\": \"https://experts.mcmaster.ca/display/publication3461856\", \"journal\": \"ACP journal club\", \"year\": \"2018\", \"doi\": \"10.7326/M17-0939\"}, {\"title\": \"Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism\", \"url\": \"https://experts.mcmaster.ca/display/publication1486915\", \"journal\": \"American Journal of Medicine\", \"year\": \"2018\", \"doi\": \"10.1016/j.amjmed.2017.11.042\"}, {\"title\": \"Guideline on terminology and definitions of updating clinical guidelines: The Updating Glossary\", \"url\": \"https://experts.mcmaster.ca/display/publication1543953\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2018\", \"doi\": \"10.1016/j.jclinepi.2017.11.023\"}, {\"title\": \"Comorbidities in persons with haemophilia aged 60 years or more compared with age\\u2010matched people from the general population\", \"url\": \"https://experts.mcmaster.ca/display/publication1486888\", \"journal\": \"Haemophilia\", \"year\": \"2018\", \"doi\": \"10.1111/hae.13379\"}, {\"title\": \"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome\", \"url\": \"https://experts.mcmaster.ca/display/publication1560548\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2018\", \"doi\": \"10.1111/jth.14192\"}, {\"title\": \"PP93 HTA Role In CoreHEM, A Multi-Stakeholder Core Outcome Set Project\", \"url\": \"https://experts.mcmaster.ca/display/publication3461854\", \"journal\": \"International Journal of Technology Assessment in Health Care\", \"year\": \"2018\", \"doi\": \"10.1017/s0266462318002386\"}, {\"title\": \"Researching what matters to improve chronic pain care in Canada: A priority-setting partnership process to support patient-oriented research\", \"url\": \"https://experts.mcmaster.ca/display/publication1941109\", \"journal\": \"Canadian Journal of Pain\", \"year\": \"2018\", \"doi\": \"10.1080/24740527.2018.1433959\"}, {\"title\": \"Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey\", \"url\": \"https://experts.mcmaster.ca/display/publication1505136\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2018\", \"doi\": \"10.1016/j.jclinepi.2018.02.016\"}, {\"title\": \"Using pharmacokinetics to individualize hemophilia therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication1484351\", \"journal\": \"Hematology. American Society of Hematology. Education Program\", \"year\": \"2017\", \"doi\": \"10.1182/asheducation-2017.1.595\"}, {\"title\": \"Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia\\u00a0A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH\", \"url\": \"https://experts.mcmaster.ca/display/publication1478482\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2017\", \"doi\": \"10.1111/jth.13867\"}, {\"title\": \"McMaster Optimal Aging Portal: an evidence-based database for geriatrics-focused health professionals\", \"url\": \"https://experts.mcmaster.ca/display/publication761870\", \"journal\": \"BMC Research Notes\", \"year\": \"2017\", \"doi\": \"10.1186/s13104-017-2595-8\"}, {\"title\": \"Systematic reviews of prognosis studies: a critical appraisal of five core clinical journals\", \"url\": \"https://experts.mcmaster.ca/display/publication1641332\", \"journal\": \"Diagnostic and Prognostic Research\", \"year\": \"2017\", \"doi\": \"10.1186/s41512-017-0008-z\"}, {\"title\": \"Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1478566\", \"journal\": \"Thrombosis Research\", \"year\": \"2017\", \"doi\": \"10.1016/j.thromres.2017.11.001\"}, {\"title\": \"Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis\", \"url\": \"https://experts.mcmaster.ca/display/publication1467895\", \"journal\": \"Pharmaceutics\", \"year\": \"2017\", \"doi\": \"10.3390/pharmaceutics9040047\"}, {\"title\": \"Discrimination and Calibration of Clinical Prediction Models\", \"url\": \"https://experts.mcmaster.ca/display/publication1467059\", \"journal\": \"Journal of the American Medical Association (JAMA)\", \"year\": \"2017\", \"doi\": \"10.1001/jama.2017.12126\"}, {\"title\": \"Minimal dataset for post\\u2010registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH\", \"url\": \"https://experts.mcmaster.ca/display/publication1314668\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2017\", \"doi\": \"10.1111/jth.13762\"}, {\"title\": \"Point of care ultrasound in haemophilia: Building a strong foundation for clinical implementation\", \"url\": \"https://experts.mcmaster.ca/display/publication172697\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13269\"}, {\"title\": \"Overall prognosis of preschool autism spectrum disorder diagnoses\", \"url\": \"https://experts.mcmaster.ca/display/publication1601234\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2017\", \"doi\": \"10.1002/14651858.cd012749\"}, {\"title\": \"Computer-Aided Systematic Review Screening Comes of Age\", \"url\": \"https://experts.mcmaster.ca/display/publication172694\", \"journal\": \"ACP journal club\", \"year\": \"2017\", \"doi\": \"10.7326/m17-1295\"}, {\"title\": \"Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta\\u2010analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication172704\", \"journal\": \"Blood\", \"year\": \"2017\", \"doi\": \"10.1111/jth.13701\"}, {\"title\": \"Exploring some intersections between pharmacokinetics, factorVIIImeasurement and human morphometrics \\u2013 impact of recent advances in haemophilia study design on our understanding of optimal haemophilia treatment\", \"url\": \"https://experts.mcmaster.ca/display/publication172712\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13210\"}, {\"title\": \"Large scale studies assessing anti\\u2010factorVIIIantibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more\", \"url\": \"https://experts.mcmaster.ca/display/publication172706\", \"journal\": \"British Journal of Haematology\", \"year\": \"2017\", \"doi\": \"10.1111/bjh.14610\"}, {\"title\": \"Switching to extended half\\u2010life products in Canada \\u2013 preliminary data\", \"url\": \"https://experts.mcmaster.ca/display/publication172698\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13245\"}, {\"title\": \"IDO1 activity in selected immune cells controls antibody responses\", \"url\": \"https://experts.mcmaster.ca/display/publication3461842\", \"journal\": \"Journal of Immunology\", \"year\": \"2017\", \"doi\": \"10.4049/jimmunol.198.supp.67.25\"}, {\"title\": \"Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factorVIIIFc fusion protein and conventional recombinant factorVIIIproducts\", \"url\": \"https://experts.mcmaster.ca/display/publication172715\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13160\"}, {\"title\": \"Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development\", \"url\": \"https://experts.mcmaster.ca/display/publication172717\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13176\"}, {\"title\": \"Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement\", \"url\": \"https://experts.mcmaster.ca/display/publication172708\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13215\"}, {\"title\": \"What is the role for population pharmacokinetics in hemophilia?\", \"url\": \"https://experts.mcmaster.ca/display/publication3461858\", \"journal\": \"International Journal of Pharmacokinetics\", \"year\": \"2017\", \"doi\": \"10.4155/ipk-2016-0018\"}, {\"title\": \"Oral contraceptive use is a provoking factor for venous thromboembolism\", \"url\": \"https://experts.mcmaster.ca/display/publication172702\", \"journal\": \"The BMJ\", \"year\": \"2017\", \"doi\": \"10.1136/bmj.j2073\"}, {\"title\": \"Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption\", \"url\": \"https://experts.mcmaster.ca/display/publication172729\", \"journal\": \"Journal of Medical Economics\", \"year\": \"2017\", \"doi\": \"10.1080/13696998.2016.1265973\"}, {\"title\": \"A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews\", \"url\": \"https://experts.mcmaster.ca/display/publication172721\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2017\", \"doi\": \"10.1016/j.jclinepi.2016.11.012\"}, {\"title\": \"Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.\", \"url\": \"https://experts.mcmaster.ca/display/publication3461859\", \"journal\": \"ACP journal club\", \"year\": \"2017\", \"doi\": \"10.7326/M16-1785\"}, {\"title\": \"Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series\", \"url\": \"https://experts.mcmaster.ca/display/publication172718\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13167\"}, {\"title\": \"Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians\", \"url\": \"https://experts.mcmaster.ca/display/publication1314670\", \"journal\": \"ACP journal club\", \"year\": \"2017\", \"doi\": \"10.7326/m16-1860\"}, {\"title\": \"A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument\", \"url\": \"https://experts.mcmaster.ca/display/publication172735\", \"journal\": \"International Urology and Nephrology\", \"year\": \"2017\", \"doi\": \"10.1007/s11255-016-1436-3\"}, {\"title\": \"The current state of adverse event reporting in hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication172723\", \"journal\": \"Expert Review of Hematology\", \"year\": \"2017\", \"doi\": \"10.1080/17474086.2017.1272410\"}, {\"title\": \"Authors seldom report the most patient-important outcomes and absolute effect measures in systematic review abstracts\", \"url\": \"https://experts.mcmaster.ca/display/publication172755\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2017\", \"doi\": \"10.1016/j.jclinepi.2016.08.004\"}, {\"title\": \"Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA\", \"url\": \"https://experts.mcmaster.ca/display/publication172713\", \"journal\": \"PLoS ONE\", \"year\": \"2017\", \"doi\": \"10.1371/journal.pone.0171028\"}, {\"title\": \"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence\", \"url\": \"https://experts.mcmaster.ca/display/publication172699\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2017\", \"doi\": \"10.1016/j.jclinepi.2017.05.005\"}, {\"title\": \"Guideline for opioid therapy and chronic noncancer pain\", \"url\": \"https://experts.mcmaster.ca/display/publication61466\", \"journal\": \"CANADIAN MEDICAL ASSOCIATION JOURNAL\", \"year\": \"2017\", \"doi\": \"10.1503/cmaj.170363\"}, {\"title\": \"If You Build It, Who Will Come? A Description of User Characteristics and Experiences With the McMaster Optimal Aging Portal\", \"url\": \"https://experts.mcmaster.ca/display/publication1478576\", \"journal\": \"Gerontology and Geriatric Medicine\", \"year\": \"2017\", \"doi\": \"10.1177/2333721417737681\"}, {\"title\": \"Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data\", \"url\": \"https://experts.mcmaster.ca/display/publication172726\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13127\"}, {\"title\": \"Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours\", \"url\": \"https://experts.mcmaster.ca/display/publication172722\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2017\", \"doi\": \"10.1160/th16-09-0680\"}, {\"title\": \"Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates\", \"url\": \"https://experts.mcmaster.ca/display/publication172707\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2017\", \"doi\": \"10.1160/th16-12-0942\"}, {\"title\": \"The GRADE Working Group clarifies the construct of certainty of evidence\", \"url\": \"https://experts.mcmaster.ca/display/publication172700\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2017\", \"doi\": \"10.1016/j.jclinepi.2017.05.006\"}, {\"title\": \"The demographics, treatment characteristics and quality of life of adult people with haemophilia in China \\u2013 results from theHEROstudy\", \"url\": \"https://experts.mcmaster.ca/display/publication172749\", \"journal\": \"Haemophilia\", \"year\": \"2017\", \"doi\": \"10.1111/hae.13071\"}, {\"title\": \"Thrombosis in Inherited Fibrinogen Disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication172701\", \"journal\": \"Transfusion Medicine and Hemotherapy\", \"year\": \"2017\", \"doi\": \"10.1159/000452864\"}, {\"title\": \"VP57 Test-Retest Reliability Analysis Of The Patient Reported Outcomes Burdens And Experiences (PROBE) Study Questionnaire Test-Retest Reliability Analysis Of The PROBE Study Questionnaire\", \"url\": \"https://experts.mcmaster.ca/display/publication3461857\", \"journal\": \"International Journal of Technology Assessment in Health Care\", \"year\": \"2017\", \"doi\": \"10.1017/s0266462317003361\"}, {\"title\": \"Development of a Web-Accessible Population Pharmacokinetic Service\\u2014Hemophilia (WAPPS-Hemo): Study Protocol\", \"url\": \"https://experts.mcmaster.ca/display/publication172725\", \"journal\": \"JMIR Research Protocols\", \"year\": \"2016\", \"doi\": \"10.2196/resprot.6558\"}, {\"title\": \"Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo)\", \"url\": \"https://experts.mcmaster.ca/display/publication172728\", \"journal\": \"JMIR Research Protocols\", \"year\": \"2016\", \"doi\": \"10.2196/resprot.6559\"}, {\"title\": \"Interpreting trial sequential analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication172730\", \"journal\": \"Transfusion\", \"year\": \"2016\", \"doi\": \"10.1111/trf.13910\"}, {\"title\": \"Evaluation of the utility of theISTH\\u2010BATin haemophilia carriers: a multinational study\", \"url\": \"https://experts.mcmaster.ca/display/publication594662\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.13089\"}, {\"title\": \"The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication172759\", \"journal\": \"Expert Opinion on Drug Metabolism and Toxicology\", \"year\": \"2016\", \"doi\": \"10.1080/17425255.2016.1214711\"}, {\"title\": \"Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication172737\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2016\", \"doi\": \"10.1160/th16-04-0266\"}, {\"title\": \"User Experiences of the McMaster Optimal Aging Portal\\u2019s Evidence Summaries and Blog Posts: Usability Study\", \"url\": \"https://experts.mcmaster.ca/display/publication172757\", \"journal\": \"JMIR Human Factors\", \"year\": \"2016\", \"doi\": \"10.2196/humanfactors.6208\"}, {\"title\": \"Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study\", \"url\": \"https://experts.mcmaster.ca/display/publication172761\", \"journal\": \"BMJ Open\", \"year\": \"2016\", \"doi\": \"10.1136/bmjopen-2015-010983\"}, {\"title\": \"Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH\", \"url\": \"https://experts.mcmaster.ca/display/publication172763\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2016\", \"doi\": \"10.1111/jth.13382\"}, {\"title\": \"Care models in the management of haemophilia: a systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication172773\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.13000\"}, {\"title\": \"Integrated multidisciplinary care for the management of chronic conditions in adults: an overview of reviews and an example of using indirect evidence to inform clinical practice recommendations in the field of rare diseases\", \"url\": \"https://experts.mcmaster.ca/display/publication172771\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.13010\"}, {\"title\": \"Methodology for the development of theNHF\\u2010McMaster Guideline on Care Models for Haemophilia Management\", \"url\": \"https://experts.mcmaster.ca/display/publication172777\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.13007\"}, {\"title\": \"NHF\\u2010McMaster Guideline on Care Models for Haemophilia Management\", \"url\": \"https://experts.mcmaster.ca/display/publication172779\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.13008\"}, {\"title\": \"Understanding intravenous iron ordering practices for inpatients and outpatients at a large academic institution\", \"url\": \"https://experts.mcmaster.ca/display/publication2181222\", \"journal\": \"Transfusion Medicine Reviews\", \"year\": \"2016\", \"doi\": \"10.1016/j.tmrv.2016.05.005\"}, {\"title\": \"Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study\", \"url\": \"https://experts.mcmaster.ca/display/publication172775\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.13009\"}, {\"title\": \"The McMaster Optimal Aging Portal: Usability Evaluation of a Unique Evidence-Based Health Information Website\", \"url\": \"https://experts.mcmaster.ca/display/publication172783\", \"journal\": \"JMIR Human Factors\", \"year\": \"2016\", \"doi\": \"10.2196/humanfactors.4800\"}, {\"title\": \"Report on the International Society for Laboratory Hematology Survey on guidelines to support clinical hematology laboratory practice\", \"url\": \"https://experts.mcmaster.ca/display/publication172784\", \"journal\": \"International Journal of Laboratory Hematology\", \"year\": \"2016\", \"doi\": \"10.1111/ijlh.12501\"}, {\"title\": \"Variation of DNA Fragmentation Levels During Density Gradient Sperm Selection for Assisted Reproduction Techniques\", \"url\": \"https://experts.mcmaster.ca/display/publication1457859\", \"journal\": \"Medicine (United States)\", \"year\": \"2016\", \"doi\": \"10.1097/md.0000000000003624\"}, {\"title\": \"Haemophilia in a real\\u2010world setting: the value of clinical experience in data collection\", \"url\": \"https://experts.mcmaster.ca/display/publication172789\", \"journal\": \"European Journal of Haematology\", \"year\": \"2016\", \"doi\": \"10.1111/ejh.12715\"}, {\"title\": \"FVIIIinhibitor development according to concentrate: data from theEUHASSregistry excluding overlap with other studies\", \"url\": \"https://experts.mcmaster.ca/display/publication172810\", \"journal\": \"Haemophilia\", \"year\": \"2016\", \"doi\": \"10.1111/hae.12764\"}, {\"title\": \"A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation\", \"url\": \"https://experts.mcmaster.ca/display/publication172793\", \"journal\": \"International Journal of Cardiology\", \"year\": \"2016\", \"doi\": \"10.1016/j.ijcard.2015.11.035\"}, {\"title\": \"Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study\", \"url\": \"https://experts.mcmaster.ca/display/publication172733\", \"journal\": \"Journal of Blood Medicine\", \"year\": \"2016\", \"doi\": \"10.2147/jbm.s103087\"}, {\"title\": \"Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication172782\", \"journal\": \"PLoS ONE\", \"year\": \"2016\", \"doi\": \"10.1371/journal.pone.0156891\"}, {\"title\": \"Erratum to Fischer et al. \\u201cInhibitor development in nonsevere haemophilia across Europe\\u201d (Thromb Haemost 2015; 114: 670-675)\", \"url\": \"https://experts.mcmaster.ca/display/publication995684\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2016\", \"doi\": \"10.1160/th16030001\"}, {\"title\": \"Systematic reviews experience major limitations in reporting absolute effects\", \"url\": \"https://experts.mcmaster.ca/display/publication172795\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2016\", \"doi\": \"10.1016/j.jclinepi.2015.11.002\"}, {\"title\": \"Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol\", \"url\": \"https://experts.mcmaster.ca/display/publication172785\", \"journal\": \"BMJ Open\", \"year\": \"2016\", \"doi\": \"10.1136/bmjopen-2015-010569\"}, {\"title\": \"Desmopressin acetate (DDAVP) for preventing and treating bleeding in people with mild or moderate haemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1747319\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2015\", \"doi\": \"10.1002/14651858.cd011985\"}, {\"title\": \"Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication172791\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2015\", \"doi\": \"10.1002/14651858.cd004449.pub4\"}, {\"title\": \"Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions\", \"url\": \"https://experts.mcmaster.ca/display/publication172853\", \"journal\": \"BMC Blood Disorders\", \"year\": \"2015\", \"doi\": \"10.1186/s12878-015-0022-8\"}, {\"title\": \"A systematic review of definitions and reporting of bleeding outcome measures in haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication172812\", \"journal\": \"Haemophilia\", \"year\": \"2015\", \"doi\": \"10.1111/hae.12750\"}, {\"title\": \"Cardiovascular disease (CVD) in Canadians with haemophilia: Age\\u2010Related CVD in Haemophilia Epidemiological Research (ARCHER study)\", \"url\": \"https://experts.mcmaster.ca/display/publication172808\", \"journal\": \"Haemophilia\", \"year\": \"2015\", \"doi\": \"10.1111/hae.12768\"}, {\"title\": \"Individualizing Factor Replacement Therapy in Severe Hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication172806\", \"journal\": \"Seminars in Thrombosis and Hemostasis\", \"year\": \"2015\", \"doi\": \"10.1055/s-0035-1552563\"}, {\"title\": \"Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta\\u2010analysis of randomized controlled trials\", \"url\": \"https://experts.mcmaster.ca/display/publication172803\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\", \"doi\": \"10.1111/jth.13139\"}, {\"title\": \"Point of care ultrasonography in haemophilia care: recommendations for training and competency evaluation\", \"url\": \"https://experts.mcmaster.ca/display/publication172809\", \"journal\": \"Haemophilia\", \"year\": \"2015\", \"doi\": \"10.1111/hae.12767\"}, {\"title\": \"IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII\", \"url\": \"https://experts.mcmaster.ca/display/publication172801\", \"journal\": \"Journal of Clinical Investigation\", \"year\": \"2015\", \"doi\": \"10.1172/jci81859\"}, {\"title\": \"Inhibitor development in haemophilia according to concentrate\", \"url\": \"https://experts.mcmaster.ca/display/publication172861\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2015\", \"doi\": \"10.1160/th14-10-0826\"}, {\"title\": \"Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication172857\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2015\", \"doi\": \"10.1160/th14-07-0621\"}, {\"title\": \"Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication172814\", \"journal\": \"Blood\", \"year\": \"2015\", \"doi\": \"10.1182/blood-2014-10-608471\"}, {\"title\": \"Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia\", \"url\": \"https://experts.mcmaster.ca/display/publication411179\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2015\", \"doi\": \"10.1016/j.ejim.2015.04.002\"}, {\"title\": \"Cardiovascular disease prevalence and relevance in haemophilia: a scoping review\", \"url\": \"https://experts.mcmaster.ca/display/publication172875\", \"journal\": \"Haemophilia\", \"year\": \"2015\", \"doi\": \"10.1111/hae.12596\"}, {\"title\": \"Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data\", \"url\": \"https://experts.mcmaster.ca/display/publication172855\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\", \"doi\": \"10.1111/jth.12871\"}, {\"title\": \"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients\", \"url\": \"https://experts.mcmaster.ca/display/publication172849\", \"journal\": \"The BMJ\", \"year\": \"2015\", \"doi\": \"10.1136/bmj.h870\"}, {\"title\": \"Pharmacokinetics of plasma\\u2010derived vs. recombinantFVIIIconcentrates: a comparative study\", \"url\": \"https://experts.mcmaster.ca/display/publication172883\", \"journal\": \"Haemophilia\", \"year\": \"2015\", \"doi\": \"10.1111/hae.12550\"}, {\"title\": \"Commentary\", \"url\": \"https://experts.mcmaster.ca/display/publication1640361\", \"journal\": \"Epidemiology\", \"year\": \"2015\", \"doi\": \"10.1097/ede.0000000000000212\"}, {\"title\": \"Developing methodology for the creation of clinical practice guidelines for rare diseases: A report from RARE-Bestpractices\", \"url\": \"https://experts.mcmaster.ca/display/publication1634028\", \"journal\": \"Rare Diseases\", \"year\": \"2015\", \"doi\": \"10.1080/21675511.2015.1058463\"}, {\"title\": \"Development of haemophilic arthropathy of the ankle: results of a Delphi consensus survey on potential contributory factors\", \"url\": \"https://experts.mcmaster.ca/display/publication172873\", \"journal\": \"Haemophilia\", \"year\": \"2015\", \"doi\": \"10.1111/hae.12500\"}, {\"title\": \"Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor\", \"url\": \"https://experts.mcmaster.ca/display/publication172817\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2015\", \"doi\": \"10.1160/th14-10-0882\"}, {\"title\": \"Haemophilia Experiences, Results and Opportunities (HERO) study: treatment\\u2010related characteristics of the population\", \"url\": \"https://experts.mcmaster.ca/display/publication172879\", \"journal\": \"Haemophilia\", \"year\": \"2015\", \"doi\": \"10.1111/hae.12545\"}, {\"title\": \"Inhibitor development in non-severe haemophilia across Europe\", \"url\": \"https://experts.mcmaster.ca/display/publication172805\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2015\", \"doi\": \"10.1160/th14-12-1044\"}, {\"title\": \"Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews: a methodological survey\", \"url\": \"https://experts.mcmaster.ca/display/publication172802\", \"journal\": \"BMJ Open\", \"year\": \"2015\", \"doi\": \"10.1136/bmjopen-2015-009368\"}, {\"title\": \"Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study\", \"url\": \"https://experts.mcmaster.ca/display/publication172794\", \"journal\": \"International Journal of Qualitative Studies on Health and Well-being\", \"year\": \"2015\", \"doi\": \"10.3402/qhw.v10.28915\"}, {\"title\": \"Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study.\", \"url\": \"https://experts.mcmaster.ca/display/publication172863\", \"journal\": \"International Journal of Qualitative Studies on Health and Well-being\", \"year\": \"2015\", \"doi\": \"10.3402/qhw.v10.28915\"}, {\"title\": \"The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels\", \"url\": \"https://experts.mcmaster.ca/display/publication172769\", \"journal\": \"Implementation Science\", \"year\": \"2015\", \"doi\": \"10.1186/s13012-016-0462-y\"}, {\"title\": \"Effectiveness of Computerized Decision Support Systems Linked to Electronic Health Records: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication172881\", \"journal\": \"American Journal of Public Health\", \"year\": \"2014\", \"doi\": \"10.2105/ajph.2014.302164\"}, {\"title\": \"Increasing the quantity and quality of searching for current best evidence to answer clinical questions: protocol and intervention design of the MacPLUS FS Factorial Randomized Controlled Trials\", \"url\": \"https://experts.mcmaster.ca/display/publication61497\", \"journal\": \"Implementation Science\", \"year\": \"2014\", \"doi\": \"10.1186/s13012-014-0125-9\"}, {\"title\": \"Interventions for enhancing medication adherence\", \"url\": \"https://experts.mcmaster.ca/display/publication61512\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2014\", \"doi\": \"10.1002/14651858.cd000011.pub4\"}, {\"title\": \"Developing a two\\u2010sided intervention to facilitate shared decision\\u2010making in haemophilia: decision boxes for clinicians and patient decision aids for patients\", \"url\": \"https://experts.mcmaster.ca/display/publication172885\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12495\"}, {\"title\": \"Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly\", \"url\": \"https://experts.mcmaster.ca/display/publication411180\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2014\", \"doi\": \"10.1016/j.ejim.2014.09.019\"}, {\"title\": \"Non-invasive ventilation in the treatment of sleep-related breathing disorders: A review and update\", \"url\": \"https://experts.mcmaster.ca/display/publication411183\", \"journal\": \"Revista Portuguesa de Pneumologia (English Edition)\", \"year\": \"2014\", \"doi\": \"10.1016/j.rppneu.2014.03.009\"}, {\"title\": \"Patient data meta\\u2010analysis of Post\\u2010Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated withrAHF\\u2010PFM\", \"url\": \"https://experts.mcmaster.ca/display/publication172891\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12480\"}, {\"title\": \"Heart failure and chronic kidney disease in a registry of internal medicine wards\", \"url\": \"https://experts.mcmaster.ca/display/publication995630\", \"journal\": \"European Geriatric Medicine\", \"year\": \"2014\", \"doi\": \"10.1016/j.eurger.2014.08.005\"}, {\"title\": \"Multimorbidity and polypharmacy in the elderly: lessons from REPOSI\", \"url\": \"https://experts.mcmaster.ca/display/publication411181\", \"journal\": \"Internal and emergency medicine\", \"year\": \"2014\", \"doi\": \"10.1007/s11739-014-1124-1\"}, {\"title\": \"Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The\\u00a0Euro Heart Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication172905\", \"journal\": \"American Journal of Medicine\", \"year\": \"2014\", \"doi\": \"10.1016/j.amjmed.2014.05.003\"}, {\"title\": \"Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward\", \"url\": \"https://experts.mcmaster.ca/display/publication172889\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12511\"}, {\"title\": \"Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study\", \"url\": \"https://experts.mcmaster.ca/display/publication411182\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2014\", \"doi\": \"10.1016/j.ejim.2014.06.027\"}, {\"title\": \"Aryl hydrocarbon receptor control of a disease tolerance defence pathway\", \"url\": \"https://experts.mcmaster.ca/display/publication172899\", \"journal\": \"Nature\", \"year\": \"2014\", \"doi\": \"10.1038/nature13323\"}, {\"title\": \"Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa\", \"url\": \"https://experts.mcmaster.ca/display/publication172931\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12371\"}, {\"title\": \"First analysis of 10\\u2010year trends in national factor concentrates usage in haemophilia: data fromCHARMS, the Canadian Hemophilia Assessment and Resource Management System\", \"url\": \"https://experts.mcmaster.ca/display/publication172897\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12477\"}, {\"title\": \"Haemophilia Experiences, Results and Opportunities (HERO) Study: Influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication172907\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12454\"}, {\"title\": \"Evaluation of an automated method for measuring vonWillebrand factor activity in clinical samples without ristocetin\", \"url\": \"https://experts.mcmaster.ca/display/publication172915\", \"journal\": \"International Journal of Laboratory Hematology\", \"year\": \"2014\", \"doi\": \"10.1111/ijlh.12218\"}, {\"title\": \"JointWFH\\u2010ISTHsession: issues in clinical trial design\", \"url\": \"https://experts.mcmaster.ca/display/publication172913\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12415\"}, {\"title\": \"PSY40 Indirect Comparison Of The Efficacy Of Recombinant Factor Viii Fc Fusion Protein And Other Factor Viii Products For ProphylaxisModeling The Effect Of Compliance\", \"url\": \"https://experts.mcmaster.ca/display/publication3461871\", \"journal\": \"Value in Health\", \"year\": \"2014\", \"doi\": \"10.1016/j.jval.2014.03.1345\"}, {\"title\": \"PSY41 Indirect Comparison Of The Efficacy Of Recombinant Factor Ix Fc Fusion Protein And Other Factor Ix Products For Prophylaxis: Simulating The Effect Of Compliance On Real-World Effectiveness\", \"url\": \"https://experts.mcmaster.ca/display/publication3461867\", \"journal\": \"Value in Health\", \"year\": \"2014\", \"doi\": \"10.1016/j.jval.2014.03.1346\"}, {\"title\": \"Patterns of tertiary prophylaxis inCanadian adults with severe and moderately severe haemophiliaB\", \"url\": \"https://experts.mcmaster.ca/display/publication172927\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12391\"}, {\"title\": \"Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B\", \"url\": \"https://experts.mcmaster.ca/display/publication172911\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2014\", \"doi\": \"10.1002/14651858.cd010561.pub2\"}, {\"title\": \"The haemophilia certification system in Canada.\", \"url\": \"https://experts.mcmaster.ca/display/publication172901\", \"journal\": \"Blood Transfusion\", \"year\": \"2014\", \"doi\": \"10.2450/2014.0032-14s\"}, {\"title\": \"Ruling out DVT using the Wells rule and a D-dimer test\", \"url\": \"https://experts.mcmaster.ca/display/publication172925\", \"journal\": \"The BMJ\", \"year\": \"2014\", \"doi\": \"10.1136/bmj.g1637\"}, {\"title\": \"Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity\", \"url\": \"https://experts.mcmaster.ca/display/publication172929\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12283\"}, {\"title\": \"A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol (vol 2, 113, 2013)\", \"url\": \"https://experts.mcmaster.ca/display/publication172939\", \"journal\": \"Systematic Reviews\", \"year\": \"2014\", \"doi\": \"10.1186/2046-4053-2-113\"}, {\"title\": \"Erratum to: A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol\", \"url\": \"https://experts.mcmaster.ca/display/publication411199\", \"journal\": \"Systematic Reviews\", \"year\": \"2014\", \"doi\": \"10.1186/2046-4053-3-76\"}, {\"title\": \"Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics\", \"url\": \"https://experts.mcmaster.ca/display/publication172947\", \"journal\": \"Haemophilia\", \"year\": \"2014\", \"doi\": \"10.1111/hae.12239\"}, {\"title\": \"Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study\", \"url\": \"https://experts.mcmaster.ca/display/publication172871\", \"journal\": \"Systematic Reviews\", \"year\": \"2014\", \"doi\": \"10.1186/2046-4053-3-137\"}, {\"title\": \"Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication172942\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2014\", \"doi\": \"10.1160/th13-04-0336\"}, {\"title\": \"High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance\", \"url\": \"https://experts.mcmaster.ca/display/publication172945\", \"journal\": \"Journal of Hematology and Oncology\", \"year\": \"2013\", \"doi\": \"10.1186/1756-8722-6-63\"}, {\"title\": \"Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation\", \"url\": \"https://experts.mcmaster.ca/display/publication172944\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2013\", \"doi\": \"10.1016/j.ejim.2013.08.697\"}, {\"title\": \"Drug\\u2013drug interactions in a cohort of hospitalized elderly patients\", \"url\": \"https://experts.mcmaster.ca/display/publication172943\", \"journal\": \"Pharmacoepidemiology and Drug Safety\", \"year\": \"2013\", \"doi\": \"10.1002/pds.3510\"}, {\"title\": \"Erratum to \\u201cSmall intestinal bacterial overgrowth and warfarin dose requirement variability\\u201d [Thromb. Res. 126 (1) (2010) 12\\u201317]\", \"url\": \"https://experts.mcmaster.ca/display/publication995768\", \"journal\": \"Thrombosis Research\", \"year\": \"2013\", \"doi\": \"10.1016/j.thromres.2013.05.022\"}, {\"title\": \"Inhibitor development in previously treated hemophilia A patients: a systematic review, meta\\u2010analysis, and meta\\u2010regression\", \"url\": \"https://experts.mcmaster.ca/display/publication172949\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\", \"doi\": \"10.1111/jth.12335\"}, {\"title\": \"Prevalence of potentially inappropriate medications in a cohort of hospitalized elderly: Results from the REPOSI study\", \"url\": \"https://experts.mcmaster.ca/display/publication3461870\", \"journal\": \"European Geriatric Medicine\", \"year\": \"2013\", \"doi\": \"10.1016/j.eurger.2013.07.018\"}, {\"title\": \"Prophylaxis of venous thromboembolism in elderly patients with multimorbidity\", \"url\": \"https://experts.mcmaster.ca/display/publication172954\", \"journal\": \"Internal and emergency medicine\", \"year\": \"2013\", \"doi\": \"10.1007/s11739-013-0944-8\"}, {\"title\": \"Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B\", \"url\": \"https://experts.mcmaster.ca/display/publication1747317\", \"journal\": \"Clinical Respiratory Journal\", \"year\": \"2013\", \"doi\": \"10.1002/14651858.cd010561\"}, {\"title\": \"The Rodin (Research Of Determinants of INhibitor Development among PUPs with haemophilia) study: the clinical conundrum from the perspective of haemophilia treaters\", \"url\": \"https://experts.mcmaster.ca/display/publication172956\", \"journal\": \"Haemophilia\", \"year\": \"2013\", \"doi\": \"10.1111/hae.12149\"}, {\"title\": \"Factor VIII Products and Inhibitors in Severe Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication411185\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2013\", \"doi\": \"10.1056/nejmc1301995\"}, {\"title\": \"Factor VIII Products and Inhibitors in Severe Hemophilia A REPLY\", \"url\": \"https://experts.mcmaster.ca/display/publication1508943\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2013\"}, {\"title\": \"Factor VIII products and inhibitors in severe hemophilia A.\", \"url\": \"https://experts.mcmaster.ca/display/publication172957\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2013\", \"doi\": \"10.1056/NEJMc1301995\"}, {\"title\": \"Adverse Clinical Events and Mortality During Hospitalization and 3 Months After Discharge in Cognitively Impaired Elderly Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication172971\", \"journal\": \"The journals of gerontology. Series A, Biological sciences and medical sciences\", \"year\": \"2013\", \"doi\": \"10.1093/gerona/gls181\"}, {\"title\": \"Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.\", \"url\": \"https://experts.mcmaster.ca/display/publication172959\", \"journal\": \"Blood Transfusion\", \"year\": \"2013\", \"doi\": \"10.2450/2012.0158-12\"}, {\"title\": \"Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach\", \"url\": \"https://experts.mcmaster.ca/display/publication172962\", \"journal\": \"Current Treatment Options in Cardiovascular Medicine\", \"year\": \"2013\", \"doi\": \"10.1007/s11936-012-0225-2\"}, {\"title\": \"Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences\", \"url\": \"https://experts.mcmaster.ca/display/publication172960\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2013\", \"doi\": \"10.1016/j.jclinepi.2012.08.007\"}, {\"title\": \"Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale\", \"url\": \"https://experts.mcmaster.ca/display/publication172964\", \"journal\": \"Drugs and Aging\", \"year\": \"2013\", \"doi\": \"10.1007/s40266-012-0044-x\"}, {\"title\": \"Clinical validation of a new algorithm for computerized dosing of vitamin\\u00a0K antagonist therapy: a retrospective simulation study\", \"url\": \"https://experts.mcmaster.ca/display/publication173027\", \"journal\": \"Internal and emergency medicine\", \"year\": \"2013\", \"doi\": \"10.1007/s11739-011-0581-z\"}, {\"title\": \"Comparison of Disease Clusters in Two Elderly Populations Hospitalized in 2008 and 2010\", \"url\": \"https://experts.mcmaster.ca/display/publication172961\", \"journal\": \"Gerontology\", \"year\": \"2013\", \"doi\": \"10.1159/000346353\"}, {\"title\": \"Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study\", \"url\": \"https://experts.mcmaster.ca/display/publication172941\", \"journal\": \"BioMed Research International\", \"year\": \"2013\", \"doi\": \"10.1155/2013/901975\"}, {\"title\": \"Risk factors for hospital readmission of elderly patients\", \"url\": \"https://experts.mcmaster.ca/display/publication172967\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2013\", \"doi\": \"10.1016/j.ejim.2012.10.005\"}, {\"title\": \"Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends\", \"url\": \"https://experts.mcmaster.ca/display/publication1973978\", \"journal\": \"Blood\", \"year\": \"2012\", \"doi\": \"10.1182/blood.v120.21.1186.1186\"}, {\"title\": \"Uncertainties in baseline risk estimates and confidence in treatment effects\", \"url\": \"https://experts.mcmaster.ca/display/publication172965\", \"journal\": \"The BMJ\", \"year\": \"2012\", \"doi\": \"10.1136/bmj.e7401\"}, {\"title\": \"Applicability of the AGREE II Instrument in Evaluating the Development Process and Quality of Current National Academy of Clinical Biochemistry Guidelines\", \"url\": \"https://experts.mcmaster.ca/display/publication172972\", \"journal\": \"Clinical Chemistry\", \"year\": \"2012\", \"doi\": \"10.1373/clinchem.2012.185850\"}, {\"title\": \"Summarizing the theoretical foundation for hospital communication research: a scoping review of interdisciplinary literature\", \"url\": \"https://experts.mcmaster.ca/display/publication1933902\", \"year\": \"2012\"}, {\"title\": \"Clotting factor concentrate switching and inhibitor development in hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication172975\", \"journal\": \"Blood\", \"year\": \"2012\", \"doi\": \"10.1182/blood-2012-03-378927\"}, {\"title\": \"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)\", \"url\": \"https://experts.mcmaster.ca/display/publication172978\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2012\", \"doi\": \"10.1111/j.1538-7836.2012.04735.x\"}, {\"title\": \"Psychosocial aspects of haemophilia: a systematic review of methodologies and findings\", \"url\": \"https://experts.mcmaster.ca/display/publication172991\", \"journal\": \"Haemophilia\", \"year\": \"2012\", \"doi\": \"10.1111/j.1365-2516.2011.02683.x\"}, {\"title\": \"Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients\", \"url\": \"https://experts.mcmaster.ca/display/publication172984\", \"journal\": \"International Psychogeriatrics\", \"year\": \"2012\", \"doi\": \"10.1017/s1041610211002353\"}, {\"title\": \"Central nervous system bleeding in patients with rare bleeding disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication173025\", \"journal\": \"Haemophilia\", \"year\": \"2012\", \"doi\": \"10.1111/j.1365-2516.2011.02545.x\"}, {\"title\": \"Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication173020\", \"journal\": \"Haemophilia\", \"year\": \"2012\", \"doi\": \"10.1111/j.1365-2516.2011.02611.x\"}, {\"title\": \"Association between clusters of diseases and polypharmacy in hospitalized elderly patients: Results from the REPOSI study\", \"url\": \"https://experts.mcmaster.ca/display/publication172989\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2011\", \"doi\": \"10.1016/j.ejim.2011.08.029\"}, {\"title\": \"Individual participant data meta-analyses compared with meta-analyses based on aggregate data\", \"url\": \"https://experts.mcmaster.ca/display/publication3461869\", \"journal\": \"Trials\", \"year\": \"2011\", \"doi\": \"10.1186/1745-6215-12-s1-a57\"}, {\"title\": \"Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3461849\", \"journal\": \"Blood\", \"year\": \"2011\", \"doi\": \"10.1182/blood.v118.21.26.26\"}, {\"title\": \"Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score\", \"url\": \"https://experts.mcmaster.ca/display/publication3461848\", \"journal\": \"Blood\", \"year\": \"2011\", \"doi\": \"10.1182/blood.v118.21.544.544\"}, {\"title\": \"Concentrate\\u2010related inhibitor risk: is a difference always real?\", \"url\": \"https://experts.mcmaster.ca/display/publication172999\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2011\", \"doi\": \"10.1111/j.1538-7836.2011.04480.x\"}, {\"title\": \"Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study\", \"url\": \"https://experts.mcmaster.ca/display/publication172995\", \"journal\": \"American Journal of Hematology\", \"year\": \"2011\", \"doi\": \"10.1002/ajh.22156\"}, {\"title\": \"Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication172982\", \"journal\": \"Seminars in Thrombosis and Hemostasis\", \"year\": \"2011\", \"doi\": \"10.1055/s-0031-1297171\"}, {\"title\": \"Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B\", \"url\": \"https://experts.mcmaster.ca/display/publication172997\", \"journal\": \"Clinical Respiratory Journal\", \"year\": \"2011\", \"doi\": \"10.1002/14651858.cd003429.pub4\"}, {\"title\": \"In\\u2010hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study\", \"url\": \"https://experts.mcmaster.ca/display/publication173001\", \"journal\": \"International Journal of Geriatric Psychiatry\", \"year\": \"2011\", \"doi\": \"10.1002/gps.2627\"}, {\"title\": \"The association between venous thromboembolism and physical inactivity in everyday life\", \"url\": \"https://experts.mcmaster.ca/display/publication173022\", \"journal\": \"The BMJ\", \"year\": \"2011\", \"doi\": \"10.1136/bmj.d3865\"}, {\"title\": \"Management of Inheritedvon Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication172987\", \"journal\": \"Seminars in Thrombosis and Hemostasis\", \"year\": \"2011\", \"doi\": \"10.1055/s-0031-1281037\"}, {\"title\": \"Commentary\", \"url\": \"https://experts.mcmaster.ca/display/publication1747328\", \"journal\": \"Annals of Internal Medicine\", \"year\": \"2011\"}, {\"title\": \"The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care\", \"url\": \"https://experts.mcmaster.ca/display/publication173023\", \"journal\": \"ACP journal club\", \"year\": \"2011\", \"doi\": \"10.7326/0003-4819-154-12-201106210-02013\"}, {\"title\": \"More about optimal choices in cardioembolism prevention\", \"url\": \"https://experts.mcmaster.ca/display/publication995613\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2011\", \"doi\": \"10.1016/j.ejim.2011.01.009\"}, {\"title\": \"Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism\", \"url\": \"https://experts.mcmaster.ca/display/publication995796\", \"journal\": \"ACP journal club\", \"year\": \"2011\", \"doi\": \"10.7326/0003-4819-154-9-201105030-00016\"}, {\"title\": \"Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study\", \"url\": \"https://experts.mcmaster.ca/display/publication173030\", \"journal\": \"European Journal of Clinical Pharmacology\", \"year\": \"2011\", \"doi\": \"10.1007/s00228-010-0977-0\"}, {\"title\": \"Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly\", \"url\": \"https://experts.mcmaster.ca/display/publication173028\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2011\", \"doi\": \"10.1016/j.ejim.2010.11.009\"}, {\"title\": \"Referat zu: Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study\", \"url\": \"https://experts.mcmaster.ca/display/publication1747356\", \"journal\": \"Vasomed\", \"year\": \"2011\"}, {\"title\": \"Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication173029\", \"journal\": \"The BMJ\", \"year\": \"2011\", \"doi\": \"10.1136/bmj.d813\"}, {\"title\": \"Clinical efficacy and safety of moroctocog alfa\", \"url\": \"https://experts.mcmaster.ca/display/publication3461860\", \"journal\": \"Clinical Investigation\", \"year\": \"2011\", \"doi\": \"10.4155/cli.10.27\"}, {\"title\": \"Recombinant Factor VIIa Concentrate versus Plasma-derived Concentrates for the Treatment of Acute Bleeding Episodes in Persons with Haemophilia and Inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication3461861\", \"journal\": \"European Oncology and Haematology\", \"year\": \"2011\", \"doi\": \"10.17925/eoh.2011.07.02.140\"}, {\"title\": \"Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy.\", \"url\": \"https://experts.mcmaster.ca/display/publication173033\", \"journal\": \"Blood Transfusion\", \"year\": \"2011\", \"doi\": \"10.2450/2010.0011-10\"}, {\"title\": \"Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards\", \"url\": \"https://experts.mcmaster.ca/display/publication173032\", \"journal\": \"European Journal of Internal Medicine\", \"year\": \"2010\", \"doi\": \"10.1016/j.ejim.2010.07.014\"}, {\"title\": \"A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3461850\", \"journal\": \"Blood\", \"year\": \"2010\", \"doi\": \"10.1182/blood.v116.21.710.710\"}, {\"title\": \"Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication3461853\", \"journal\": \"Blood\", \"year\": \"2010\", \"doi\": \"10.1182/blood.v116.21.238.238\"}, {\"title\": \"Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]\", \"url\": \"https://experts.mcmaster.ca/display/publication1973972\", \"journal\": \"Blood\", \"year\": \"2010\", \"doi\": \"10.1182/blood.v116.21.3169.3169\"}, {\"title\": \"Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient\\u2010level meta\\u2010analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication173040\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2010\", \"doi\": \"10.1111/j.1538-7836.2010.04022.x\"}, {\"title\": \"Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor\", \"url\": \"https://experts.mcmaster.ca/display/publication173034\", \"journal\": \"JAMA Internal Medicine\", \"year\": \"2010\", \"doi\": \"10.1001/archinternmed.2010.367\"}, {\"title\": \"A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication173036\", \"journal\": \"ACP journal club\", \"year\": \"2010\", \"doi\": \"10.7326/0003-4819-153-8-201010190-02013\"}, {\"title\": \"Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism\", \"url\": \"https://experts.mcmaster.ca/display/publication173035\", \"journal\": \"ACP journal club\", \"year\": \"2010\", \"doi\": \"10.7326/0003-4819-153-8-201010190-00009\"}, {\"title\": \"Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication173038\", \"journal\": \"Current Pharmaceutical Design\", \"year\": \"2010\", \"doi\": \"10.2174/138161210793563428\"}, {\"title\": \"Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting\", \"url\": \"https://experts.mcmaster.ca/display/publication173039\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2010\", \"doi\": \"10.1111/j.1538-7836.2010.03991.x\"}, {\"title\": \"In-Hospital Death and Adverse Clinical Events in Elderly Patients According to Disease Clustering: The REPOSI Study\", \"url\": \"https://experts.mcmaster.ca/display/publication173043\", \"journal\": \"Rejuvenation Research\", \"year\": \"2010\", \"doi\": \"10.1089/rej.2009.1002\"}, {\"title\": \"Small intestinal bacterial overgrowth and warfarin dose requirement variability\", \"url\": \"https://experts.mcmaster.ca/display/publication173056\", \"journal\": \"Thrombosis Research\", \"year\": \"2010\", \"doi\": \"10.1016/j.thromres.2009.11.032\"}, {\"title\": \"Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma\\u2010derived or recombinant factor VIII concentrates: a systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication173049\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2010\", \"doi\": \"10.1111/j.1538-7836.2010.03823.x\"}, {\"title\": \"Mortality and causes of death in Italian persons with haemophilia, 1990\\u20132007\", \"url\": \"https://experts.mcmaster.ca/display/publication173052\", \"journal\": \"Haemophilia\", \"year\": \"2010\", \"doi\": \"10.1111/j.1365-2516.2009.02188.x\"}, {\"title\": \"Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children\", \"url\": \"https://experts.mcmaster.ca/display/publication173048\", \"journal\": \"Circulation\", \"year\": \"2010\", \"doi\": \"10.1161/circulationaha.109.913673\"}, {\"title\": \"Influenza Vaccination and Vitamin K Antagonist Treatment\", \"url\": \"https://experts.mcmaster.ca/display/publication173047\", \"journal\": \"JAMA Internal Medicine\", \"year\": \"2010\", \"doi\": \"10.1001/archinternmed.2010.49\"}, {\"title\": \"Selective outcome reporting: telling and detecting true lies. The state of the science\", \"url\": \"https://experts.mcmaster.ca/display/publication173050\", \"journal\": \"Internal and emergency medicine\", \"year\": \"2010\", \"doi\": \"10.1007/s11739-010-0371-z\"}, {\"title\": \"Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study\", \"url\": \"https://experts.mcmaster.ca/display/publication173057\", \"journal\": \"European Journal of Vascular and Endovascular Surgery\", \"year\": \"2010\", \"doi\": \"10.1016/j.ejvs.2009.11.022\"}, {\"title\": \"Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus\", \"url\": \"https://experts.mcmaster.ca/display/publication173053\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2010\", \"doi\": \"10.1002/14651858.cd004888.pub2\"}, {\"title\": \"Bone mineral density in haemophilia patients\", \"url\": \"https://experts.mcmaster.ca/display/publication173055\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2010\", \"doi\": \"10.1160/th09-09-0629\"}, {\"title\": \"Response: Comparing joint arthroplasties in severe hemophilia A with severe hemophilia B\", \"url\": \"https://experts.mcmaster.ca/display/publication995836\", \"journal\": \"Blood\", \"year\": \"2009\", \"doi\": \"10.1182/blood-2009-09-244566\"}, {\"title\": \"Impact of Thrombophilia On Arterial Ischemic Stroke or Cerebral Venous Sinus Thromboses in Children: A Systematic Review & Meta-Analysis of Observational Studies.\", \"url\": \"https://experts.mcmaster.ca/display/publication1973969\", \"journal\": \"Blood\", \"year\": \"2009\", \"doi\": \"10.1182/blood.v114.22.3993.3993\"}, {\"title\": \"Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.\", \"url\": \"https://experts.mcmaster.ca/display/publication3461851\", \"journal\": \"Blood\", \"year\": \"2009\", \"doi\": \"10.1182/blood.v114.22.3494.3494\"}, {\"title\": \"Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature.\", \"url\": \"https://experts.mcmaster.ca/display/publication3461852\", \"journal\": \"Blood\", \"year\": \"2009\", \"doi\": \"10.1182/blood.v114.22.3154.3154\"}, {\"title\": \"Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)\", \"url\": \"https://experts.mcmaster.ca/display/publication173063\", \"journal\": \"Thrombosis Research\", \"year\": \"2009\", \"doi\": \"10.1016/j.thromres.2009.05.014\"}, {\"title\": \"Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus\", \"url\": \"https://experts.mcmaster.ca/display/publication173064\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2009\", \"doi\": \"10.1038/ajg.2009.311\"}, {\"title\": \"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment\", \"url\": \"https://experts.mcmaster.ca/display/publication173061\", \"journal\": \"American Journal of Hematology\", \"year\": \"2009\", \"doi\": \"10.1002/ajh.21469\"}, {\"title\": \"Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication173069\", \"journal\": \"Blood\", \"year\": \"2009\", \"doi\": \"10.1182/blood-2009-01-195313\"}, {\"title\": \"Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends?\", \"url\": \"https://experts.mcmaster.ca/display/publication173066\", \"journal\": \"Haemophilia\", \"year\": \"2009\", \"doi\": \"10.1111/j.1365-2516.2009.02031.x\"}, {\"title\": \"Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication1747358\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\", \"doi\": \"10.1111/j.1538-7836.2009.03318.x\"}, {\"title\": \"Performance of recalibrated ReFacto\\u00aelaboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one\\u2010stage assays after infusion of recalibrated ReFacto\\u00ae(B\\u2010domain deleted recombinant factor VIII)\", \"url\": \"https://experts.mcmaster.ca/display/publication173071\", \"journal\": \"Haemophilia\", \"year\": \"2009\", \"doi\": \"10.1111/j.1365-2516.2009.01983.x\"}, {\"title\": \"Errata\", \"url\": \"https://experts.mcmaster.ca/display/publication1747359\", \"journal\": \"Haemophilia\", \"year\": \"2009\", \"doi\": \"10.1111/j.1365-2516.2009.02014_3.x\"}, {\"title\": \"Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis (vol 14, pg 444, 2008)\", \"url\": \"https://experts.mcmaster.ca/display/publication995840\", \"journal\": \"Haemophilia\", \"year\": \"2009\"}, {\"title\": \"Patients\\u2019, physicians\\u2019, and pharmacists\\u2019 preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study\", \"url\": \"https://experts.mcmaster.ca/display/publication411187\", \"journal\": \"Haemophilia\", \"year\": \"2009\", \"doi\": \"10.1111/j.1365-2516.2008.01926.x\"}, {\"title\": \"Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature\", \"url\": \"https://experts.mcmaster.ca/display/publication3461846\", \"journal\": \"Blood\", \"year\": \"2008\", \"doi\": \"10.1182/blood.v112.11.3029.3029\"}, {\"title\": \"Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase.\", \"url\": \"https://experts.mcmaster.ca/display/publication173072\", \"journal\": \"Blood Transfusion\", \"year\": \"2008\", \"doi\": \"10.2450/2008.0042-07\"}, {\"title\": \"Selecting references that match constructs: the difficult job of citing the parachute hyperbole\", \"url\": \"https://experts.mcmaster.ca/display/publication173087\", \"journal\": \"Internal and emergency medicine\", \"year\": \"2008\", \"doi\": \"10.1007/s11739-008-0149-8\"}, {\"title\": \"Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication173093\", \"journal\": \"Haemophilia\", \"year\": \"2008\", \"doi\": \"10.1111/j.1365-2516.2008.01679.x\"}, {\"title\": \"Interventions for enhancing medication adherence\", \"url\": \"https://experts.mcmaster.ca/display/publication175104\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2008\", \"doi\": \"10.1002/14651858.cd000011.pub3\"}, {\"title\": \"Iatrogenic causes of an ICH\", \"url\": \"https://experts.mcmaster.ca/display/publication173089\", \"journal\": \"European Journal of Anaesthesiology\", \"year\": \"2008\", \"doi\": \"10.1017/s0265021507003171\"}, {\"title\": \"Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting\", \"url\": \"https://experts.mcmaster.ca/display/publication173097\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2008\", \"doi\": \"10.1160/th07-06-0409\"}, {\"title\": \"The good use of plasma. A critical analysis of five international guidelines.\", \"url\": \"https://experts.mcmaster.ca/display/publication173077\", \"journal\": \"Blood Transfusion\", \"year\": \"2008\", \"doi\": \"10.2450/2008.0041-07\"}, {\"title\": \"Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence\", \"url\": \"https://experts.mcmaster.ca/display/publication173103\", \"journal\": \"Internal and emergency medicine\", \"year\": \"2007\", \"doi\": \"10.1007/s11739-007-0058-2\"}, {\"title\": \"RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS\", \"url\": \"https://experts.mcmaster.ca/display/publication3461862\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2007\", \"doi\": \"10.1111/j.1538-7836.2007.tb01920.x\"}, {\"title\": \"Chronic Prostatitis\", \"url\": \"https://experts.mcmaster.ca/display/publication411191\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2007\", \"doi\": \"10.1056/nejmc063135\"}, {\"title\": \"Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients\", \"url\": \"https://experts.mcmaster.ca/display/publication173107\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2007\", \"doi\": \"10.1160/th07-03-0201\"}, {\"title\": \"Thrombophilia and Cerebral Vein Thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication173101\", \"journal\": \"Frontiers of Neurology and Neuroscience\", \"year\": \"2007\", \"doi\": \"10.1159/000111261\"}, {\"title\": \"Influenza vaccination in patients on long-term anticoagulant therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication173128\", \"journal\": \"Vaccine\", \"year\": \"2006\", \"doi\": \"10.1016/j.vaccine.2006.05.036\"}, {\"title\": \"d-Dimer Testing to Determine the Duration of Anticoagulation Therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication173119\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2006\", \"doi\": \"10.1056/nejmoa054444\"}, {\"title\": \"Are placebo\\u2010controlled trials ethical in areas where current guidelines recommend therapy? No\", \"url\": \"https://experts.mcmaster.ca/display/publication173125\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2006\", \"doi\": \"10.1111/j.1538-7836.2006.02133.x\"}, {\"title\": \"High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C.\", \"url\": \"https://experts.mcmaster.ca/display/publication1688439\", \"journal\": \"Haematologica\", \"year\": \"2006\"}, {\"title\": \"Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B\", \"url\": \"https://experts.mcmaster.ca/display/publication173131\", \"journal\": \"Clinical Respiratory Journal\", \"year\": \"2006\", \"doi\": \"10.1002/14651858.cd003429.pub3\"}, {\"title\": \"Can evidence harm? Certainly not hemophilia treatment and community\", \"url\": \"https://experts.mcmaster.ca/display/publication173132\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2006\", \"doi\": \"10.1111/j.1538-7836.2006.01853.x\"}, {\"title\": \"Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma\\u2010derived solvent\\u2010detergent factor VIII concentrate\", \"url\": \"https://experts.mcmaster.ca/display/publication411193\", \"journal\": \"Haemophilia\", \"year\": \"2006\", \"doi\": \"10.1111/j.1365-2516.2006.01201.x\"}, {\"title\": \"Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments\", \"url\": \"https://experts.mcmaster.ca/display/publication173127\", \"journal\": \"Cerebrovascular Diseases\", \"year\": \"2006\", \"doi\": \"10.1159/000094604\"}, {\"title\": \"High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.\", \"url\": \"https://experts.mcmaster.ca/display/publication3461845\", \"journal\": \"Blood\", \"year\": \"2005\", \"doi\": \"10.1182/blood.v106.11.3219.3219\"}, {\"title\": \"Differences between patients\\u2019, physicians\\u2019 and pharmacists\\u2019 preferences for treatment products in haemophilia: a discrete choice experiment\", \"url\": \"https://experts.mcmaster.ca/display/publication411195\", \"journal\": \"Haemophilia\", \"year\": \"2005\", \"doi\": \"10.1111/j.1365-2516.2005.01159.x\"}, {\"title\": \"Performance Comparison of Three Assay Methods Used in Fasting and Postmethionine Load Plasma Homocysteine Determinations From Patients With Vascular Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication173137\", \"journal\": \"American Journal of Clinical Pathology\", \"year\": \"2005\", \"doi\": \"10.1309/0f85mtu8kl3d7jjp\"}, {\"title\": \"Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease\", \"url\": \"https://experts.mcmaster.ca/display/publication995646\", \"journal\": \"American Journal of Clinical Pathology\", \"year\": \"2005\", \"doi\": \"10.1309/0F85MTU8KI.3D7.JJP\"}, {\"title\": \"Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism\", \"url\": \"https://experts.mcmaster.ca/display/publication173135\", \"journal\": \"Current Pharmaceutical Design\", \"year\": \"2005\", \"doi\": \"10.2174/138161205774580534\"}, {\"title\": \"Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves\", \"url\": \"https://experts.mcmaster.ca/display/publication173141\", \"journal\": \"International Journal of Laboratory Hematology\", \"year\": \"2005\", \"doi\": \"10.1111/j.1365-2257.2005.00713.x\"}, {\"title\": \"Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B\", \"url\": \"https://experts.mcmaster.ca/display/publication173143\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2005\", \"doi\": \"10.1002/14651858.cd003429.pub2\"}, {\"title\": \"Interventions to enhance medication adherence\", \"url\": \"https://experts.mcmaster.ca/display/publication1161503\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2005\", \"doi\": \"10.1002/14651858.CD000011.pub2\"}, {\"title\": \"Corrigenda\", \"url\": \"https://experts.mcmaster.ca/display/publication1747345\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2004\", \"doi\": \"10.1111/j.1538-7836.2004.00945.x\"}, {\"title\": \"Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents (vol 2, pg 1055, 2004)\", \"url\": \"https://experts.mcmaster.ca/display/publication995722\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2004\"}, {\"title\": \"Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents\", \"url\": \"https://experts.mcmaster.ca/display/publication173234\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2004\", \"doi\": \"10.1111/j.1538-7836.2004.00753.x\"}, {\"title\": \"Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Beh\\u00e7et's disease and deep vein thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication173238\", \"journal\": \"Arthritis and Rheumatism\", \"year\": \"2004\", \"doi\": \"10.1002/art.20237\"}, {\"title\": \"Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants\", \"url\": \"https://experts.mcmaster.ca/display/publication173248\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2003\", \"doi\": \"10.1046/j.1538-7836.2003.00364.x\"}, {\"title\": \"Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen\", \"url\": \"https://experts.mcmaster.ca/display/publication173252\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2003\", \"doi\": \"10.1046/j.1538-7836.2003.00241.x\"}, {\"title\": \"Flow cytometric measurement of intracellular IFN-gamma induction in aged subjects before and after parenteral influenza vaccination.\", \"url\": \"https://experts.mcmaster.ca/display/publication1747329\", \"journal\": \"Developments in Biologicals\", \"year\": \"2003\"}, {\"title\": \"Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months\", \"url\": \"https://experts.mcmaster.ca/display/publication173228\", \"journal\": \"Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research\", \"year\": \"2003\", \"doi\": \"10.1159/000081508\"}, {\"title\": \"Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.\", \"url\": \"https://experts.mcmaster.ca/display/publication173270\", \"journal\": \"Haematologica\", \"year\": \"2002\"}, {\"title\": \"Influenza A Virus Specific T Cell Immunity in Humans during Aging\", \"url\": \"https://experts.mcmaster.ca/display/publication411197\", \"journal\": \"Virology\", \"year\": \"2002\", \"doi\": \"10.1006/viro.2002.1491\"}, {\"title\": \"Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication173284\", \"journal\": \"New England Journal of Medicine\", \"year\": \"2001\", \"doi\": \"10.1056/nejm200107193450302\"}, {\"title\": \"Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery\", \"url\": \"https://experts.mcmaster.ca/display/publication173290\", \"journal\": \"JAMA Internal Medicine\", \"year\": \"2000\", \"doi\": \"10.1001/archinte.160.15.2327\"}, {\"title\": \"Mesenteric-portal Vein Thrombosis in a Patient with Hyperhomocysteinemia and Heterozygous for 20210A Prothrombin Allele\", \"url\": \"https://experts.mcmaster.ca/display/publication173289\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2000\", \"doi\": \"10.1055/s-0037-1614025\"}, {\"title\": \"Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity\", \"url\": \"https://experts.mcmaster.ca/display/publication173292\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"2000\", \"doi\": \"10.1055/s-0037-1613916\"}, {\"title\": \"Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery\", \"url\": \"https://experts.mcmaster.ca/display/publication3461864\", \"journal\": \"Investigative Urology\", \"year\": \"1999\", \"doi\": \"10.1097/00005392-199910000-00130\"}, {\"title\": \"Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery\", \"url\": \"https://experts.mcmaster.ca/display/publication3461872\", \"journal\": \"Investigative Urology\", \"year\": \"1999\", \"doi\": \"10.1016/s0022-5347(05)68386-3\"}, {\"title\": \"Withdrawal of warfarin after deep vein thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication173299\", \"journal\": \"Blood Coagulation and Fibrinolysis\", \"year\": \"1999\", \"doi\": \"10.1097/00001721-199907000-00011\"}, {\"title\": \"Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery\", \"url\": \"https://experts.mcmaster.ca/display/publication3461863\", \"journal\": \"Obstetrical and Gynecological Survey\", \"year\": \"1998\", \"doi\": \"10.1097/00006254-199811000-00013\"}, {\"title\": \"Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery\", \"url\": \"https://experts.mcmaster.ca/display/publication173307\", \"journal\": \"New England Journal of Medicine\", \"year\": \"1998\", \"doi\": \"10.1056/nejm199807093390204\"}, {\"title\": \"Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism\", \"url\": \"https://experts.mcmaster.ca/display/publication995612\", \"journal\": \"Blood Coagulation and Fibrinolysis\", \"year\": \"1997\", \"doi\": \"10.1097/00001721-199706000-00002\"}, {\"title\": \"Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.\", \"url\": \"https://experts.mcmaster.ca/display/publication173310\", \"journal\": \"Blood Coagulation and Fibrinolysis\", \"year\": \"1997\", \"doi\": \"10.1097/00001721-199706000-00002\"}, {\"title\": \"Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication173315\", \"journal\": \"Clinical Pharmacokinetics\", \"year\": \"1997\", \"doi\": \"10.2165/00003088-199732020-00005\"}, {\"title\": \"Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents\", \"url\": \"https://experts.mcmaster.ca/display/publication173312\", \"journal\": \"Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research\", \"year\": \"1997\", \"doi\": \"10.1159/000217438\"}, {\"title\": \"Post-discharge deep-vein thrombosis after orthopaedic surgery\", \"url\": \"https://experts.mcmaster.ca/display/publication173317\", \"journal\": \"The Lancet\", \"year\": \"1996\", \"doi\": \"10.1016/s0140-6736(05)65324-x\"}, {\"title\": \"Increased Plasma Levels of Tissue Factor Pathway Inhibitor (TFPI) after n-3 Polyunsaturated Fatty Acids Supplementation in Patients with Chronic Atherosclerotic Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication173319\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1996\", \"doi\": \"10.1055/s-0038-1650285\"}, {\"title\": \"Post Discharge Clinically Overt Venous Thromboembolism in Orthopaedic Surgery Patients with Negative Venography -an Overview Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication173316\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1996\", \"doi\": \"10.1055/s-0038-1650681\"}, {\"title\": \"Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins\", \"url\": \"https://experts.mcmaster.ca/display/publication173320\", \"journal\": \"Circulation\", \"year\": \"1995\", \"doi\": \"10.1161/01.cir.92.10.2819\"}, {\"title\": \"Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.\", \"url\": \"https://experts.mcmaster.ca/display/publication173321\", \"journal\": \"Translational Research\", \"year\": \"1995\"}, {\"title\": \"Dermatan sulphate in heparin-induced thrombocytopenia\", \"url\": \"https://experts.mcmaster.ca/display/publication173322\", \"journal\": \"The Lancet\", \"year\": \"1994\", \"doi\": \"10.1016/s0140-6736(94)90780-3\"}, {\"title\": \"Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications\", \"url\": \"https://experts.mcmaster.ca/display/publication173323\", \"journal\": \"Seminars in Thrombosis and Hemostasis\", \"year\": \"1994\", \"doi\": \"10.1055/s-2007-1001912\"}, {\"title\": \"Antipyretic analgesics\", \"url\": \"https://experts.mcmaster.ca/display/publication1747354\", \"journal\": \"Side Effects of Drugs Annual\", \"year\": \"1994\", \"doi\": \"10.1016/s0378-6080(05)80253-3\"}, {\"title\": \"Streptokinase and rt-PA activate platelets by a different way: Implications on the rethrombosis rate after their administration in myocardial infarction\", \"url\": \"https://experts.mcmaster.ca/display/publication3461868\", \"journal\": \"Fibrinolysis and Proteolysis\", \"year\": \"1994\", \"doi\": \"10.1016/0268-9499(94)90489-8\"}, {\"title\": \"Fibrinogen degradation products generation is the major determinant of platelet inhibition induced by plasminogen activators in platelet-rich plasma\", \"url\": \"https://experts.mcmaster.ca/display/publication995622\", \"journal\": \"Fibrinolysis and Proteolysis\", \"year\": \"1993\", \"doi\": \"10.1016/0268-9499(93)90062-z\"}, {\"title\": \"Thrombolytic and haemorrhagic effects of bolus doses of rt-PA and A hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935)\", \"url\": \"https://experts.mcmaster.ca/display/publication3461873\", \"journal\": \"Thrombosis Research\", \"year\": \"1993\", \"doi\": \"10.1016/0049-3848(93)90428-q\"}, {\"title\": \"PB2629: LATE DIAGNOSIS OF TWO ADULT SIBLINGS WITH BERNARD SOULIER SYNDROME (BSS)\", \"url\": \"https://experts.mcmaster.ca/display/publication3461840\", \"journal\": \"HemaSphere\", \"doi\": \"10.1097/01.hs9.0000977204.63685.a6\"}, {\"title\": \"PB2647: USE OF EMICIZUMAB FOR THE TREATMENT OF ACQUIRED HEMOPHILIA A: A SYSTEMATIC REVIEW\", \"url\": \"https://experts.mcmaster.ca/display/publication3461841\", \"journal\": \"HemaSphere\", \"doi\": \"10.1097/01.hs9.0000977272.39179.7d\"}, {\"title\": \"Psychological interventions for people with hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication3461865\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"doi\": \"10.1002/14651858.cd010215\"}, {\"title\": \"Reflections on the Canadian Bleeding Disorders Registry: Lessons Learned and Future Perspectives\", \"url\": \"https://experts.mcmaster.ca/display/publication2716670\", \"journal\": \"Canadian Journal of Health Technologies\", \"doi\": \"10.51731/cjht.2022.425\"}], \"chapters\": [{\"title\": \"Non-Anticoagulant Actions of Glycosaminoglycans\", \"url\": \"https://experts.mcmaster.ca/display/publication3461866\", \"year\": \"1996\", \"doi\": \"10.1007/978-1-4613-0371-8_8\"}], \"conferences\": [{\"title\": \"Test\\u2013retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995654\", \"journal\": \"Haemophilia\", \"year\": \"2024\", \"doi\": \"10.1111/hae.14969\"}, {\"title\": \"Characterisation of the first global VWD cohort from the WFH world bleeding disorders registry\", \"url\": \"https://experts.mcmaster.ca/display/publication3513406\", \"journal\": \"Haemophilia\", \"year\": \"2024\"}, {\"title\": \"Evolution of haemophilia care: Analysing factor VIII usage trends and the impact of novel therapies\", \"url\": \"https://experts.mcmaster.ca/display/publication3513404\", \"journal\": \"Haemophilia\", \"year\": \"2024\"}, {\"title\": \"Gene therapy with the Padua variant of a codon-optimised human factor IX gene etranacogene dezaparvovec in people with haemophilia B: Effects on patient-oriented outcomes measured using the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire in the HOPE-B study\", \"url\": \"https://experts.mcmaster.ca/display/publication3513402\", \"journal\": \"Haemophilia\", \"year\": \"2024\"}, {\"title\": \"Real-world effectiveness of pegylated, recombinant antihaemophilic factor (Rurioctocog alfa pegol) prophylaxis in patients with haemophilia A in Canada: A retrospective, intra-patient comparison with a before-after design\", \"url\": \"https://experts.mcmaster.ca/display/publication3513405\", \"journal\": \"Haemophilia\", \"year\": \"2024\"}, {\"title\": \"Self-reflections, lessons learned and suggestions for data quality assurance from a retrospective data analysis from the Canadian Bleeding Disorders Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication3513403\", \"journal\": \"Haemophilia\", \"year\": \"2024\"}, {\"title\": \"Comparing inhibitor development in (plasma derived vs. recombinant) FVIII/FIX concentrates in severe haemophilia: Reporting on 1392 PUPs from EUHASS and canadian registries\", \"url\": \"https://experts.mcmaster.ca/display/publication3429332\", \"journal\": \"Haemophilia\", \"year\": \"2024\"}, {\"title\": \"International data integration program of the WFH world bleeding disorders registry: bringing europe data to the global stage\", \"url\": \"https://experts.mcmaster.ca/display/publication3429333\", \"journal\": \"Haemophilia\", \"year\": \"2024\"}, {\"title\": \"Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication3403139\", \"journal\": \"Blood\", \"year\": \"2023\", \"doi\": \"10.1182/blood-2023-174057\"}, {\"title\": \"A COMPARATIVE STUDY OF DIFFERENT METHODS OF HANDLING MISSING DATA IN PATIENT REPORTED OUTCOMES, BURDENS AND EXPERIENCES (PROBE) SCORE ALGORITHM AMONG PEOPLE WITH HEMOPHILIA\", \"url\": \"https://experts.mcmaster.ca/display/publication2980744\", \"journal\": \"American Journal of Hematology\", \"year\": \"2023\"}, {\"title\": \"BUILDING A GLOBAL RESOURCE FOR THE LONG-TERM FOLLOW-UP OF HEMOPHILIA PATIENTS TREATED WITH GENE THERAPY: COLLABORATION BETWEEN THE WORLD FEDERATION OF HEMOPHILIA AND NATIONAL REGISTRIES\", \"url\": \"https://experts.mcmaster.ca/display/publication3282185\", \"journal\": \"Haemophilia\", \"year\": \"2023\"}, {\"title\": \"COLLABORATION FOR THE LONG-TERM FOLLOW-UP OF PEOPLE WITH HEMOPHILIA TREATED WITH GENE THERAPY: WORLD FEDERATION OF HEMOPHILIA- AMERICAN THROMBOSIS AND HEMOSTASIS NETWORK\", \"url\": \"https://experts.mcmaster.ca/display/publication2981099\", \"journal\": \"American Journal of Hematology\", \"year\": \"2023\"}, {\"title\": \"TEST-RETEST RELIABILITY ANALYSIS OF THE PATIENT REPORTED OUTCOMES BURDENS AND EXPERIENCES (PROBE) STUDY\", \"url\": \"https://experts.mcmaster.ca/display/publication3281999\", \"journal\": \"Haemophilia\", \"year\": \"2023\"}, {\"title\": \"Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication2922803\", \"journal\": \"Blood\", \"year\": \"2022\", \"doi\": \"10.1182/blood-2022-157531\"}, {\"title\": \"COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS\", \"url\": \"https://experts.mcmaster.ca/display/publication2424575\", \"journal\": \"Value in Health\", \"year\": \"2022\"}, {\"title\": \"Comparison of change in number of identified people with haemophilia A and factor VIII use per patient over time\", \"url\": \"https://experts.mcmaster.ca/display/publication2188826\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"Empowering people with haemophilia to take control of their care and treatment through myWBDR and myPROBE-A patient-reported outcomes tool for achieving a 360-degree patient-centred evaluation\", \"url\": \"https://experts.mcmaster.ca/display/publication2187647\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"Feasibility of integrating PROBE (patient reported outcomes, burdens and experiences) into a clinical care pathway to facilitate transformation to a value-based health care model in haemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication2187650\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"Integration of the Mexican Registry of Coagulopathies (RMC) with PROBE\", \"url\": \"https://experts.mcmaster.ca/display/publication2187649\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"Prevalence of selected bleeding and thrombotic events in persons with congenital haemophilia versus the general non-haemophilia population\", \"url\": \"https://experts.mcmaster.ca/display/publication2188825\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"Using the World Federation of Haemophilia gene therapy registry for the long-term follow-up of haemophilia patients treated with gene therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication2187651\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"WFH world bleeding disorders registry highlights gaps in haemophilia diagnosis and management\", \"url\": \"https://experts.mcmaster.ca/display/publication2188824\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"CANADIAN CLINICAL EXPERIENCE ON SWITCHING FROM OCTOCOG ALFA TO EXTENDED-HALF-LIFE FVIII DAMOCTOCOG ALFA PEGOL IN PATIENTS WITH SEVERE HAEMOPHILIA A\", \"url\": \"https://experts.mcmaster.ca/display/publication2165640\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY - A GLOBAL RESOURCE FOR THE LONG-TERM FOLLOW-UP OF HEMOPHILIA PATIENTS TREATED WITH GENE THERAPY\", \"url\": \"https://experts.mcmaster.ca/display/publication2165639\", \"journal\": \"Haemophilia\", \"year\": \"2022\"}, {\"title\": \"Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication2427707\", \"journal\": \"Blood\", \"year\": \"2021\", \"doi\": \"10.1182/blood-2021-147195\"}, {\"title\": \"Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study\", \"url\": \"https://experts.mcmaster.ca/display/publication2428077\", \"journal\": \"Blood\", \"year\": \"2021\", \"doi\": \"10.1182/blood-2021-147550\"}, {\"title\": \"ANALYSIS OF HEMOPHILIA PATIENT IDENTIFICATION IN DIFFERENT ECONOMIC SETTINGS\", \"url\": \"https://experts.mcmaster.ca/display/publication1962896\", \"journal\": \"Haemophilia\", \"year\": \"2021\"}, {\"title\": \"EQUITY IN THE USE OF PROPHYLAXIS IN CHILDREN WITH SEVERE HEMOPHILIA\", \"url\": \"https://experts.mcmaster.ca/display/publication1962898\", \"journal\": \"Haemophilia\", \"year\": \"2021\"}, {\"title\": \"THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY\", \"url\": \"https://experts.mcmaster.ca/display/publication1962004\", \"journal\": \"Haemophilia\", \"year\": \"2021\"}, {\"title\": \"WORLD BLEEDING DISORDERS REGISTRY SHOWCASES DISPARITIES IN HEMOPHILIA CARE AROUND THE WORLD\", \"url\": \"https://experts.mcmaster.ca/display/publication1962897\", \"journal\": \"Haemophilia\", \"year\": \"2021\"}, {\"title\": \"Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication1963023\", \"journal\": \"Blood\", \"year\": \"2020\", \"doi\": \"10.1182/blood-2020-137320\"}, {\"title\": \"Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database\", \"url\": \"https://experts.mcmaster.ca/display/publication3434164\", \"journal\": \"Blood\", \"year\": \"2020\", \"doi\": \"10.1182/blood-2020-142816\"}, {\"title\": \"Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication3434165\", \"journal\": \"Blood\", \"year\": \"2020\", \"doi\": \"10.1182/blood-2020-136586\"}, {\"title\": \"Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments\", \"url\": \"https://experts.mcmaster.ca/display/publication3434163\", \"journal\": \"Blood\", \"year\": \"2020\", \"doi\": \"10.1182/blood-2020-141801\"}, {\"title\": \"Comparative PK evaluation of SHL vs EHL by non-compartmental and compartmental population PK analysis in patients with severe and moderate HA\", \"url\": \"https://experts.mcmaster.ca/display/publication1914750\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"Data is the new currency: The World Bleeding Disorders Registry Data Quality Accreditation Program\", \"url\": \"https://experts.mcmaster.ca/display/publication1914744\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"Education in people with Hemophilia - Insights from the PROBE Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1914746\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"International Standard Set of Health Outcomes that matter for people living with hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1914745\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"What the future might look like-The PROBE Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1894316\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"ASSESSING A POPULATION PHARMACOKINETIC MODEL OF A PLASMA-DERIVED, VON WILLEBRAND FACTOR-CONTAINING FVIII CONCENTRATE FOR BAYESIAN FORECASTING IN LOW DOSE SCENARIOS\", \"url\": \"https://experts.mcmaster.ca/display/publication1694212\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY\", \"url\": \"https://experts.mcmaster.ca/display/publication1692273\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"INTERNATIONAL STANDARD SET OF HEALTH OUTCOMES THAT MATTER FOR PEOPLE LIVING WITH HEMOPHILIA\", \"url\": \"https://experts.mcmaster.ca/display/publication1692275\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS\", \"url\": \"https://experts.mcmaster.ca/display/publication1694213\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"REPORT ON THE ANNUAL GLOBAL SURVEY-20 YEARS ON AND MORE INFORMATIVE\", \"url\": \"https://experts.mcmaster.ca/display/publication1694211\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"THE WORLD BLEEDING DISORDERS REGISTRY CELEBRATES 2 YEARS!\", \"url\": \"https://experts.mcmaster.ca/display/publication1694210\", \"journal\": \"Haemophilia\", \"year\": \"2020\"}, {\"title\": \"Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1942922\", \"journal\": \"Blood\", \"year\": \"2019\", \"doi\": \"10.1182/blood-2019-127046\"}, {\"title\": \"Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products\", \"url\": \"https://experts.mcmaster.ca/display/publication1942921\", \"journal\": \"Blood\", \"year\": \"2019\", \"doi\": \"10.1182/blood-2019-127946\"}, {\"title\": \"Routine Double Filtration Plasmapheresis Affects Hemostatic Proteins and Prolongs Clotting Tests\", \"url\": \"https://experts.mcmaster.ca/display/publication1942080\", \"journal\": \"Blood\", \"year\": \"2019\", \"doi\": \"10.1182/blood-2019-127524\"}, {\"title\": \"Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization\", \"url\": \"https://experts.mcmaster.ca/display/publication1500755\", \"journal\": \"Journal of Pharmacokinetics and Pharmacodynamics\", \"year\": \"2019\", \"doi\": \"10.1007/s10928-019-09634-7\"}, {\"title\": \"Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients\", \"url\": \"https://experts.mcmaster.ca/display/publication1600586\", \"journal\": \"Journal of Pharmacokinetics and Pharmacodynamics\", \"year\": \"2019\", \"doi\": \"10.1007/s10928-019-09637-4\"}, {\"title\": \"PROSPECTIVE STUDY OF THE IMMUNOLOGICAL RES PONSE TO FACTOR VIII IN SEVERE HEMOPHILIA A PATIENTS DURING IMMUNE TOLERANCE INDUCTION TREATMENT\", \"url\": \"https://experts.mcmaster.ca/display/publication1671698\", \"journal\": \"Haematologica\", \"year\": \"2019\"}, {\"title\": \"coreHEM, a Multistakeholder Core Outcome Set Project for Gene Therapy in Hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1639464\", \"journal\": \"Molecular Therapy\", \"year\": \"2019\"}, {\"title\": \"ASSESSMENT OF PHARMACOKINETIC BAYESIAN PREDICTIONS IN HEMOPHILIA B USING LIMITED SAMPLING ANALYSIS.\", \"url\": \"https://experts.mcmaster.ca/display/publication1632300\", \"journal\": \"Clinical Pharmacology and Therapeutics\", \"year\": \"2019\"}, {\"title\": \"Part-time employment and early retirement in people with severe haemophilia: Insights from the PROBE study\", \"url\": \"https://experts.mcmaster.ca/display/publication1628469\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"Predictors for acute and chronic pain in patients with severe haemophilia in the PROBE cohort\", \"url\": \"https://experts.mcmaster.ca/display/publication1628470\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"The WFH world bleeding disorders registry\", \"url\": \"https://experts.mcmaster.ca/display/publication1629942\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"The Web-Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-HEMO) contribution to tailoring treatment in children: Examples for hemophilia A and B\", \"url\": \"https://experts.mcmaster.ca/display/publication1629941\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"Using individual pharmacokinetic parameters on octocog alfa to predict individual pharmacokinetic parameters on efmoroctocog alfa in persons with hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1629943\", \"journal\": \"Haemophilia\", \"year\": \"2019\"}, {\"title\": \"Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform\", \"url\": \"https://experts.mcmaster.ca/display/publication1632298\", \"journal\": \"Blood\", \"year\": \"2018\", \"doi\": \"10.1182/blood-2018-99-115308\"}, {\"title\": \"Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada\", \"url\": \"https://experts.mcmaster.ca/display/publication1632119\", \"journal\": \"Blood\", \"year\": \"2018\", \"doi\": \"10.1182/blood-2018-99-113858\"}, {\"title\": \"Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1630926\", \"journal\": \"Blood\", \"year\": \"2018\", \"doi\": \"10.1182/blood-2018-99-119568\"}, {\"title\": \"Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of anti-hemophilic factor recombinant plasma/albumin-free method (rAHF-PFM) concentrate in patients with Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1541344\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem\", \"url\": \"https://experts.mcmaster.ca/display/publication1581308\", \"journal\": \"Value in Health\", \"year\": \"2018\", \"doi\": \"10.1016/j.jval.2018.04.1439\"}, {\"title\": \"The PROBE Data Dashboard - A new tool for real-time data visualization and analysis of patient reported outcomes\", \"url\": \"https://experts.mcmaster.ca/display/publication1543698\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"The PROBE Study - Global burden of bleeding from the mouth in Haemophilia - a call to action\", \"url\": \"https://experts.mcmaster.ca/display/publication1543701\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"The WFH World Bleeding Disorders Registry\", \"url\": \"https://experts.mcmaster.ca/display/publication1543700\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"coreHEM: A multi-stakeholder approach to developing a core outcome set for gene therapy in hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication1543702\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice\", \"url\": \"https://experts.mcmaster.ca/display/publication1543699\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of factor VIII concentrate in patients with hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication1498587\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study\", \"url\": \"https://experts.mcmaster.ca/display/publication1498586\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice\", \"url\": \"https://experts.mcmaster.ca/display/publication1498585\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"Perioperative management for patients with congenital factor XI deficiency\", \"url\": \"https://experts.mcmaster.ca/display/publication1498588\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"The WFH world bleeding disorders registry\", \"url\": \"https://experts.mcmaster.ca/display/publication1498589\", \"journal\": \"Haemophilia\", \"year\": \"2018\"}, {\"title\": \"Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1979440\", \"journal\": \"Blood\", \"year\": \"2017\"}, {\"title\": \"Comparative Assessment of the Performance of Pharmacokinetic Tools for Prophylactic Dosing of Antihemophilic Factor Recombinant Plasma/Albumin-Free Method (rAHF-PFM) Concentrate in Patients with Hemophilia A\", \"url\": \"https://experts.mcmaster.ca/display/publication3272670\", \"journal\": \"Blood\", \"year\": \"2017\"}, {\"title\": \"Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a\", \"url\": \"https://experts.mcmaster.ca/display/publication1589072\", \"journal\": \"Blood\", \"year\": \"2017\"}, {\"title\": \"Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3272671\", \"journal\": \"Blood\", \"year\": \"2017\"}, {\"title\": \"Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1979441\", \"journal\": \"Blood\", \"year\": \"2017\"}, {\"title\": \"The Development of the World Bleeding Disorders Registry Pilot Phase\", \"url\": \"https://experts.mcmaster.ca/display/publication995663\", \"journal\": \"Haemophilia\", \"year\": \"2017\"}, {\"title\": \"An individual participant data meta-analysis of 13 randomized trials to evaluate the impact of prophylactic use of heparin in oncological patients\", \"url\": \"https://experts.mcmaster.ca/display/publication1563461\", \"journal\": \"Blood\", \"year\": \"2017\", \"doi\": \"10.1182/blood.v130.suppl_1.626.626\"}, {\"title\": \"Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome\", \"url\": \"https://experts.mcmaster.ca/display/publication1471695\", \"journal\": \"Arthritis & Rheumatology\", \"year\": \"2017\"}, {\"title\": \"THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome\", \"url\": \"https://experts.mcmaster.ca/display/publication1477831\", \"journal\": \"Annals of the Rheumatic Diseases\", \"year\": \"2017\", \"doi\": \"10.1136/annrheumdis-2017-eular.2085\"}, {\"title\": \"The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1563464\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2017\", \"doi\": \"10.1111/jth.14824\"}, {\"title\": \"Clinical and Biological Determinants of Bleeding Manifestation in Congenital Factor XI Deficiency; A Systematic Review\", \"url\": \"https://experts.mcmaster.ca/display/publication995657\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.1407.1407\"}, {\"title\": \"Installing FVIII-Specific Tolerance in Hemophilia Via Engagement of the Aryl Hydrocarbon Receptor By Tryptophan Derivatives\", \"url\": \"https://experts.mcmaster.ca/display/publication995659\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.2563.2563\"}, {\"title\": \"Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate\\u00ae)\", \"url\": \"https://experts.mcmaster.ca/display/publication995656\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.2593.2593\"}, {\"title\": \"Perioperative Management for Congenital Factor XI Deficiency; A Systematic Review\", \"url\": \"https://experts.mcmaster.ca/display/publication995658\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.3796.3796\"}, {\"title\": \"Perioperative Management of Von Willebrand Disease, a Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication995664\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.1408.1408\"}, {\"title\": \"Rwd Study for Epidemiology and Characteristics of Patients with Multiple Myeloma in Italy\", \"url\": \"https://experts.mcmaster.ca/display/publication995652\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.5693.5693\"}, {\"title\": \"Test-Retest Reliability Analysis of the Patient Reported Outcomes Burdens and Experiences (PROBE)\", \"url\": \"https://experts.mcmaster.ca/display/publication995651\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.5964.5964\"}, {\"title\": \"The Effect of Platelet Transfusion on Death in the Intensive Care Unit\", \"url\": \"https://experts.mcmaster.ca/display/publication554330\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.3850.3850\"}, {\"title\": \"Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication710721\", \"journal\": \"Blood\", \"year\": \"2016\", \"doi\": \"10.1182/blood.v128.22.3821.3821\"}, {\"title\": \"NHF-MCMASTER GUIDELINE ON CARE MODELS FOR HEMOPHILIA MANAGEMENT\", \"url\": \"https://experts.mcmaster.ca/display/publication626825\", \"journal\": \"American Journal of Hematology\", \"year\": \"2016\"}, {\"title\": \"Hemophilia research and clinical care needs: Regional variation in future priorities\", \"url\": \"https://experts.mcmaster.ca/display/publication995672\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Home therapy consensus in an under resourced hemophilia setting\", \"url\": \"https://experts.mcmaster.ca/display/publication995680\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Measuring the quality of hemophilia care across different settings: a set of performance indices derived from demographics data\", \"url\": \"https://experts.mcmaster.ca/display/publication995671\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"The patient reported outcomes burdens and experiences (PROBE) study phase 1 methodology and feasibility results\", \"url\": \"https://experts.mcmaster.ca/display/publication995670\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"When health care professionals express themselves: results overview of the qualitative phase of Hero initiative\", \"url\": \"https://experts.mcmaster.ca/display/publication995673\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"The patient reported outcome burdens and experiences (PROBE) study - phase 1 results show PROBE study methodology feasible\", \"url\": \"https://experts.mcmaster.ca/display/publication995693\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2016\"}, {\"title\": \"Evidence Based Haemophilia Care - Current Status and Where to Go?\", \"url\": \"https://experts.mcmaster.ca/display/publication995697\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Haemophilia Research and Clinical Care Needs: Assessing Future Priorities\", \"url\": \"https://experts.mcmaster.ca/display/publication995701\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Health Status of Elderly Persons with Hemophilia Compared with the General Population: The Sphera Study\", \"url\": \"https://experts.mcmaster.ca/display/publication995683\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Nonacog Alfa as Prophylaxis in Moderately Severe to Severe (FIX:C <= 2%) Hemophilia B Patients: Identifying Clinical Predictors of Response\", \"url\": \"https://experts.mcmaster.ca/display/publication995700\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"The Patient Reported Outcomes, Burdens, and Experiences (Probe) Phase 1 Study Methodology and Feasibility\", \"url\": \"https://experts.mcmaster.ca/display/publication995689\", \"journal\": \"Haemophilia\", \"year\": \"2016\"}, {\"title\": \"Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication440320\", \"journal\": \"Blood\", \"year\": \"2015\", \"doi\": \"10.1182/blood.v126.23.1120.1120\"}, {\"title\": \"Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors\", \"url\": \"https://experts.mcmaster.ca/display/publication440317\", \"journal\": \"Blood\", \"year\": \"2015\", \"doi\": \"10.1182/blood.v126.23.428.428\"}, {\"title\": \"Safety and Effectiveness of Desmopressin for the Management of Delivery and Major Surgery in Patients with Mild-Moderate Von Willebrand Disease: Final Analysis of the Prodeswil Study\", \"url\": \"https://experts.mcmaster.ca/display/publication995699\", \"journal\": \"Blood\", \"year\": \"2015\", \"doi\": \"10.1182/blood.v126.23.759.759\"}, {\"title\": \"Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis\", \"url\": \"https://experts.mcmaster.ca/display/publication440289\", \"journal\": \"Blood\", \"year\": \"2015\", \"doi\": \"10.1182/blood.v126.23.430.430\"}, {\"title\": \"Study Design: A Critical Aspect of Research\", \"url\": \"https://experts.mcmaster.ca/display/publication995719\", \"journal\": \"Haemophilia\", \"year\": \"2015\"}, {\"title\": \"Web Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-Hemo): A Service for Bayesian Post Hoc Estimation\", \"url\": \"https://experts.mcmaster.ca/display/publication995695\", \"journal\": \"Journal of Pharmacokinetics and Pharmacodynamics\", \"year\": \"2015\"}, {\"title\": \"A population approach to hemophilia pharmacokinetics. Wapps: a web-service for bayesian post hoc estimation\", \"url\": \"https://experts.mcmaster.ca/display/publication623885\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Assessing the indication and success of treatment for haemophilia patients: results from a delphi panel\", \"url\": \"https://experts.mcmaster.ca/display/publication995716\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Bayesian approach to the assessment of the population specific risk of inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication623879\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Determinants of inhibitor development in previously treated hemophilia A patients\", \"url\": \"https://experts.mcmaster.ca/display/publication771728\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Indirect comparisons of factor consumption, bleeding rates, and infusion frequencies during routine prophylaxis with recombinant factor IX FC fusion protein and other recombinant factor IX products\", \"url\": \"https://experts.mcmaster.ca/display/publication995704\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Indirect comparisons of factor consumption, bleeding rates, and infusion frequencies during routine prophylaxis with recombinant factor VIII FC fusion protein and other recombinant factor VIII products\", \"url\": \"https://experts.mcmaster.ca/display/publication995708\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Investigating potential determinants of ITI success using immune gene expression profiling: a preliminary study\", \"url\": \"https://experts.mcmaster.ca/display/publication995702\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"OPTIMAL DURATION OF ANTICOAGULANT THERAPY FOR THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS\", \"url\": \"https://experts.mcmaster.ca/display/publication995712\", \"journal\": \"Haematologica\", \"year\": \"2015\"}, {\"title\": \"Pharmacokinetic characteristics of factor VIII and IX concentrates - a systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication623901\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Surveillance study of safety and efficacy of a VWF/FVIII concentrate in patients with von willebrand disease (WIL-20) - a planned interim analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication995707\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Utilization of anti-inhibitors products and inhibitors status of severe hemophilia patients: 5 years national data from the Canadian hemophilia assessment and resource management system\", \"url\": \"https://experts.mcmaster.ca/display/publication995703\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2015\"}, {\"title\": \"Population pharmacokinetics for busy clinicians and active patients: how to get the most out of it?\", \"url\": \"https://experts.mcmaster.ca/display/publication995737\", \"journal\": \"Haemophilia\", \"year\": \"2015\"}, {\"title\": \"A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication623891\", \"journal\": \"Blood\", \"year\": \"2014\", \"doi\": \"10.1182/blood.v124.21.2821.2821\"}, {\"title\": \"Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients\", \"url\": \"https://experts.mcmaster.ca/display/publication771740\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2014\"}, {\"title\": \"Risk of inhibitor development in previously treated patients with positive inhibitor history or low titer of inhibitor at baseline: results of a survey of hemophilia experts\", \"url\": \"https://experts.mcmaster.ca/display/publication623977\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2014\"}, {\"title\": \"An evaluation of whether the ankle is now the dominant site of chronic hemophilic arthropathy in young adults with severe hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication995759\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"An indirect comparison of the efficacy of prophylactic use of rFIXFc and other rFIX products and simulation of the effect of compliance on effectiveness\", \"url\": \"https://experts.mcmaster.ca/display/publication995755\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"An indirect comparison of the efficacy of prophylactic use of rFVIIIFc and other rFVIII products and model of the effect of compliance\", \"url\": \"https://experts.mcmaster.ca/display/publication995747\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Assessment of patient preferences and perceived value of the comprehensive interdisciplinary combined hemophilia and orthopedic clinic using a validated questionnaire\", \"url\": \"https://experts.mcmaster.ca/display/publication959070\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Cardiac risk factors in older patients with hemophilia: Report of the age related cardiovascular disease in hemophilia epidemiologic research (archer) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995760\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Factor VII deficiency patients: 5 years factors concentrates utilization trend based on the Canadian Hemophilia Assessment and Resource Management System (CHARMS)\", \"url\": \"https://experts.mcmaster.ca/display/publication995752\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Factors influencing quality of life in Chinese adults with hemophilia: Results from the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995728\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Fathers' and Mothers' Perceptions and Communication on Carrier Status and Diagnosis of Congenital Haemophilia: Global Results from the Haemophilia Experiences, Results and Opportunities (HERO) Study\", \"url\": \"https://experts.mcmaster.ca/display/publication995725\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Investigating Attitudes and Practices of Canadian Physiotherapists on Sexual Health: A Comparison to the HERO Dataset\", \"url\": \"https://experts.mcmaster.ca/display/publication995726\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Physiotherapy and point of care ultrasonography in the management of hemophilia: Training phase\", \"url\": \"https://experts.mcmaster.ca/display/publication959071\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Safety of antihemophilic factor recombinant plasma/albumin-free method [rAHF-PFM] in hemophilia A patients with low titer inhibitors or a personal history of inhibitor: A meta-analysis of ADVATE Post-Authorization Safety Studies data\", \"url\": \"https://experts.mcmaster.ca/display/publication624036\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Does product type influence the development on inhibitor in PTPs and PUPs?\", \"url\": \"https://experts.mcmaster.ca/display/publication995756\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Does product type influence the development on inhibitor in PTPs and PUPs?\", \"url\": \"https://experts.mcmaster.ca/display/publication995770\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients\", \"url\": \"https://experts.mcmaster.ca/display/publication771722\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"The use of FVIII concentrate in hemophilia A patients with low titer inhibitors or a personal history of inhibitor: a meta-analysis of advate post-authorization safety studies in different countries\", \"url\": \"https://experts.mcmaster.ca/display/publication624005\", \"journal\": \"Haemophilia\", \"year\": \"2014\"}, {\"title\": \"Venous thromboembolism prophylaxis in elderly patients admitted to Italian internal medicine wards\", \"url\": \"https://experts.mcmaster.ca/display/publication995769\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Developing a Two-Sided Intervention To Facilitate Shared Decision Making In Haemophilia: Decision Boxes For Clinicians and Brief Patient Decision Aids For Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication771741\", \"journal\": \"Blood\", \"year\": \"2013\"}, {\"title\": \"Association between treatment regimen and quality of life assessed by EQ-5D-3L and pain interference in adults with haemophilia with and without inhibitors in the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995741\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Association of treatment regimen and location with bleed frequency, quality of life and comorbidities in adults and children with haemophilia from the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995749\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia A patients carrying F8 gene null mutations\", \"url\": \"https://experts.mcmaster.ca/display/publication995750\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Do bleed rates and haemophilia treatment centre/provider utilisation vary with physical activity risk in adults with haemophilia: An analysis from the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995746\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Do inhibitors, treatment regimen and bleed frequency impact haemophilia treatment centre and provider utilisation: an analysis of adults with haemophilia in the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995758\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Do inhibitors, treatment regimen and bleed frequency impact parent-directed haemophilia treatment centre and provider utilisation: An analysis of parents of children with haemophilia in the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995742\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Does higher risk activity change bleed frequency and haemophilia treatment center/provider utilisation in children with haemophilia: an analysis from the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995748\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Effect of type and intensity of FVIII exposure on inhibitors development in hemophilia A: first results of an individual patient data meta-analytic project\", \"url\": \"https://experts.mcmaster.ca/display/publication995751\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"External validation and updating of the Vienna Prediction Model for recurrent venous thromboembolism using a pooled individual patient data database\", \"url\": \"https://experts.mcmaster.ca/display/publication995743\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Meta-analysis of Post Authorization Safety Studies: worldwide postmarking surveillance of hemophilia A patients treated with antihemophilic factor recombinant plasma/albumin-free method rAHF-PFM\", \"url\": \"https://experts.mcmaster.ca/display/publication624017\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Potential relationships between negative impacts on employment or relationships and haemophilia treatment centre/provider utilisation: an analysis of adults with haemophilia from the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995754\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Potential relationships between negative impacts on employment or relationships with haemophilia centre/provider utilisation: An analysis of parents of children with haemophilia from the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995753\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Quality of life and well-being of haemophilia patients and parents in China: subgroup analysis of the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995757\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Relationship of quality of life, pain and self-reported arthritis with activity, bleed rate and haemophilia treatment centre/provider utilisation: results from the HERO study\", \"url\": \"https://experts.mcmaster.ca/display/publication995745\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2013\"}, {\"title\": \"Access to haemophilia treatment centres (HTCS), treatment and information sources: european results from the hero study\", \"url\": \"https://experts.mcmaster.ca/display/publication995771\", \"journal\": \"Haemophilia\", \"year\": \"2013\"}, {\"title\": \"Demographic characteristics of European respondents in the hero study\", \"url\": \"https://experts.mcmaster.ca/display/publication995776\", \"journal\": \"Haemophilia\", \"year\": \"2013\"}, {\"title\": \"Effect of turoctocog alfa on quality of life of children, adolescents and adults with haemophilia A: results from two clinical trials\", \"url\": \"https://experts.mcmaster.ca/display/publication995765\", \"journal\": \"Haemophilia\", \"year\": \"2013\"}, {\"title\": \"Effects of haemophilia on relationships, intimacy and family: european results from the hero study\", \"url\": \"https://experts.mcmaster.ca/display/publication995764\", \"journal\": \"Haemophilia\", \"year\": \"2013\"}, {\"title\": \"Quality of life in adults with haemophilia: european results from the hero study\", \"url\": \"https://experts.mcmaster.ca/display/publication995767\", \"journal\": \"Haemophilia\", \"year\": \"2013\"}, {\"title\": \"Hemophilia Experiences, Results and Opportunities (HERO) Study: US Respondent Demographics and Impact of Diagnosis On Career and Lifestyle Decisions and Quality of Life\", \"url\": \"https://experts.mcmaster.ca/display/publication995785\", \"journal\": \"Blood\", \"year\": \"2012\", \"doi\": \"10.1182/blood.v120.21.4244.4244\"}, {\"title\": \"Assessment of treatment-related risk factors for inhibitor development in previously untreated hemophilia A patients: Different statistical approaches\", \"url\": \"https://experts.mcmaster.ca/display/publication995787\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Clinical presentation and management of adult patients responding to the Hemophilia Experiences Results Opportunities (HERO) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995786\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Clinical presentation and management of pediatric hemophilia patients as reported by parents surveyed in the Haemophilia Experiences Results Opportunities (HERO) survey\", \"url\": \"https://experts.mcmaster.ca/display/publication995794\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Demographic characteristics of adult patient respondents in the Hemophilia Experiences Results Opportunities (HERO) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995790\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Demographic characteristics of parents of children/adolescents with hemophilia responding in the Hemophilia Experiences Results Opportunities (HERO) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995793\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Hemophilia knowledge and frequently used and valued information sources: Patient/parent perceptions from the Hero study\", \"url\": \"https://experts.mcmaster.ca/display/publication995788\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Impact of hemophilia on interpersonal relationships: Assessment of parent/caregiver respondents in the hemophilia experiences, results, opportunities (hero) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995780\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Impact of hemophilia on relationships with partners, family, and friends: Assessment of adult patient respondents in the hemophilia experiences, results, opportunities (HERO) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995791\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Low bone mineral density and increased fat mass in boys with severe hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication179544\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Nutritional intake and bone mineral density in boys with severe hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication179542\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Osteochondral Lesions of the Ankle Joint in Patients with Hemophilia A: A Retrospective Case Series\", \"url\": \"https://experts.mcmaster.ca/display/publication179516\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Predictors of success of immune tolerance induction in hemophilia A patients with high-responding inhibitors: A score from the Italian registry\", \"url\": \"https://experts.mcmaster.ca/display/publication995779\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Qualitative and quantitative assessment of sexual intimacy in adult patients in the hemophilia experiences results opportunities (HERO) study\", \"url\": \"https://experts.mcmaster.ca/display/publication995778\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Quality of life (QOL) and well-being of hemophilia patients and parents managing hemophilia: Hero study analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication995792\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Concentrate type and dose in hemophilia A patients: is there an independent effect on risk of inhibitor formation?\", \"url\": \"https://experts.mcmaster.ca/display/publication995805\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"The use of the clinical trial design in Hemophilia: methodological considerations\", \"url\": \"https://experts.mcmaster.ca/display/publication995808\", \"journal\": \"Haemophilia\", \"year\": \"2012\"}, {\"title\": \"Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study\", \"url\": \"https://experts.mcmaster.ca/display/publication995804\", \"journal\": \"Blood\", \"year\": \"2011\"}, {\"title\": \"Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score\", \"url\": \"https://experts.mcmaster.ca/display/publication995810\", \"journal\": \"Blood\", \"year\": \"2011\"}, {\"title\": \"Bioequivalence of B-domain deleted and plasma derived FVIII concentrates\", \"url\": \"https://experts.mcmaster.ca/display/publication995729\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2011\"}, {\"title\": \"HERO - an international initiative exploring unmet psychosocial needs in haemophilia: results from a qualitative survey targeting 150 subjects in seven countries\", \"url\": \"https://experts.mcmaster.ca/display/publication995724\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2011\"}, {\"title\": \"HERO, an international initiative exploring unmet psychosocial needs in haemophilia: characteristics of a quantitative survey targeting 1200 subjects in 12 countries\", \"url\": \"https://experts.mcmaster.ca/display/publication995731\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2011\"}, {\"title\": \"Heterogeneity of the clinical, laboratory and molecular markers of VWD type 3: results from the retrospective/prospective studies on 122/52 Italian patients\", \"url\": \"https://experts.mcmaster.ca/display/publication995740\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2011\"}, {\"title\": \"Impact of persistent antiphospholipid antibodies on symptomatic thromboembolism in children: a systematic review & meta-analysis [observational studies]\", \"url\": \"https://experts.mcmaster.ca/display/publication995736\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2011\"}, {\"title\": \"Psychosocial aspects of living with haemophilia: the hero project and a narrative review of the published literature\", \"url\": \"https://experts.mcmaster.ca/display/publication995738\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2011\"}, {\"title\": \"Predictive model to assess the risk of inhibitor development in children with severe and moderate haemophilia A - results of a multicenter cohort study\", \"url\": \"https://experts.mcmaster.ca/display/publication995806\", \"journal\": \"Haemophilia\", \"year\": \"2011\"}, {\"title\": \"Predictors of inhibitor development in haemophilia A previously untreated patients: the role of factor concentrate type. An individual patient data meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication995811\", \"journal\": \"Haemophilia\", \"year\": \"2011\"}, {\"title\": \"A Predictive Model for the Development of High-Responding Inhibitor In Children. with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study\", \"url\": \"https://experts.mcmaster.ca/display/publication995803\", \"journal\": \"Blood\", \"year\": \"2010\"}, {\"title\": \"Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication995795\", \"journal\": \"Blood\", \"year\": \"2010\"}, {\"title\": \"Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]\", \"url\": \"https://experts.mcmaster.ca/display/publication995802\", \"journal\": \"Blood\", \"year\": \"2010\"}, {\"title\": \"Bioequivalence of B-domain deleted and plasma derived FVIII concentrates\", \"url\": \"https://experts.mcmaster.ca/display/publication995814\", \"journal\": \"Haemophilia\", \"year\": \"2010\"}, {\"title\": \"Bone mineral density in hemophilia patients: a meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication995817\", \"journal\": \"Haemophilia\", \"year\": \"2010\"}, {\"title\": \"Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B\", \"url\": \"https://experts.mcmaster.ca/display/publication995821\", \"journal\": \"Haemophilia\", \"year\": \"2010\"}, {\"title\": \"Effect of plasma-derived or recombinant factor VIII on inhibitor development: a systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication995823\", \"journal\": \"Haemophilia\", \"year\": \"2010\"}, {\"title\": \"Predictors of success in immune tolerance induction (ITI) in haemophilia A patients with high-responding inhibitors: the Italian ITI registry\", \"url\": \"https://experts.mcmaster.ca/display/publication995830\", \"journal\": \"Haemophilia\", \"year\": \"2010\"}, {\"title\": \"Recombinant factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication995820\", \"journal\": \"Haemophilia\", \"year\": \"2010\"}, {\"title\": \"IDIOPATHIC VEIN THROMBOSIS: IDENTIFICATION OF POPULATIONS AT DIFFERENT RISK OF RELAPSE FOLLOWING ORAL ANTICOAGULANT TREATMENT. THE RESULTS OF THE 'EXTENDED-DACUS STUDY'\", \"url\": \"https://experts.mcmaster.ca/display/publication1683963\", \"journal\": \"Haematologica\", \"year\": \"2010\"}, {\"title\": \"PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS\", \"url\": \"https://experts.mcmaster.ca/display/publication1683964\", \"journal\": \"Haematologica\", \"year\": \"2010\"}, {\"title\": \"IDIOPATHIC VEIN THROMBOSIS: IDENTIFICATION OF POPULATIONS AT DIFFERENT RISK OF RELAPSE FOLLOWING ORAL ANTICOAGULANT TREATMENT. THE RESULTS OF THE 'EXTENDED-DACUS STUDY'\", \"url\": \"https://experts.mcmaster.ca/display/publication995826\", \"journal\": \"Haematologica\", \"year\": \"2010\"}, {\"title\": \"PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS\", \"url\": \"https://experts.mcmaster.ca/display/publication995822\", \"journal\": \"Haematologica\", \"year\": \"2010\"}, {\"title\": \"Effect of plasma-derived or recombinant factor VIII on inhibitor development. A systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication995833\", \"journal\": \"Haemophilia\", \"year\": \"2010\"}, {\"title\": \"Impact of Thrombophilia On Arterial Ischemic Stroke or Cerebral Venous Sinus Thromboses in Children: A Systematic Review & Meta-Analysis of Observational Studies\", \"url\": \"https://experts.mcmaster.ca/display/publication995844\", \"journal\": \"Blood\", \"year\": \"2009\"}, {\"title\": \"Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.\", \"url\": \"https://experts.mcmaster.ca/display/publication995832\", \"journal\": \"Blood\", \"year\": \"2009\"}, {\"title\": \"Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature\", \"url\": \"https://experts.mcmaster.ca/display/publication995839\", \"journal\": \"Blood\", \"year\": \"2009\"}, {\"title\": \"Audit of the clinical use of fresh-frozen plasma in umbria: study design and results\", \"url\": \"https://experts.mcmaster.ca/display/publication3305094\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Bone mineral density in hemophilia patients: a meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3305009\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Central nervous system (CNS) bleeding in patients with rare bleeding disorders (RBDS)\", \"url\": \"https://experts.mcmaster.ca/display/publication3305093\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Clinical prediction guide to predict thrombosis recurrence after a first unprovoked venous thromboembolism\", \"url\": \"https://experts.mcmaster.ca/display/publication3305013\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the two coagulation disorders\", \"url\": \"https://experts.mcmaster.ca/display/publication3305092\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Computer assisted VKA monitoring with point of care device by general practitioners\", \"url\": \"https://experts.mcmaster.ca/display/publication3305089\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"D-dimer to predict thrombosis recurrence after unprovoked venous thromboembolism: effect of patient- and D-dimer-related factors on recurrence prediction\", \"url\": \"https://experts.mcmaster.ca/display/publication3305008\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"D-dimer to predict thrombosis recurrence: comparison of aggregate data and individual patient data meta-analyses\", \"url\": \"https://experts.mcmaster.ca/display/publication3305007\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Does patient sex and prior hormonal therapy predict risk for thrombosis recurrence after a first venous thromboembolism?\", \"url\": \"https://experts.mcmaster.ca/display/publication3305010\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Does the clinical presentation of venous thromboembolism predict the risk for and type of thrombosis recurrence?\", \"url\": \"https://experts.mcmaster.ca/display/publication3305012\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Factor VIII gene (F8) mutations as a predictor of outcome in immune tolerance induction (ITI) in hemophilia A patients with high-responding inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication3305090\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Intracranial haemorrhage in haemophilia A and B: an italian retrospective survey\", \"url\": \"https://experts.mcmaster.ca/display/publication3305091\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Multicentric evaluation of current dosing practice of recombinant fix in italy\", \"url\": \"https://experts.mcmaster.ca/display/publication3305087\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Plasma derived (PD) and recombinant (R) factor VIII (FVIII) concentrates induce a different rate of inhibitor development in hemophilia A patients. a systematic review of the literature\", \"url\": \"https://experts.mcmaster.ca/display/publication3305014\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Prospective assessment of clinical endpoints of VKA treatment in a primary care computer assisted management model\", \"url\": \"https://experts.mcmaster.ca/display/publication3305088\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"Venous thromboembolism recurrence after a first episode of provoked venous thrombosis due to a transient risk factor. A systematic review of the literature\", \"url\": \"https://experts.mcmaster.ca/display/publication3305011\", \"journal\": \"Journal of Thrombosis and Haemostasis\", \"year\": \"2009\"}, {\"title\": \"International clinical trials are the best way to improve global haemophilia care? No\", \"url\": \"https://experts.mcmaster.ca/display/publication995837\", \"journal\": \"Haemophilia\", \"year\": \"2009\"}, {\"title\": \"Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature\", \"url\": \"https://experts.mcmaster.ca/display/publication995834\", \"journal\": \"Blood\", \"year\": \"2008\"}, {\"title\": \"Antiviral therapy for chronic hepatitis C in haemophilia patients with human immunodeficiency virus\", \"url\": \"https://experts.mcmaster.ca/display/publication995632\", \"journal\": \"Clinical Respiratory Journal\", \"year\": \"2008\", \"doi\": \"10.1002/14651858.cd004888\"}, {\"title\": \"Causes of death among Italian hemophiliacs: results from the Italian Association of Hemophilia Centers (AICE) Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication995634\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Clinical audit of fresh frozen plasma usage in Umbria, Italy\", \"url\": \"https://experts.mcmaster.ca/display/publication995627\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Critical appraisal of five international guidelines on fresh frozen plasma clinical use\", \"url\": \"https://experts.mcmaster.ca/display/publication995629\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Factor IX pharmacokinetics: differences between plasma\\u2010derived and recombinant products and the clinical and economic implications: a meeting report\", \"url\": \"https://experts.mcmaster.ca/display/publication995625\", \"journal\": \"Haemophilia\", \"year\": \"2008\", \"doi\": \"10.1111/j.1365-2516.2008.01762.x\"}, {\"title\": \"Haemophilia A and B and other rare bleeding disorders: an Italian retrospective survey on the intracranial haemorrhagic episodes\", \"url\": \"https://experts.mcmaster.ca/display/publication995626\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Immune tolerance induction (ITI) in patients with hemophilia A and inhibitors: the Italian retrospective-prospective registry - the PROFIT study\", \"url\": \"https://experts.mcmaster.ca/display/publication995628\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger?\", \"url\": \"https://experts.mcmaster.ca/display/publication995633\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Pharmacokinetics of reformulated B-domain deleted recombinant factor VIII (BDD-rFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS)\", \"url\": \"https://experts.mcmaster.ca/display/publication995631\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Replacement therapy with recombinant FIX - multicentre evaluation of current dosing practice in Italy\", \"url\": \"https://experts.mcmaster.ca/display/publication995636\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"The haemophilia registry of the Italian Association of Haemophilia Centres\", \"url\": \"https://experts.mcmaster.ca/display/publication995635\", \"journal\": \"Haemophilia\", \"year\": \"2008\"}, {\"title\": \"Pharmacokinetics of the reformulated B-DOMAIN deleted recombinant factor VIII (BDD-RFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS)\", \"url\": \"https://experts.mcmaster.ca/display/publication995644\", \"journal\": \"Haematologica\", \"year\": \"2007\"}, {\"title\": \"Pharmacokinetics of the reformulated B-domain deleted recombinant factor VIII concentrate using chromogenicand one-stage assays with pooled normal plasma and refacto laboratory standard\", \"url\": \"https://experts.mcmaster.ca/display/publication995637\", \"journal\": \"Haematologica\", \"year\": \"2007\"}, {\"title\": \"Systematic Review of Randomized Controlled Trials of Prophylactic Clotting Factor Concentrate in Hemophilia.\", \"url\": \"https://experts.mcmaster.ca/display/publication995640\", \"journal\": \"Blood\", \"year\": \"2005\", \"doi\": \"10.1182/blood.v106.11.3114.3114\"}, {\"title\": \"Accreditation standard for surveillance center for patients undergoing oral anticoagulant therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication1747348\", \"journal\": \"Rivista di Medicina di Laboratorio\", \"year\": \"2002\"}, {\"title\": \"Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: A metanalysis\", \"url\": \"https://experts.mcmaster.ca/display/publication995829\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1999\"}, {\"title\": \"Plasma homocysteine measurement: Comparison of three different assay methods in plasma from vascular patients\", \"url\": \"https://experts.mcmaster.ca/display/publication995825\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1999\"}, {\"title\": \"Risk factors for venous thromboembolism in patients undergoing elective neurosurgery\", \"url\": \"https://experts.mcmaster.ca/display/publication995816\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1999\"}, {\"title\": \"Serine base exchange enzyme in commercially available porcine lyophilized platelets: Different effect of unfractionated heparin and low molecular weight heparin\", \"url\": \"https://experts.mcmaster.ca/display/publication995824\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1999\"}, {\"title\": \"The role of thrombophilic states in the bleeding tendency of patients with hemophilia\", \"url\": \"https://experts.mcmaster.ca/display/publication995815\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1999\"}, {\"title\": \"Three-months compared with one-year of oral anticoagulant treatment after a first idiopathic deep vein thrombosis: The warfarin optimal duration Italian trial (WODIT)\", \"url\": \"https://experts.mcmaster.ca/display/publication995827\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1999\"}, {\"title\": \"Enoxaparin plus compression stockings versus compression stockings alone in the prevention of venous thromboembolism (VTE) in neurosurgery patients: A randomised double blind venography study\", \"url\": \"https://experts.mcmaster.ca/display/publication995881\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1997\"}, {\"title\": \"Plasma heparin level and coronary patency in patients with acute myocardial infarction treated with a double rt-PA bolus and randomised to two different heparin regimens\", \"url\": \"https://experts.mcmaster.ca/display/publication995866\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1997\"}, {\"title\": \"Withdrawal of warfarin therapy after deep vein thrombosis: A randomised study on the effects of a very low fixed dose regimen\", \"url\": \"https://experts.mcmaster.ca/display/publication995872\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1997\"}, {\"title\": \"EFFECTS OF DERMATAN SULFATE ON ACTIVATED PARTIAL THROMBOPLASTIN TIME DETERMINED WITH 5 DIFFERENT REAGENTS\", \"url\": \"https://experts.mcmaster.ca/display/publication995870\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1995\"}, {\"title\": \"FIBRINOGENOLYSIS AND THROMBIN ACTIVATION AFTER ACCELERATED WEIGHT-ADJUSTED OR CONVENTIONAL ADMINISTRATION OF RT-PA FOR PULMONARY-EMBOLISM\", \"url\": \"https://experts.mcmaster.ca/display/publication995877\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1995\"}, {\"title\": \"POSTDISCHARGE CLINICALLY OVERT THROMBOEMBOLIC EVENTS IN ORTHOPEDIC-SURGERY PATIENTS WITH NEGATIVE VENOGRAPHY\", \"url\": \"https://experts.mcmaster.ca/display/publication995874\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1995\"}, {\"title\": \"THE DISPLACEMENT OF NONSPECIFICALLY BOUND UNFRACTIONATED HEPARIN FROM PLASMA-PROTEINS PRODUCES AN ANTITHROMBOTIC EFFECT\", \"url\": \"https://experts.mcmaster.ca/display/publication995883\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1995\"}, {\"title\": \"EX-VIVO COMPARISON OF THE NONSPECIFIC-BINDING OF UNFRACTIONATED HEPARIN AND ENOXAPARIN TO PLASMA-PROTEINS\", \"url\": \"https://experts.mcmaster.ca/display/publication821713\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1993\"}, {\"title\": \"INHIBITION OF FLUID-PHASE AND CLOT-BOUND THROMBIN - EFFECTS OF HEPARIN, HIRUDIN AND A THROMBIN-INHIBITING DECAPEPTIDE (LU-58463)\", \"url\": \"https://experts.mcmaster.ca/display/publication995867\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1993\"}, {\"title\": \"KINETICS OF PLASMA THROMBIN NEUTRALIZING ACTIVITY IN PATIENTS WITH DEEP-VEIN THROMBOSIS TREATED WITH SUBCUTANEOUS HEPARIN TWICE A DAY\", \"url\": \"https://experts.mcmaster.ca/display/publication995871\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1993\"}, {\"title\": \"PLASMA HALF-LIFE OF THE ANTI-IIA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS ASSESSED WITH A SENSITIVE TEST (PTNA)\", \"url\": \"https://experts.mcmaster.ca/display/publication821717\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1993\"}, {\"title\": \"PLATELET INHIBITION INDUCED BY PLASMINOGEN ACTIVATORS - ROLE OF FIBRINOGEN DEGRADATION PRODUCTS\", \"url\": \"https://experts.mcmaster.ca/display/publication995879\", \"journal\": \"Thrombosis and Haemostasis\", \"year\": \"1993\"}, {\"title\": \"SELECTIVE-INHIBITION OF ALLOGRAFT-RESPONSE BY MURINE VIRUS\", \"url\": \"https://experts.mcmaster.ca/display/publication3520895\", \"journal\": \"Annali Sclavo. Collana monografica\", \"year\": \"1975\"}, {\"title\": \"EVIDENCE FOR VIRAL NATURE OF AN IMMUNODEPRESSIVE FACTOR (IDF) ASSOCIATED WITH VARIOUS TRANSPLANTABLE TUMORS\", \"url\": \"https://experts.mcmaster.ca/display/publication3520896\", \"journal\": \"The FASEB Journal\", \"year\": \"1974\"}], \"other\": [], \"preprints\": [{\"title\": \"Attitudes and Perceptions of University Students and Postdoctoral Fellows in the Medical and Life Sciences Towards the Use of Artificial Intelligence Chatbots in the Educational Process: A Large-Scale, International Cross-Sectional Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication3607070\", \"year\": \"2025\", \"doi\": \"10.1101/2025.06.25.25328523\"}, {\"title\": \"Policies on Artificial Intelligence Chatbots Among Academic Publishers: A Cross-Sectional Audit\", \"url\": \"https://experts.mcmaster.ca/display/publication3441879\", \"year\": \"2024\", \"doi\": \"10.1101/2024.06.19.24309148\"}, {\"title\": \"The McMaster Health Information Research Unit: Over a Quarter-Century of Health Informatics Supporting Evidence-Based Medicine (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3413012\", \"year\": \"2024\", \"doi\": \"10.2196/preprints.58764\"}, {\"title\": \"Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Large-Scale, International Cross-Sectional Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication3402622\", \"year\": \"2024\", \"doi\": \"10.1101/2024.02.27.24303462\"}, {\"title\": \"Researcher and Clinician Preferences for a Journal Transparency Tool: A Mixed-Methods Survey and Focus Group Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3490130\", \"year\": \"2024\", \"doi\": \"10.1101/2024.05.28.24307345\"}, {\"title\": \"Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Protocol for a Cross-Sectional Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication3282107\", \"year\": \"2023\", \"doi\": \"10.1101/2023.07.26.23293211\"}, {\"title\": \"Machine learning to increase the efficiency of a literature surveillance system: a performance evaluation\", \"url\": \"https://experts.mcmaster.ca/display/publication3267865\", \"year\": \"2023\", \"doi\": \"10.1101/2023.06.18.23291567\"}, {\"title\": \"Selective serotonin reuptake inhibitors for children with Autism Spectrum Disorder: a systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3437457\", \"year\": \"2023\", \"doi\": \"10.21203/rs.3.rs-2757603/v1\"}, {\"title\": \"Machine learning to increase the efficiency of a literature surveillance system: a performance evaluation (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3236693\", \"year\": \"2022\", \"doi\": \"10.2196/preprints.42982\"}, {\"title\": \"User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3285816\", \"year\": \"2021\", \"doi\": \"10.2196/preprints.30797\"}, {\"title\": \"Machine Learning Approaches to Retrieve High-Quality, Clinically Relevant Evidence From the Biomedical Literature: Systematic Review (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3401692\", \"year\": \"2021\", \"doi\": \"10.2196/preprints.30401\"}, {\"title\": \"A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3236696\", \"year\": \"2021\", \"doi\": \"10.2196/preprints.29398\"}, {\"title\": \"A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3461855\", \"doi\": \"10.2196/preprints.10281\"}, {\"title\": \"Attitudes and Perceptions of Biomedical Journal Editors-in-Chief Towards the Use of Artificial Intelligence Chatbots in the Scholarly Publishing Process: A Cross-Sectional Survey\", \"url\": \"https://experts.mcmaster.ca/display/publication3593236\", \"doi\": \"10.1101/2025.05.26.25328101\"}, {\"title\": \"Effects of Electronic Prescribing on Adherence to Prescribed Medications in Community Settings: A Systematic Review (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3582039\", \"doi\": \"10.2196/preprints.73599\"}, {\"title\": \"Fine-Tuning and Benchmarking Transformer Models for Multiclass Classification of Clinical Research Articles: Modeling Study (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3587738\", \"doi\": \"10.2196/preprints.77311\"}, {\"title\": \"Knowledge translation strategies for sharing evidence-based health information with older adults and their caregivers: Findings from a co-design study\", \"url\": \"https://experts.mcmaster.ca/display/publication3461844\", \"doi\": \"10.21203/rs.3.rs-373549/v1\"}, {\"title\": \"Recommendations and Guidelines for Creating Scholarly Journals: A Scoping Review\", \"url\": \"https://experts.mcmaster.ca/display/publication3461843\", \"doi\": \"10.31219/osf.io/5d72z\"}, {\"title\": \"Translating Clinical Questions by Physicians Into Searchable Queries: Analytical Survey Study (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3461847\", \"doi\": \"10.2196/preprints.16777\"}]}",
  "teaching_activities_json": "[{\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2025\", \"year\": \"2025\"}, {\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2024\", \"year\": \"2024\"}, {\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2023\", \"year\": \"2023\"}, {\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2022\", \"year\": \"2022\"}, {\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2021\", \"year\": \"2021\"}, {\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2020\", \"year\": \"2020\"}, {\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2019\", \"year\": \"2019\"}, {\"course\": \"Methods for Diagnostic and Prognostic Research - HTHRSM 777\", \"role\": \"Instructor2018\", \"year\": \"2018\"}]",
  "teaching_courses_count": 1,
  "coauthor_network_url": "https://experts.mcmaster.ca/vis/author-network/iorioa",
  "science_map_url": "https://experts.mcmaster.ca/vis/map-of-science/iorioa",
  "profile_url": "https://experts.mcmaster.ca/individual/iorioa",
  "scraped_date": "2025-07-27T15:08:22.957606",
  "csv_name": "Alfonso Iorio",
  "csv_degree": "MD, PhD, FRCPC",
  "csv_university": "McMaster University",
  "csv_faculty": "Faculty of Health Sciences",
  "csv_department": "Department of Health Research Methods, Evidence, and Impact (HEI)",
  "csv_other_depts": NaN,
  "csv_position": "Professor",
  "csv_full_time": true,
  "csv_faculty_type": "Michael Gent Chair in Healthcare Research; Chair, HEI",
  "csv_adjunct": false,
  "csv_uni_email": "iorioa@mcmaster.ca",
  "csv_other_email": NaN,
  "csv_website": NaN,
  "csv_misc": NaN,
  "csv_twitter": NaN,
  "csv_phone": NaN,
  "csv_fax": NaN,
  "csv_gscholar": NaN,
  "csv_scopus": NaN,
  "csv_wos": NaN,
  "csv_orcid": NaN,
  "csv_researchgate": NaN,
  "csv_academicedu": NaN,
  "csv_linkedin": NaN,
  "csv_mendely": NaN,
  "publications": {
    "journal_articles": [
      {
        "title": "A Hemophilia Joint Health Score-Based Model for the Economic Evaluation of Hemophilia A Prophylaxis Interventions.",
        "url": "https://experts.mcmaster.ca/display/publication3562694",
        "journal": "PharmacoEconomics (Auckland)",
        "year": "2025",
        "doi": "10.1007/s40273-025-01484-1"
      },
      {
        "title": "Developing a Two-Sided Decision Box to Facilitate Shared Decision-Making for Switching From Conventional to Pharmacokinetic-Tailored Prophylaxis in Haemophilia.",
        "url": "https://experts.mcmaster.ca/display/publication3607068",
        "journal": "Haemophilia",
        "year": "2025",
        "doi": "10.1111/hae.70072"
      },
      {
        "title": "2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura.",
        "url": "https://experts.mcmaster.ca/display/publication3596642",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2025",
        "doi": "10.1016/j.jtha.2025.06.002"
      },
      {
        "title": "Core GRADE 7: principles for moving from evidence to recommendations and decisions",
        "url": "https://experts.mcmaster.ca/display/publication3590750",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-083867"
      },
      {
        "title": "Benchmarking domain-specific pretrained language models to identify the best model for methodological rigor in clinical studies.",
        "url": "https://experts.mcmaster.ca/display/publication3570978",
        "journal": "Journal of Biomedical Informatics",
        "year": "2025",
        "doi": "10.1016/j.jbi.2025.104825"
      },
      {
        "title": "Core GRADE 6: presenting the evidence in summary of findings tables.",
        "url": "https://experts.mcmaster.ca/display/publication3587715",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-083866"
      },
      {
        "title": "Core GRADE 5: rating certainty of evidence—assessing indirectness",
        "url": "https://experts.mcmaster.ca/display/publication3584132",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-083865"
      },
      {
        "title": "Rating certainty when the target threshold is the null and the point estimate is close to the null.",
        "url": "https://experts.mcmaster.ca/display/publication3554782",
        "journal": "BMJ Evidence-Based Medicine",
        "year": "2025",
        "doi": "10.1136/bmjebm-2024-113077"
      },
      {
        "title": "Core GRADE 4: rating certainty of evidence—risk of bias, publication bias, and reasons for rating up certainty",
        "url": "https://experts.mcmaster.ca/display/publication3582028",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-083864"
      },
      {
        "title": "A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A.",
        "url": "https://experts.mcmaster.ca/display/publication3582044",
        "journal": "Haemophilia",
        "year": "2025",
        "doi": "10.1111/hae.70061"
      },
      {
        "title": "Core GRADE 3: rating certainty of evidence—assessing inconsistency",
        "url": "https://experts.mcmaster.ca/display/publication3579501",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-081905"
      },
      {
        "title": "Exploring the Impact of Laboratory Reagents on Pharmacokinetic Profiling.",
        "url": "https://experts.mcmaster.ca/display/publication3558104",
        "journal": "Haemophilia",
        "year": "2025",
        "doi": "10.1111/hae.70021"
      },
      {
        "title": "What You May Have Missed in 2024: Navigating New Medical Evidence.",
        "url": "https://experts.mcmaster.ca/display/publication3562693",
        "journal": "ACP journal club",
        "year": "2025",
        "doi": "10.7326/ANNALS-25-01164"
      },
      {
        "title": "Core GRADE 2: choosing the target of certainty rating and assessing imprecision.",
        "url": "https://experts.mcmaster.ca/display/publication3576756",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-081904"
      },
      {
        "title": "Core GRADE 1: overview of the Core GRADE approach.",
        "url": "https://experts.mcmaster.ca/display/publication3574383",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-081903"
      },
      {
        "title": "Why Core GRADE is needed: introduction to a new series in The BMJ.",
        "url": "https://experts.mcmaster.ca/display/publication3569000",
        "journal": "The BMJ",
        "year": "2025",
        "doi": "10.1136/bmj-2024-081902"
      },
      {
        "title": "Policies on artificial intelligence chatbots among academic publishers: a cross-sectional audit.",
        "url": "https://experts.mcmaster.ca/display/publication3546878",
        "journal": "Research Integrity and Peer Review",
        "year": "2025",
        "doi": "10.1186/s41073-025-00158-y"
      },
      {
        "title": "Attitudes and perceptions of medical researchers towards the use of artificial intelligence chatbots in the scientific process: an international cross-sectional survey.",
        "url": "https://experts.mcmaster.ca/display/publication3489774",
        "journal": "The Lancet Digital Health",
        "year": "2025",
        "doi": "10.1016/S2589-7500(24)00202-4"
      },
      {
        "title": "RWD150 First Patient Enrolled in Pilot Phase of the Economics and Patient Outcomes in China in Hemophilia (EPOCH) Study",
        "url": "https://experts.mcmaster.ca/display/publication3520196",
        "journal": "Value in Health",
        "year": "2024",
        "doi": "10.1016/j.jval.2024.10.3708"
      },
      {
        "title": "From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation",
        "url": "https://experts.mcmaster.ca/display/publication3506476",
        "journal": "Blood",
        "year": "2024",
        "doi": "10.1182/blood-2024-198579"
      },
      {
        "title": "A mixed-methods survey and focus group study to understand researcher and clinician preferences for a Journal transparency Tool.",
        "url": "https://experts.mcmaster.ca/display/publication3486229",
        "journal": "Scientific Reports",
        "year": "2024",
        "doi": "10.1038/s41598-024-77790-z"
      },
      {
        "title": "Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.",
        "url": "https://experts.mcmaster.ca/display/publication3474659",
        "journal": "New England Journal of Medicine",
        "year": "2024",
        "doi": "10.1056/NEJMoa2302982"
      },
      {
        "title": "Thrombophilia testing: does practice follow guidelines?",
        "url": "https://experts.mcmaster.ca/display/publication3474660",
        "journal": "Blood Advances",
        "year": "2024",
        "doi": "10.1182/bloodadvances.2024013478"
      },
      {
        "title": "Boosting efficiency in a clinical literature surveillance system with LightGBM.",
        "url": "https://experts.mcmaster.ca/display/publication3472557",
        "journal": "PLOS Digital Health",
        "year": "2024",
        "doi": "10.1371/journal.pdig.0000299"
      },
      {
        "title": "The McMaster Health Information Research Unit: Over a Quarter-Century of Health Informatics Supporting Evidence-Based Medicine",
        "url": "https://experts.mcmaster.ca/display/publication3450481",
        "journal": "Journal of Medical Internet Research",
        "year": "2024",
        "doi": "10.2196/58764"
      },
      {
        "title": "Kinetic Modeling for BT200 to Predict the Level of Plasma-Derived Coagulation Factor VIII in Humans",
        "url": "https://experts.mcmaster.ca/display/publication3452076",
        "journal": "AAPS PharmSciTech",
        "year": "2024",
        "doi": "10.1208/s12248-024-00952-4"
      },
      {
        "title": "Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS‐Hemo platform",
        "url": "https://experts.mcmaster.ca/display/publication3429329",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.15027"
      },
      {
        "title": "Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi‐country severe WAPPS‐Hemo haemophilia patients",
        "url": "https://experts.mcmaster.ca/display/publication3429328",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.15032"
      },
      {
        "title": "Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication3450418",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2024",
        "doi": "10.1016/j.jtha.2024.07.002"
      },
      {
        "title": "GRADE concept paper 8: judging the certainty of discrimination performance estimates of prognostic models in a body of validation studies",
        "url": "https://experts.mcmaster.ca/display/publication3413027",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2024",
        "doi": "10.1016/j.jclinepi.2024.111344"
      },
      {
        "title": "Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate",
        "url": "https://experts.mcmaster.ca/display/publication3447909",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2024",
        "doi": "10.1016/j.jtha.2024.06.015"
      },
      {
        "title": "Scoping review of the recommendations and guidance for improving the quality of rare disease registries",
        "url": "https://experts.mcmaster.ca/display/publication3428521",
        "journal": "Orphanet Journal of Rare Diseases",
        "year": "2024",
        "doi": "10.1186/s13023-024-03193-y"
      },
      {
        "title": "Health utilities in adults with hemophilia A: A retrospective cohort study",
        "url": "https://experts.mcmaster.ca/display/publication3410784",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.14979"
      },
      {
        "title": "Protocol for the development of the Chatbot Assessment Reporting Tool (CHART) for clinical advice",
        "url": "https://experts.mcmaster.ca/display/publication3450342",
        "journal": "BMJ Open",
        "year": "2024",
        "doi": "10.1136/bmjopen-2023-081155"
      },
      {
        "title": "What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence",
        "url": "https://experts.mcmaster.ca/display/publication3414586",
        "journal": "ACP journal club",
        "year": "2024",
        "doi": "10.7326/m24-0832"
      },
      {
        "title": "Lower-dose emicizumab prophylaxis: can less be more?",
        "url": "https://experts.mcmaster.ca/display/publication3410430",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2024",
        "doi": "10.1016/j.jtha.2024.01.018"
      },
      {
        "title": "Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada",
        "url": "https://experts.mcmaster.ca/display/publication3401766",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.14960"
      },
      {
        "title": "GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists",
        "url": "https://experts.mcmaster.ca/display/publication3383056",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2024",
        "doi": "10.1016/j.jclinepi.2023.111241"
      },
      {
        "title": "Publisher preferences for a journal transparency tool: A modified three-round Delphi study.",
        "url": "https://experts.mcmaster.ca/display/publication3557719",
        "journal": "F1000Prime Reports",
        "year": "2024",
        "doi": "10.12688/f1000research.154408.2"
      },
      {
        "title": "American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing",
        "url": "https://experts.mcmaster.ca/display/publication3234482",
        "journal": "Blood Advances",
        "year": "2023",
        "doi": "10.1182/bloodadvances.2023010177"
      },
      {
        "title": "Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada",
        "url": "https://experts.mcmaster.ca/display/publication3320151",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.102265"
      },
      {
        "title": "The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients",
        "url": "https://experts.mcmaster.ca/display/publication3384977",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.102264"
      },
      {
        "title": "Impact of strategies to mitigate misinformation in diverse settings and populations: a protocol for a living evidence synthesis",
        "url": "https://experts.mcmaster.ca/display/publication3300566",
        "journal": "BMJ Open",
        "year": "2023",
        "doi": "10.1136/bmjopen-2023-076672"
      },
      {
        "title": "Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study",
        "url": "https://experts.mcmaster.ca/display/publication3307056",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.102228"
      },
      {
        "title": "OC 06.5 Use of Emicizumab for the Treatment of Acquired Hemophilia A: A Systematic Review",
        "url": "https://experts.mcmaster.ca/display/publication3461835",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.100462"
      },
      {
        "title": "OC 20.5 The WFH Gene Therapy Registry: A Collaborative Approach Towards a Global Resource for the Long-Term Follow-up of People with Hemophilia Treated with Gene Therapy",
        "url": "https://experts.mcmaster.ca/display/publication3461836",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.100445"
      },
      {
        "title": "OC 24.1 Effect of the Type of F9 Mutation on the Pharmacokinetic Profile of Patients with Hemophilia B Treated with Extended Half-Life FIX Concentrates",
        "url": "https://experts.mcmaster.ca/display/publication3461837",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.100443"
      },
      {
        "title": "OC 24.2 Estimated Factor VIII Activity Levels at the Time of Bleeding Events in Individuals with Hemophilia a Without Inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication3461839",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.100436"
      },
      {
        "title": "OC 24.4 Effect of F8 Mutations and Von Willebrand Factor on Pharmacokinetics of FVIII Concentrates in Severe Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication3461838",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.100438"
      },
      {
        "title": "PB0175 Impact of Reagent on the Estimation of Eloctate and Adynovate Pharmacokinetic (PK) Parameters?",
        "url": "https://experts.mcmaster.ca/display/publication3461834",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.101061"
      },
      {
        "title": "PB0191 myGTR: A Patient Engagement Tool from the World Federation of Hemophilia Gene Therapy Registry",
        "url": "https://experts.mcmaster.ca/display/publication3461831",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.101212"
      },
      {
        "title": "PB0644 Evaluation of the Burden of Bone Fractures in People Living with Hemophilia: A Registry-Based Case-Control Study",
        "url": "https://experts.mcmaster.ca/display/publication3461832",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.101184"
      },
      {
        "title": "PB0661 Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Canadian Patients with Hemophilia A: Interim Results from the HEM-POWR Study",
        "url": "https://experts.mcmaster.ca/display/publication3461833",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.101178"
      },
      {
        "title": "PB0827 WFH World Bleeding Disorders Registry Launches the First Global Data Collection on People with von Willebrand Disease",
        "url": "https://experts.mcmaster.ca/display/publication3461828",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.101579"
      },
      {
        "title": "PB0837 Analysis of the Change in Diagnosis of von Willebrand Disease by Region and Economic Status",
        "url": "https://experts.mcmaster.ca/display/publication3461829",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.101562"
      },
      {
        "title": "PB1392 Late Diagnosis of Two Adult Siblings with Bernard Soulier Syndrome (BSS)",
        "url": "https://experts.mcmaster.ca/display/publication3461830",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.101516"
      },
      {
        "title": "Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness",
        "url": "https://experts.mcmaster.ca/display/publication3291906",
        "journal": "Vaccine",
        "year": "2023",
        "doi": "10.1016/j.vaccine.2023.09.012"
      },
      {
        "title": "Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review",
        "url": "https://experts.mcmaster.ca/display/publication3247183",
        "journal": "Haemophilia",
        "year": "2023",
        "doi": "10.1111/hae.14803"
      },
      {
        "title": "Reported prevalence of von Willebrand disease worldwide in relation to income classification",
        "url": "https://experts.mcmaster.ca/display/publication3251275",
        "journal": "Haemophilia",
        "year": "2023",
        "doi": "10.1111/hae.14810"
      },
      {
        "title": "Von Willebrand Disease: Gaining a global perspective",
        "url": "https://experts.mcmaster.ca/display/publication3238619",
        "journal": "Haemophilia",
        "year": "2023",
        "doi": "10.1111/hae.14804"
      },
      {
        "title": "Deep learning to refine the identification of high-quality clinical research articles from the biomedical literature: Performance evaluation",
        "url": "https://experts.mcmaster.ca/display/publication3236692",
        "journal": "Journal of Biomedical Informatics",
        "year": "2023",
        "doi": "10.1016/j.jbi.2023.104384"
      },
      {
        "title": "GRADE guidance 36: updates to GRADE's approach to addressing inconsistency",
        "url": "https://experts.mcmaster.ca/display/publication2951096",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2023",
        "doi": "10.1016/j.jclinepi.2023.03.003"
      },
      {
        "title": "Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance",
        "url": "https://experts.mcmaster.ca/display/publication2184076",
        "journal": "BMJ Evidence-Based Medicine",
        "year": "2023",
        "doi": "10.1136/bmjebm-2022-111962"
      },
      {
        "title": "The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication2431117",
        "journal": "Blood",
        "year": "2023",
        "doi": "10.1182/blood.2022016571"
      },
      {
        "title": "Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada",
        "url": "https://experts.mcmaster.ca/display/publication2632548",
        "journal": "Haemophilia",
        "year": "2023",
        "doi": "10.1111/hae.14723"
      },
      {
        "title": "Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes",
        "url": "https://experts.mcmaster.ca/display/publication3068251",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2023.100106"
      },
      {
        "title": "Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review",
        "url": "https://experts.mcmaster.ca/display/publication2952021",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2023",
        "doi": "10.1016/j.rpth.2022.100007"
      },
      {
        "title": "Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature",
        "url": "https://experts.mcmaster.ca/display/publication2440132",
        "journal": "Haemophilia",
        "year": "2023",
        "doi": "10.1111/hae.14676"
      },
      {
        "title": "Recommendations and guidelines for creating scholarly biomedical journals: A scoping review",
        "url": "https://experts.mcmaster.ca/display/publication3067556",
        "journal": "PLoS ONE",
        "year": "2023",
        "doi": "10.1371/journal.pone.0282168"
      },
      {
        "title": "Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia",
        "url": "https://experts.mcmaster.ca/display/publication2430999",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2022",
        "doi": "10.1111/jth.15885"
      },
      {
        "title": "Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal",
        "url": "https://experts.mcmaster.ca/display/publication2184075",
        "journal": "BMJ Evidence-Based Medicine",
        "year": "2022",
        "doi": "10.1136/bmjebm-2021-111866"
      },
      {
        "title": "Switching from standard to extended half‐life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics",
        "url": "https://experts.mcmaster.ca/display/publication2424750",
        "journal": "Haemophilia",
        "year": "2022",
        "doi": "10.1111/hae.14649"
      },
      {
        "title": "GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach",
        "url": "https://experts.mcmaster.ca/display/publication2428181",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2022",
        "doi": "10.1016/j.jclinepi.2022.07.014"
      },
      {
        "title": "GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions",
        "url": "https://experts.mcmaster.ca/display/publication2435789",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2022",
        "doi": "10.1016/j.jclinepi.2022.07.015"
      },
      {
        "title": "Overall prognosis of preschool autism spectrum disorder diagnoses",
        "url": "https://experts.mcmaster.ca/display/publication2441907",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2022",
        "doi": "10.1002/14651858.cd012749.pub2"
      },
      {
        "title": "A personalized limited sampling approach to better estimate terminal half‐life of FVIII concentrates",
        "url": "https://experts.mcmaster.ca/display/publication2294458",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2022",
        "doi": "10.1111/jth.15803"
      },
      {
        "title": "A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map",
        "url": "https://experts.mcmaster.ca/display/publication2192610",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2022",
        "doi": "10.1016/j.jclinepi.2022.04.012"
      },
      {
        "title": "An evaluation of the COVID-19 recommendation map identified diverging clinical and public health guidance",
        "url": "https://experts.mcmaster.ca/display/publication2188998",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2022",
        "doi": "10.1016/j.jclinepi.2022.03.008"
      },
      {
        "title": "EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication2716673",
        "journal": "Value in Health",
        "year": "2022",
        "doi": "10.1016/j.jval.2022.04.724"
      },
      {
        "title": "von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient‐derived endothelial colony‐forming cells",
        "url": "https://experts.mcmaster.ca/display/publication2188703",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2022",
        "doi": "10.1111/jth.15740"
      },
      {
        "title": "Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature",
        "url": "https://experts.mcmaster.ca/display/publication2182254",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2022",
        "doi": "10.1111/jth.15723"
      },
      {
        "title": "Emicizumab state‐of‐the‐art update",
        "url": "https://experts.mcmaster.ca/display/publication2188827",
        "journal": "Haemophilia",
        "year": "2022",
        "doi": "10.1111/hae.14524"
      },
      {
        "title": "Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19",
        "url": "https://experts.mcmaster.ca/display/publication2188857",
        "journal": "Vaccine",
        "year": "2022",
        "doi": "10.1016/j.vaccine.2022.04.005"
      },
      {
        "title": "Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication2182322",
        "journal": "HemaSphere",
        "year": "2022",
        "doi": "10.1097/hs9.0000000000000694"
      },
      {
        "title": "User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study",
        "url": "https://experts.mcmaster.ca/display/publication2172480",
        "journal": "JMIR Human Factors",
        "year": "2022",
        "doi": "10.2196/30797"
      },
      {
        "title": "GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies",
        "url": "https://experts.mcmaster.ca/display/publication2157243",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2022",
        "doi": "10.1016/j.jclinepi.2021.11.024"
      },
      {
        "title": "New methods facilitated the process of prioritizing questions and health outcomes in guideline development",
        "url": "https://experts.mcmaster.ca/display/publication2157242",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2022",
        "doi": "10.1016/j.jclinepi.2021.11.031"
      },
      {
        "title": "Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study",
        "url": "https://experts.mcmaster.ca/display/publication2180875",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2022",
        "doi": "10.1002/rth2.12661"
      },
      {
        "title": "Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders",
        "url": "https://experts.mcmaster.ca/display/publication2158375",
        "journal": "European Journal of Haematology",
        "year": "2022",
        "doi": "10.1111/ejh.13731"
      },
      {
        "title": "Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature",
        "url": "https://experts.mcmaster.ca/display/publication2163956",
        "journal": "Journal of Medical Internet Research",
        "year": "2022",
        "doi": "10.2196/30791"
      },
      {
        "title": "A taxonomy and framework for identifying and developing actionable statements in guidelines suggests avoiding informal recommendations",
        "url": "https://experts.mcmaster.ca/display/publication2142168",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2022",
        "doi": "10.1016/j.jclinepi.2021.09.028"
      },
      {
        "title": "POSC37 Economic Cost of Treatment in Canada: A Multi-Centre, Retrospective Study",
        "url": "https://experts.mcmaster.ca/display/publication2429733",
        "journal": "Value in Health",
        "year": "2022",
        "doi": "10.1016/j.jval.2021.11.442"
      },
      {
        "title": "Sexual issues in people with haemophilia: Awareness and strategies for overcoming communication barriers",
        "url": "https://experts.mcmaster.ca/display/publication2146388",
        "journal": "Haemophilia",
        "year": "2022",
        "doi": "10.1111/hae.14447"
      },
      {
        "title": "Knowledge translation strategies for sharing evidence-based health information with older adults and their caregivers: findings from a persona-scenario method",
        "url": "https://experts.mcmaster.ca/display/publication2149454",
        "journal": "BMC Geriatrics",
        "year": "2021",
        "doi": "10.1186/s12877-021-02588-x"
      },
      {
        "title": "A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation",
        "url": "https://experts.mcmaster.ca/display/publication2149453",
        "journal": "JMIR Research Protocols",
        "year": "2021",
        "doi": "10.2196/29398"
      },
      {
        "title": "How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines",
        "url": "https://experts.mcmaster.ca/display/publication2126643",
        "journal": "Blood Advances",
        "year": "2021",
        "doi": "10.1182/bloodadvances.2020003577"
      },
      {
        "title": "Evaluation of the sexual health in people living with hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication2129783",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14410"
      },
      {
        "title": "Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines",
        "url": "https://experts.mcmaster.ca/display/publication1969571",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2021",
        "doi": "10.1016/j.jclinepi.2021.04.016"
      },
      {
        "title": "External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data",
        "url": "https://experts.mcmaster.ca/display/publication2146886",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2021",
        "doi": "10.1002/rth2.12599"
      },
      {
        "title": "The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B",
        "url": "https://experts.mcmaster.ca/display/publication2142105",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2021",
        "doi": "10.1002/rth2.12601"
      },
      {
        "title": "Machine Learning Approaches to Retrieve High-Quality, Clinically Relevant Evidence From the Biomedical Literature: Systematic Review",
        "url": "https://experts.mcmaster.ca/display/publication2126644",
        "journal": "JMIR Medical Informatics",
        "year": "2021",
        "doi": "10.2196/30401"
      },
      {
        "title": "Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time",
        "url": "https://experts.mcmaster.ca/display/publication1984959",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14364"
      },
      {
        "title": "Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes",
        "url": "https://experts.mcmaster.ca/display/publication1984960",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14369"
      },
      {
        "title": "Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B",
        "url": "https://experts.mcmaster.ca/display/publication2126820",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2021",
        "doi": "10.1002/14651858.cd014201"
      },
      {
        "title": "Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference",
        "url": "https://experts.mcmaster.ca/display/publication1970639",
        "journal": "Journal of Trauma and Acute Care Surgery",
        "year": "2021",
        "doi": "10.1097/ta.0000000000003300"
      },
      {
        "title": "Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database",
        "url": "https://experts.mcmaster.ca/display/publication1970638",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2021",
        "doi": "10.1111/jth.15395"
      },
      {
        "title": "Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1958635",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14268"
      },
      {
        "title": "Comparison of single subject and population‐based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1969089",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14329"
      },
      {
        "title": "Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication2142041",
        "year": "2021",
        "doi": "10.2196/preprints.30791"
      },
      {
        "title": "Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation",
        "url": "https://experts.mcmaster.ca/display/publication1910784",
        "journal": "European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy",
        "year": "2021",
        "doi": "10.1093/ehjcvp/pvaa052"
      },
      {
        "title": "Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set",
        "url": "https://experts.mcmaster.ca/display/publication1963914",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2021",
        "doi": "10.1002/rth2.12488"
      },
      {
        "title": "Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study",
        "url": "https://experts.mcmaster.ca/display/publication1961033",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14292"
      },
      {
        "title": "Optimizing a literature surveillance strategy to retrieve sound overall prognosis and risk assessment model papers",
        "url": "https://experts.mcmaster.ca/display/publication1957420",
        "journal": "Journal of the American Medical Informatics Association : JAMIA",
        "year": "2021",
        "doi": "10.1093/jamia/ocaa232"
      },
      {
        "title": "Derivation of a Pharmacokinetic Model to Include a Plasma-Derived, von Willebrand Factor-Containing Factor VIII (Koate®-DVI) Concentrate and its Low-Dose Use",
        "url": "https://experts.mcmaster.ca/display/publication2152493",
        "journal": "Clinical Medicine Insights: Blood Disorders",
        "year": "2021",
        "doi": "10.1177/26348535211062229"
      },
      {
        "title": "GRADE Concept Paper 1: Validating the “F.A.C.E” instrument using stakeholder perceptions of feasibility, acceptability, cost, and equity in guideline implement",
        "url": "https://experts.mcmaster.ca/display/publication1943041",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2021",
        "doi": "10.1016/j.jclinepi.2020.11.018"
      },
      {
        "title": "Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders",
        "url": "https://experts.mcmaster.ca/display/publication1959646",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14247"
      },
      {
        "title": "Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products",
        "url": "https://experts.mcmaster.ca/display/publication1961440",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2021",
        "doi": "10.1002/rth2.12476"
      },
      {
        "title": "Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database",
        "url": "https://experts.mcmaster.ca/display/publication1936479",
        "journal": "The Lancet Respiratory Medicine",
        "year": "2021",
        "doi": "10.1016/s2213-2600(20)30417-3"
      },
      {
        "title": "Interventions to Influence Opioid Prescribing Practices for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1939077",
        "journal": "American Journal of Preventive Medicine",
        "year": "2021",
        "doi": "10.1016/j.amepre.2020.07.012"
      },
      {
        "title": "Non‐severe haemophilia: Is it benign? – Insights from the PROBE study",
        "url": "https://experts.mcmaster.ca/display/publication1923964",
        "journal": "Haemophilia",
        "year": "2021",
        "doi": "10.1111/hae.14105"
      },
      {
        "title": "A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients",
        "url": "https://experts.mcmaster.ca/display/publication1937724",
        "journal": "Thrombosis Research",
        "year": "2020",
        "doi": "10.1016/j.thromres.2020.10.024"
      },
      {
        "title": "Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide",
        "url": "https://experts.mcmaster.ca/display/publication1895932",
        "journal": "BMC Medical Research Methodology",
        "year": "2020",
        "doi": "10.1186/s12874-020-00964-6"
      },
      {
        "title": "Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults",
        "url": "https://experts.mcmaster.ca/display/publication1940446",
        "journal": "BMJ Open",
        "year": "2020",
        "doi": "10.1136/bmjopen-2020-040122"
      },
      {
        "title": "Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company",
        "url": "https://experts.mcmaster.ca/display/publication1936087",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14144"
      },
      {
        "title": "Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH",
        "url": "https://experts.mcmaster.ca/display/publication1937783",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2020",
        "doi": "10.1111/jth.15023"
      },
      {
        "title": "Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1928352",
        "journal": "Annals of Hematology",
        "year": "2020",
        "doi": "10.1007/s00277-020-04280-3"
      },
      {
        "title": "Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews",
        "url": "https://experts.mcmaster.ca/display/publication1934644",
        "journal": "Blood Advances",
        "year": "2020",
        "doi": "10.1182/bloodadvances.2020002482"
      },
      {
        "title": "Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1927366",
        "journal": "The Lancet Haematology",
        "year": "2020",
        "doi": "10.1016/s2352-3026(20)30293-3"
      },
      {
        "title": "Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura",
        "url": "https://experts.mcmaster.ca/display/publication1926003",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2020",
        "doi": "10.1111/jth.15009"
      },
      {
        "title": "ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura",
        "url": "https://experts.mcmaster.ca/display/publication1926001",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2020",
        "doi": "10.1111/jth.15006"
      },
      {
        "title": "ISTH guidelines for treatment of thrombotic thrombocytopenic purpura",
        "url": "https://experts.mcmaster.ca/display/publication1926002",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2020",
        "doi": "10.1111/jth.15010"
      },
      {
        "title": "COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine",
        "url": "https://experts.mcmaster.ca/display/publication1813096",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2020",
        "doi": "10.1016/j.jclinepi.2020.04.016"
      },
      {
        "title": "The World Federation of Hemophilia Annual Global Survey 1999‐2018",
        "url": "https://experts.mcmaster.ca/display/publication1914356",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14012"
      },
      {
        "title": "World Federation of Hemophilia Gene Therapy Registry",
        "url": "https://experts.mcmaster.ca/display/publication1910847",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.14015"
      },
      {
        "title": "Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment",
        "url": "https://experts.mcmaster.ca/display/publication1915840",
        "journal": "Blood Advances",
        "year": "2020",
        "doi": "10.1182/bloodadvances.2020001937"
      },
      {
        "title": "Context and Approach in Reporting Evaluations of Electronic Health Record–Based Implementation Projects",
        "url": "https://experts.mcmaster.ca/display/publication1914539",
        "journal": "ACP journal club",
        "year": "2020",
        "doi": "10.7326/m19-0874"
      },
      {
        "title": "Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences",
        "url": "https://experts.mcmaster.ca/display/publication1910855",
        "journal": "Blood Advances",
        "year": "2020",
        "doi": "10.1182/bloodadvances.2020001768"
      },
      {
        "title": "Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1695519",
        "journal": "Blood",
        "year": "2020",
        "doi": "10.1182/blood.2019003603"
      },
      {
        "title": "Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS‐Hemo project",
        "url": "https://experts.mcmaster.ca/display/publication1703986",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.13977"
      },
      {
        "title": "Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach",
        "url": "https://experts.mcmaster.ca/display/publication1681631",
        "journal": "Clinical Pharmacokinetics",
        "year": "2020",
        "doi": "10.1007/s40262-019-00832-7"
      },
      {
        "title": "GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks",
        "url": "https://experts.mcmaster.ca/display/publication1688441",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2020",
        "doi": "10.1016/j.jclinepi.2019.12.023"
      },
      {
        "title": "Prescriber adherence to guidelines for chronic noncancer pain management with opioids: Systematic review and meta-analysis.",
        "url": "https://experts.mcmaster.ca/display/publication1689177",
        "journal": "Health Psychology",
        "year": "2020",
        "doi": "10.1037/hea0000830"
      },
      {
        "title": "Translating Clinical Questions by Physicians Into Searchable Queries: Analytical Survey Study",
        "url": "https://experts.mcmaster.ca/display/publication1813227",
        "journal": "JMIR Medical Education",
        "year": "2020",
        "doi": "10.2196/16777"
      },
      {
        "title": "Psychological interventions for people with hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1699203",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2020",
        "doi": "10.1002/14651858.cd010215.pub2"
      },
      {
        "title": "Multicentre pharmacokinetic evaluation of rFVIII‐Fc (efmoroctocog alfa) in a real life and comparison with non‐extended half‐life FVIII concentrates",
        "url": "https://experts.mcmaster.ca/display/publication1697012",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.13946"
      },
      {
        "title": "Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup",
        "url": "https://experts.mcmaster.ca/display/publication1661992",
        "journal": "Clinical Pharmacokinetics",
        "year": "2020",
        "doi": "10.1007/s40262-019-00809-6"
      },
      {
        "title": "Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes",
        "url": "https://experts.mcmaster.ca/display/publication1696362",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2020",
        "doi": "10.1002/rth2.12305"
      },
      {
        "title": "Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest",
        "url": "https://experts.mcmaster.ca/display/publication1669971",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2020",
        "doi": "10.1016/j.jclinepi.2019.08.012"
      },
      {
        "title": "Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS‐Hemo): Patterns of blood sampling and patient characteristics among clinician users",
        "url": "https://experts.mcmaster.ca/display/publication1681632",
        "journal": "Haemophilia",
        "year": "2020",
        "doi": "10.1111/hae.13882"
      },
      {
        "title": "Predictors of treatment adherence in patients with chronic disease using the Multidimensional Adherence Model: unique considerations for patients with haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1973952",
        "journal": "The Journal of Haemophilia Practice",
        "year": "2020",
        "doi": "10.17225/jhp00152"
      },
      {
        "title": "The eCOVID-19 living recommendations map and gateway to contextualisation",
        "url": "https://experts.mcmaster.ca/display/publication2187515",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2020"
      },
      {
        "title": "Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1",
        "url": "https://experts.mcmaster.ca/display/publication1813481",
        "journal": "Frontiers in Immunology",
        "year": "2020",
        "doi": "10.3389/fimmu.2020.00620"
      },
      {
        "title": "A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients",
        "url": "https://experts.mcmaster.ca/display/publication1678145",
        "journal": "Thrombosis Research",
        "year": "2019",
        "doi": "10.1016/j.thromres.2019.10.023"
      },
      {
        "title": "Strategies for eliciting and synthesizing evidence for guidelines in rare diseases",
        "url": "https://experts.mcmaster.ca/display/publication1635403",
        "journal": "BMC Medical Research Methodology",
        "year": "2019",
        "doi": "10.1186/s12874-019-0713-0"
      },
      {
        "title": "Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide",
        "url": "https://experts.mcmaster.ca/display/publication2951105",
        "year": "2019",
        "doi": "10.21203/rs.2.16277/v1"
      },
      {
        "title": "Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males",
        "url": "https://experts.mcmaster.ca/display/publication1666149",
        "journal": "ACP journal club",
        "year": "2019",
        "doi": "10.7326/m19-1208"
      },
      {
        "title": "Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients",
        "url": "https://experts.mcmaster.ca/display/publication1655187",
        "journal": "Journal of Pharmacokinetics and Pharmacodynamics",
        "year": "2019",
        "doi": "10.1007/s10928-019-09647-2"
      },
      {
        "title": "Corrigendum",
        "url": "https://experts.mcmaster.ca/display/publication3278902",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1002/rth2.12258"
      },
      {
        "title": "Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins",
        "url": "https://experts.mcmaster.ca/display/publication1659327",
        "journal": "Microporous and Mesoporous Materials",
        "year": "2019",
        "doi": "10.1016/j.micromeso.2019.06.005"
      },
      {
        "title": "A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.",
        "url": "https://experts.mcmaster.ca/display/publication1629929",
        "journal": "Blood Transfusion",
        "year": "2019",
        "doi": "10.2450/2019.0183-18"
      },
      {
        "title": "Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1647169",
        "journal": "Annals of Hematology",
        "year": "2019",
        "doi": "10.1007/s00277-019-03747-2"
      },
      {
        "title": "Home therapy for inherited bleeding disorders in South Africa: Results of a modified Delphi consensus process",
        "url": "https://experts.mcmaster.ca/display/publication1666128",
        "journal": "SAMJ - South African Medical Journal",
        "year": "2019",
        "doi": "10.7196/samj.2019.v109i9.13637"
      },
      {
        "title": "[Population pharmacokinetics of two recombinant human coagulation factor Ⅷ preparations in patients with hemophilia A].",
        "url": "https://experts.mcmaster.ca/display/publication1666148",
        "journal": "Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi",
        "year": "2019",
        "doi": "10.3760/cma.j.issn.0253-2727.2019.08.009"
      },
      {
        "title": "Emicizumab and thrombosis: The story so far",
        "url": "https://experts.mcmaster.ca/display/publication1659325",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1111/jth.14556"
      },
      {
        "title": "Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?",
        "url": "https://experts.mcmaster.ca/display/publication1640175",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1111/jth.14469"
      },
      {
        "title": "Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review",
        "url": "https://experts.mcmaster.ca/display/publication1652668",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1002/rth2.12204"
      },
      {
        "title": "The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods",
        "url": "https://experts.mcmaster.ca/display/publication1644760",
        "journal": "ACP journal club",
        "year": "2019",
        "doi": "10.7326/m18-3290"
      },
      {
        "title": "Defining certainty of net benefit: a GRADE concept paper",
        "url": "https://experts.mcmaster.ca/display/publication1644704",
        "journal": "BMJ Open",
        "year": "2019",
        "doi": "10.1136/bmjopen-2018-027445"
      },
      {
        "title": "The association between platelet transfusions and mortality in patients with critical illness",
        "url": "https://experts.mcmaster.ca/display/publication1635948",
        "journal": "Transfusion",
        "year": "2019",
        "doi": "10.1111/trf.15277"
      },
      {
        "title": "An evidence rating service provided valid correlates of the clinical importance of medical articles and journals",
        "url": "https://experts.mcmaster.ca/display/publication1626298",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2019",
        "doi": "10.1016/j.jclinepi.2019.01.010"
      },
      {
        "title": "Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study",
        "url": "https://experts.mcmaster.ca/display/publication1634148",
        "journal": "Haemophilia",
        "year": "2019",
        "doi": "10.1111/hae.13703"
      },
      {
        "title": "Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians",
        "url": "https://experts.mcmaster.ca/display/publication1637355",
        "journal": "ACP journal club",
        "year": "2019",
        "doi": "10.7326/m18-2147"
      },
      {
        "title": "Hemophilia trials in the twenty‐first century: Defining patient important outcomes",
        "url": "https://experts.mcmaster.ca/display/publication1639469",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1002/rth2.12195"
      },
      {
        "title": "Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study",
        "url": "https://experts.mcmaster.ca/display/publication1626297",
        "journal": "Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1055/s-0039-1677700"
      },
      {
        "title": "Switching patients in the age of long-acting recombinant products?",
        "url": "https://experts.mcmaster.ca/display/publication1626302",
        "journal": "Expert Review of Hematology",
        "year": "2019",
        "doi": "10.1080/17474086.2018.1564032"
      },
      {
        "title": "Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics",
        "url": "https://experts.mcmaster.ca/display/publication1652661",
        "journal": "Clinical and Applied Thrombosis/Hemostasis",
        "year": "2019",
        "doi": "10.1177/1076029619862052"
      },
      {
        "title": "PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies",
        "url": "https://experts.mcmaster.ca/display/publication1619765",
        "journal": "ACP journal club",
        "year": "2019",
        "doi": "10.7326/m18-1376"
      },
      {
        "title": "Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population?",
        "url": "https://experts.mcmaster.ca/display/publication1623217",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2019",
        "doi": "10.1002/rth2.12172"
      },
      {
        "title": "Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains",
        "url": "https://experts.mcmaster.ca/display/publication1612046",
        "journal": "Haemophilia",
        "year": "2019",
        "doi": "10.1111/hae.13649"
      },
      {
        "title": "Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review",
        "url": "https://experts.mcmaster.ca/display/publication1608513",
        "journal": "Systematic Reviews",
        "year": "2018",
        "doi": "10.1186/s13643-018-0858-7"
      },
      {
        "title": "The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1505309",
        "journal": "Pilot and Feasibility Studies",
        "year": "2018",
        "doi": "10.1186/s40814-018-0253-0"
      },
      {
        "title": "The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1586628",
        "journal": "Thrombosis Research",
        "year": "2018",
        "doi": "10.1016/j.thromres.2018.08.004"
      },
      {
        "title": "Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age‐matched controls",
        "url": "https://experts.mcmaster.ca/display/publication1586461",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13595"
      },
      {
        "title": "Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire",
        "url": "https://experts.mcmaster.ca/display/publication1584362",
        "journal": "BMJ Open",
        "year": "2018",
        "doi": "10.1136/bmjopen-2018-021900"
      },
      {
        "title": "Core outcome set for gene therapy in haemophilia: Results of the coreHEMmultistakeholder project",
        "url": "https://experts.mcmaster.ca/display/publication1534544",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13504"
      },
      {
        "title": "Focusing in on use of pharmacokinetic profiles in routine hemophilia care",
        "url": "https://experts.mcmaster.ca/display/publication1572639",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2018",
        "doi": "10.1002/rth2.12118"
      },
      {
        "title": "Haemophilia clinical care and research needs: Assessing priorities",
        "url": "https://experts.mcmaster.ca/display/publication1570430",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13544"
      },
      {
        "title": "Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations",
        "url": "https://experts.mcmaster.ca/display/publication1580738",
        "journal": "Research and Practice in Thrombosis and Haemostasis",
        "year": "2018",
        "doi": "10.1002/rth2.12106"
      },
      {
        "title": "Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH",
        "url": "https://experts.mcmaster.ca/display/publication1534560",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2018",
        "doi": "10.1111/jth.14153"
      },
      {
        "title": "A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study",
        "url": "https://experts.mcmaster.ca/display/publication1560121",
        "journal": "Journal of Medical Internet Research",
        "year": "2018",
        "doi": "10.2196/10281"
      },
      {
        "title": "Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes",
        "url": "https://experts.mcmaster.ca/display/publication1553139",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13489"
      },
      {
        "title": "Point‐of‐care ultrasonography in haemophilia care: Training and competency for muscular haematomas",
        "url": "https://experts.mcmaster.ca/display/publication1505307",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13417"
      },
      {
        "title": "World bleeding disorders registry: The pilot study",
        "url": "https://experts.mcmaster.ca/display/publication1496730",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13431"
      },
      {
        "title": "Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.",
        "url": "https://experts.mcmaster.ca/display/publication3461856",
        "journal": "ACP journal club",
        "year": "2018",
        "doi": "10.7326/M17-0939"
      },
      {
        "title": "Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism",
        "url": "https://experts.mcmaster.ca/display/publication1486915",
        "journal": "American Journal of Medicine",
        "year": "2018",
        "doi": "10.1016/j.amjmed.2017.11.042"
      },
      {
        "title": "Guideline on terminology and definitions of updating clinical guidelines: The Updating Glossary",
        "url": "https://experts.mcmaster.ca/display/publication1543953",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2018",
        "doi": "10.1016/j.jclinepi.2017.11.023"
      },
      {
        "title": "Comorbidities in persons with haemophilia aged 60 years or more compared with age‐matched people from the general population",
        "url": "https://experts.mcmaster.ca/display/publication1486888",
        "journal": "Haemophilia",
        "year": "2018",
        "doi": "10.1111/hae.13379"
      },
      {
        "title": "McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome",
        "url": "https://experts.mcmaster.ca/display/publication1560548",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2018",
        "doi": "10.1111/jth.14192"
      },
      {
        "title": "PP93 HTA Role In CoreHEM, A Multi-Stakeholder Core Outcome Set Project",
        "url": "https://experts.mcmaster.ca/display/publication3461854",
        "journal": "International Journal of Technology Assessment in Health Care",
        "year": "2018",
        "doi": "10.1017/s0266462318002386"
      },
      {
        "title": "Researching what matters to improve chronic pain care in Canada: A priority-setting partnership process to support patient-oriented research",
        "url": "https://experts.mcmaster.ca/display/publication1941109",
        "journal": "Canadian Journal of Pain",
        "year": "2018",
        "doi": "10.1080/24740527.2018.1433959"
      },
      {
        "title": "Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey",
        "url": "https://experts.mcmaster.ca/display/publication1505136",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2018",
        "doi": "10.1016/j.jclinepi.2018.02.016"
      },
      {
        "title": "Using pharmacokinetics to individualize hemophilia therapy",
        "url": "https://experts.mcmaster.ca/display/publication1484351",
        "journal": "Hematology. American Society of Hematology. Education Program",
        "year": "2017",
        "doi": "10.1182/asheducation-2017.1.595"
      },
      {
        "title": "Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH",
        "url": "https://experts.mcmaster.ca/display/publication1478482",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2017",
        "doi": "10.1111/jth.13867"
      },
      {
        "title": "McMaster Optimal Aging Portal: an evidence-based database for geriatrics-focused health professionals",
        "url": "https://experts.mcmaster.ca/display/publication761870",
        "journal": "BMC Research Notes",
        "year": "2017",
        "doi": "10.1186/s13104-017-2595-8"
      },
      {
        "title": "Systematic reviews of prognosis studies: a critical appraisal of five core clinical journals",
        "url": "https://experts.mcmaster.ca/display/publication1641332",
        "journal": "Diagnostic and Prognostic Research",
        "year": "2017",
        "doi": "10.1186/s41512-017-0008-z"
      },
      {
        "title": "Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1478566",
        "journal": "Thrombosis Research",
        "year": "2017",
        "doi": "10.1016/j.thromres.2017.11.001"
      },
      {
        "title": "Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis",
        "url": "https://experts.mcmaster.ca/display/publication1467895",
        "journal": "Pharmaceutics",
        "year": "2017",
        "doi": "10.3390/pharmaceutics9040047"
      },
      {
        "title": "Discrimination and Calibration of Clinical Prediction Models",
        "url": "https://experts.mcmaster.ca/display/publication1467059",
        "journal": "Journal of the American Medical Association (JAMA)",
        "year": "2017",
        "doi": "10.1001/jama.2017.12126"
      },
      {
        "title": "Minimal dataset for post‐registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH",
        "url": "https://experts.mcmaster.ca/display/publication1314668",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2017",
        "doi": "10.1111/jth.13762"
      },
      {
        "title": "Point of care ultrasound in haemophilia: Building a strong foundation for clinical implementation",
        "url": "https://experts.mcmaster.ca/display/publication172697",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13269"
      },
      {
        "title": "Overall prognosis of preschool autism spectrum disorder diagnoses",
        "url": "https://experts.mcmaster.ca/display/publication1601234",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2017",
        "doi": "10.1002/14651858.cd012749"
      },
      {
        "title": "Computer-Aided Systematic Review Screening Comes of Age",
        "url": "https://experts.mcmaster.ca/display/publication172694",
        "journal": "ACP journal club",
        "year": "2017",
        "doi": "10.7326/m17-1295"
      },
      {
        "title": "Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis",
        "url": "https://experts.mcmaster.ca/display/publication172704",
        "journal": "Blood",
        "year": "2017",
        "doi": "10.1111/jth.13701"
      },
      {
        "title": "Exploring some intersections between pharmacokinetics, factorVIIImeasurement and human morphometrics – impact of recent advances in haemophilia study design on our understanding of optimal haemophilia treatment",
        "url": "https://experts.mcmaster.ca/display/publication172712",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13210"
      },
      {
        "title": "Large scale studies assessing anti‐factorVIIIantibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more",
        "url": "https://experts.mcmaster.ca/display/publication172706",
        "journal": "British Journal of Haematology",
        "year": "2017",
        "doi": "10.1111/bjh.14610"
      },
      {
        "title": "Switching to extended half‐life products in Canada – preliminary data",
        "url": "https://experts.mcmaster.ca/display/publication172698",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13245"
      },
      {
        "title": "IDO1 activity in selected immune cells controls antibody responses",
        "url": "https://experts.mcmaster.ca/display/publication3461842",
        "journal": "Journal of Immunology",
        "year": "2017",
        "doi": "10.4049/jimmunol.198.supp.67.25"
      },
      {
        "title": "Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factorVIIIFc fusion protein and conventional recombinant factorVIIIproducts",
        "url": "https://experts.mcmaster.ca/display/publication172715",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13160"
      },
      {
        "title": "Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development",
        "url": "https://experts.mcmaster.ca/display/publication172717",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13176"
      },
      {
        "title": "Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement",
        "url": "https://experts.mcmaster.ca/display/publication172708",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13215"
      },
      {
        "title": "What is the role for population pharmacokinetics in hemophilia?",
        "url": "https://experts.mcmaster.ca/display/publication3461858",
        "journal": "International Journal of Pharmacokinetics",
        "year": "2017",
        "doi": "10.4155/ipk-2016-0018"
      },
      {
        "title": "Oral contraceptive use is a provoking factor for venous thromboembolism",
        "url": "https://experts.mcmaster.ca/display/publication172702",
        "journal": "The BMJ",
        "year": "2017",
        "doi": "10.1136/bmj.j2073"
      },
      {
        "title": "Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption",
        "url": "https://experts.mcmaster.ca/display/publication172729",
        "journal": "Journal of Medical Economics",
        "year": "2017",
        "doi": "10.1080/13696998.2016.1265973"
      },
      {
        "title": "A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews",
        "url": "https://experts.mcmaster.ca/display/publication172721",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2017",
        "doi": "10.1016/j.jclinepi.2016.11.012"
      },
      {
        "title": "Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.",
        "url": "https://experts.mcmaster.ca/display/publication3461859",
        "journal": "ACP journal club",
        "year": "2017",
        "doi": "10.7326/M16-1785"
      },
      {
        "title": "Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series",
        "url": "https://experts.mcmaster.ca/display/publication172718",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13167"
      },
      {
        "title": "Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians",
        "url": "https://experts.mcmaster.ca/display/publication1314670",
        "journal": "ACP journal club",
        "year": "2017",
        "doi": "10.7326/m16-1860"
      },
      {
        "title": "A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument",
        "url": "https://experts.mcmaster.ca/display/publication172735",
        "journal": "International Urology and Nephrology",
        "year": "2017",
        "doi": "10.1007/s11255-016-1436-3"
      },
      {
        "title": "The current state of adverse event reporting in hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication172723",
        "journal": "Expert Review of Hematology",
        "year": "2017",
        "doi": "10.1080/17474086.2017.1272410"
      },
      {
        "title": "Authors seldom report the most patient-important outcomes and absolute effect measures in systematic review abstracts",
        "url": "https://experts.mcmaster.ca/display/publication172755",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2017",
        "doi": "10.1016/j.jclinepi.2016.08.004"
      },
      {
        "title": "Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA",
        "url": "https://experts.mcmaster.ca/display/publication172713",
        "journal": "PLoS ONE",
        "year": "2017",
        "doi": "10.1371/journal.pone.0171028"
      },
      {
        "title": "GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence",
        "url": "https://experts.mcmaster.ca/display/publication172699",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2017",
        "doi": "10.1016/j.jclinepi.2017.05.005"
      },
      {
        "title": "Guideline for opioid therapy and chronic noncancer pain",
        "url": "https://experts.mcmaster.ca/display/publication61466",
        "journal": "CANADIAN MEDICAL ASSOCIATION JOURNAL",
        "year": "2017",
        "doi": "10.1503/cmaj.170363"
      },
      {
        "title": "If You Build It, Who Will Come? A Description of User Characteristics and Experiences With the McMaster Optimal Aging Portal",
        "url": "https://experts.mcmaster.ca/display/publication1478576",
        "journal": "Gerontology and Geriatric Medicine",
        "year": "2017",
        "doi": "10.1177/2333721417737681"
      },
      {
        "title": "Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data",
        "url": "https://experts.mcmaster.ca/display/publication172726",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13127"
      },
      {
        "title": "Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours",
        "url": "https://experts.mcmaster.ca/display/publication172722",
        "journal": "Thrombosis and Haemostasis",
        "year": "2017",
        "doi": "10.1160/th16-09-0680"
      },
      {
        "title": "Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates",
        "url": "https://experts.mcmaster.ca/display/publication172707",
        "journal": "Thrombosis and Haemostasis",
        "year": "2017",
        "doi": "10.1160/th16-12-0942"
      },
      {
        "title": "The GRADE Working Group clarifies the construct of certainty of evidence",
        "url": "https://experts.mcmaster.ca/display/publication172700",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2017",
        "doi": "10.1016/j.jclinepi.2017.05.006"
      },
      {
        "title": "The demographics, treatment characteristics and quality of life of adult people with haemophilia in China – results from theHEROstudy",
        "url": "https://experts.mcmaster.ca/display/publication172749",
        "journal": "Haemophilia",
        "year": "2017",
        "doi": "10.1111/hae.13071"
      },
      {
        "title": "Thrombosis in Inherited Fibrinogen Disorders",
        "url": "https://experts.mcmaster.ca/display/publication172701",
        "journal": "Transfusion Medicine and Hemotherapy",
        "year": "2017",
        "doi": "10.1159/000452864"
      },
      {
        "title": "VP57 Test-Retest Reliability Analysis Of The Patient Reported Outcomes Burdens And Experiences (PROBE) Study Questionnaire Test-Retest Reliability Analysis Of The PROBE Study Questionnaire",
        "url": "https://experts.mcmaster.ca/display/publication3461857",
        "journal": "International Journal of Technology Assessment in Health Care",
        "year": "2017",
        "doi": "10.1017/s0266462317003361"
      },
      {
        "title": "Development of a Web-Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS-Hemo): Study Protocol",
        "url": "https://experts.mcmaster.ca/display/publication172725",
        "journal": "JMIR Research Protocols",
        "year": "2016",
        "doi": "10.2196/resprot.6558"
      },
      {
        "title": "Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo)",
        "url": "https://experts.mcmaster.ca/display/publication172728",
        "journal": "JMIR Research Protocols",
        "year": "2016",
        "doi": "10.2196/resprot.6559"
      },
      {
        "title": "Interpreting trial sequential analysis",
        "url": "https://experts.mcmaster.ca/display/publication172730",
        "journal": "Transfusion",
        "year": "2016",
        "doi": "10.1111/trf.13910"
      },
      {
        "title": "Evaluation of the utility of theISTH‐BATin haemophilia carriers: a multinational study",
        "url": "https://experts.mcmaster.ca/display/publication594662",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.13089"
      },
      {
        "title": "The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication172759",
        "journal": "Expert Opinion on Drug Metabolism and Toxicology",
        "year": "2016",
        "doi": "10.1080/17425255.2016.1214711"
      },
      {
        "title": "Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication172737",
        "journal": "Thrombosis and Haemostasis",
        "year": "2016",
        "doi": "10.1160/th16-04-0266"
      },
      {
        "title": "User Experiences of the McMaster Optimal Aging Portal’s Evidence Summaries and Blog Posts: Usability Study",
        "url": "https://experts.mcmaster.ca/display/publication172757",
        "journal": "JMIR Human Factors",
        "year": "2016",
        "doi": "10.2196/humanfactors.6208"
      },
      {
        "title": "Impact of including or excluding both-armed zero-event studies on using standard meta-analysis methods for rare event outcome: a simulation study",
        "url": "https://experts.mcmaster.ca/display/publication172761",
        "journal": "BMJ Open",
        "year": "2016",
        "doi": "10.1136/bmjopen-2015-010983"
      },
      {
        "title": "Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH",
        "url": "https://experts.mcmaster.ca/display/publication172763",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2016",
        "doi": "10.1111/jth.13382"
      },
      {
        "title": "Care models in the management of haemophilia: a systematic review",
        "url": "https://experts.mcmaster.ca/display/publication172773",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.13000"
      },
      {
        "title": "Integrated multidisciplinary care for the management of chronic conditions in adults: an overview of reviews and an example of using indirect evidence to inform clinical practice recommendations in the field of rare diseases",
        "url": "https://experts.mcmaster.ca/display/publication172771",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.13010"
      },
      {
        "title": "Methodology for the development of theNHF‐McMaster Guideline on Care Models for Haemophilia Management",
        "url": "https://experts.mcmaster.ca/display/publication172777",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.13007"
      },
      {
        "title": "NHF‐McMaster Guideline on Care Models for Haemophilia Management",
        "url": "https://experts.mcmaster.ca/display/publication172779",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.13008"
      },
      {
        "title": "Understanding intravenous iron ordering practices for inpatients and outpatients at a large academic institution",
        "url": "https://experts.mcmaster.ca/display/publication2181222",
        "journal": "Transfusion Medicine Reviews",
        "year": "2016",
        "doi": "10.1016/j.tmrv.2016.05.005"
      },
      {
        "title": "Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study",
        "url": "https://experts.mcmaster.ca/display/publication172775",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.13009"
      },
      {
        "title": "The McMaster Optimal Aging Portal: Usability Evaluation of a Unique Evidence-Based Health Information Website",
        "url": "https://experts.mcmaster.ca/display/publication172783",
        "journal": "JMIR Human Factors",
        "year": "2016",
        "doi": "10.2196/humanfactors.4800"
      },
      {
        "title": "Report on the International Society for Laboratory Hematology Survey on guidelines to support clinical hematology laboratory practice",
        "url": "https://experts.mcmaster.ca/display/publication172784",
        "journal": "International Journal of Laboratory Hematology",
        "year": "2016",
        "doi": "10.1111/ijlh.12501"
      },
      {
        "title": "Variation of DNA Fragmentation Levels During Density Gradient Sperm Selection for Assisted Reproduction Techniques",
        "url": "https://experts.mcmaster.ca/display/publication1457859",
        "journal": "Medicine (United States)",
        "year": "2016",
        "doi": "10.1097/md.0000000000003624"
      },
      {
        "title": "Haemophilia in a real‐world setting: the value of clinical experience in data collection",
        "url": "https://experts.mcmaster.ca/display/publication172789",
        "journal": "European Journal of Haematology",
        "year": "2016",
        "doi": "10.1111/ejh.12715"
      },
      {
        "title": "FVIIIinhibitor development according to concentrate: data from theEUHASSregistry excluding overlap with other studies",
        "url": "https://experts.mcmaster.ca/display/publication172810",
        "journal": "Haemophilia",
        "year": "2016",
        "doi": "10.1111/hae.12764"
      },
      {
        "title": "A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation",
        "url": "https://experts.mcmaster.ca/display/publication172793",
        "journal": "International Journal of Cardiology",
        "year": "2016",
        "doi": "10.1016/j.ijcard.2015.11.035"
      },
      {
        "title": "Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study",
        "url": "https://experts.mcmaster.ca/display/publication172733",
        "journal": "Journal of Blood Medicine",
        "year": "2016",
        "doi": "10.2147/jbm.s103087"
      },
      {
        "title": "Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication172782",
        "journal": "PLoS ONE",
        "year": "2016",
        "doi": "10.1371/journal.pone.0156891"
      },
      {
        "title": "Erratum to Fischer et al. “Inhibitor development in nonsevere haemophilia across Europe” (Thromb Haemost 2015; 114: 670-675)",
        "url": "https://experts.mcmaster.ca/display/publication995684",
        "journal": "Thrombosis and Haemostasis",
        "year": "2016",
        "doi": "10.1160/th16030001"
      },
      {
        "title": "Systematic reviews experience major limitations in reporting absolute effects",
        "url": "https://experts.mcmaster.ca/display/publication172795",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2016",
        "doi": "10.1016/j.jclinepi.2015.11.002"
      },
      {
        "title": "Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol",
        "url": "https://experts.mcmaster.ca/display/publication172785",
        "journal": "BMJ Open",
        "year": "2016",
        "doi": "10.1136/bmjopen-2015-010569"
      },
      {
        "title": "Desmopressin acetate (DDAVP) for preventing and treating bleeding in people with mild or moderate haemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1747319",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2015",
        "doi": "10.1002/14651858.cd011985"
      },
      {
        "title": "Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication172791",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2015",
        "doi": "10.1002/14651858.cd004449.pub4"
      },
      {
        "title": "Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions",
        "url": "https://experts.mcmaster.ca/display/publication172853",
        "journal": "BMC Blood Disorders",
        "year": "2015",
        "doi": "10.1186/s12878-015-0022-8"
      },
      {
        "title": "A systematic review of definitions and reporting of bleeding outcome measures in haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication172812",
        "journal": "Haemophilia",
        "year": "2015",
        "doi": "10.1111/hae.12750"
      },
      {
        "title": "Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study)",
        "url": "https://experts.mcmaster.ca/display/publication172808",
        "journal": "Haemophilia",
        "year": "2015",
        "doi": "10.1111/hae.12768"
      },
      {
        "title": "Individualizing Factor Replacement Therapy in Severe Hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication172806",
        "journal": "Seminars in Thrombosis and Hemostasis",
        "year": "2015",
        "doi": "10.1055/s-0035-1552563"
      },
      {
        "title": "Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials",
        "url": "https://experts.mcmaster.ca/display/publication172803",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015",
        "doi": "10.1111/jth.13139"
      },
      {
        "title": "Point of care ultrasonography in haemophilia care: recommendations for training and competency evaluation",
        "url": "https://experts.mcmaster.ca/display/publication172809",
        "journal": "Haemophilia",
        "year": "2015",
        "doi": "10.1111/hae.12767"
      },
      {
        "title": "IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII",
        "url": "https://experts.mcmaster.ca/display/publication172801",
        "journal": "Journal of Clinical Investigation",
        "year": "2015",
        "doi": "10.1172/jci81859"
      },
      {
        "title": "Inhibitor development in haemophilia according to concentrate",
        "url": "https://experts.mcmaster.ca/display/publication172861",
        "journal": "Thrombosis and Haemostasis",
        "year": "2015",
        "doi": "10.1160/th14-10-0826"
      },
      {
        "title": "Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication172857",
        "journal": "Thrombosis and Haemostasis",
        "year": "2015",
        "doi": "10.1160/th14-07-0621"
      },
      {
        "title": "Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication172814",
        "journal": "Blood",
        "year": "2015",
        "doi": "10.1182/blood-2014-10-608471"
      },
      {
        "title": "Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia",
        "url": "https://experts.mcmaster.ca/display/publication411179",
        "journal": "European Journal of Internal Medicine",
        "year": "2015",
        "doi": "10.1016/j.ejim.2015.04.002"
      },
      {
        "title": "Cardiovascular disease prevalence and relevance in haemophilia: a scoping review",
        "url": "https://experts.mcmaster.ca/display/publication172875",
        "journal": "Haemophilia",
        "year": "2015",
        "doi": "10.1111/hae.12596"
      },
      {
        "title": "Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data",
        "url": "https://experts.mcmaster.ca/display/publication172855",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015",
        "doi": "10.1111/jth.12871"
      },
      {
        "title": "Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients",
        "url": "https://experts.mcmaster.ca/display/publication172849",
        "journal": "The BMJ",
        "year": "2015",
        "doi": "10.1136/bmj.h870"
      },
      {
        "title": "Pharmacokinetics of plasma‐derived vs. recombinantFVIIIconcentrates: a comparative study",
        "url": "https://experts.mcmaster.ca/display/publication172883",
        "journal": "Haemophilia",
        "year": "2015",
        "doi": "10.1111/hae.12550"
      },
      {
        "title": "Commentary",
        "url": "https://experts.mcmaster.ca/display/publication1640361",
        "journal": "Epidemiology",
        "year": "2015",
        "doi": "10.1097/ede.0000000000000212"
      },
      {
        "title": "Developing methodology for the creation of clinical practice guidelines for rare diseases: A report from RARE-Bestpractices",
        "url": "https://experts.mcmaster.ca/display/publication1634028",
        "journal": "Rare Diseases",
        "year": "2015",
        "doi": "10.1080/21675511.2015.1058463"
      },
      {
        "title": "Development of haemophilic arthropathy of the ankle: results of a Delphi consensus survey on potential contributory factors",
        "url": "https://experts.mcmaster.ca/display/publication172873",
        "journal": "Haemophilia",
        "year": "2015",
        "doi": "10.1111/hae.12500"
      },
      {
        "title": "Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor",
        "url": "https://experts.mcmaster.ca/display/publication172817",
        "journal": "Thrombosis and Haemostasis",
        "year": "2015",
        "doi": "10.1160/th14-10-0882"
      },
      {
        "title": "Haemophilia Experiences, Results and Opportunities (HERO) study: treatment‐related characteristics of the population",
        "url": "https://experts.mcmaster.ca/display/publication172879",
        "journal": "Haemophilia",
        "year": "2015",
        "doi": "10.1111/hae.12545"
      },
      {
        "title": "Inhibitor development in non-severe haemophilia across Europe",
        "url": "https://experts.mcmaster.ca/display/publication172805",
        "journal": "Thrombosis and Haemostasis",
        "year": "2015",
        "doi": "10.1160/th14-12-1044"
      },
      {
        "title": "Reporting, handling and assessing the risk of bias associated with missing participant data in systematic reviews: a methodological survey",
        "url": "https://experts.mcmaster.ca/display/publication172802",
        "journal": "BMJ Open",
        "year": "2015",
        "doi": "10.1136/bmjopen-2015-009368"
      },
      {
        "title": "Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study",
        "url": "https://experts.mcmaster.ca/display/publication172794",
        "journal": "International Journal of Qualitative Studies on Health and Well-being",
        "year": "2015",
        "doi": "10.3402/qhw.v10.28915"
      },
      {
        "title": "Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study.",
        "url": "https://experts.mcmaster.ca/display/publication172863",
        "journal": "International Journal of Qualitative Studies on Health and Well-being",
        "year": "2015",
        "doi": "10.3402/qhw.v10.28915"
      },
      {
        "title": "The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels",
        "url": "https://experts.mcmaster.ca/display/publication172769",
        "journal": "Implementation Science",
        "year": "2015",
        "doi": "10.1186/s13012-016-0462-y"
      },
      {
        "title": "Effectiveness of Computerized Decision Support Systems Linked to Electronic Health Records: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication172881",
        "journal": "American Journal of Public Health",
        "year": "2014",
        "doi": "10.2105/ajph.2014.302164"
      },
      {
        "title": "Increasing the quantity and quality of searching for current best evidence to answer clinical questions: protocol and intervention design of the MacPLUS FS Factorial Randomized Controlled Trials",
        "url": "https://experts.mcmaster.ca/display/publication61497",
        "journal": "Implementation Science",
        "year": "2014",
        "doi": "10.1186/s13012-014-0125-9"
      },
      {
        "title": "Interventions for enhancing medication adherence",
        "url": "https://experts.mcmaster.ca/display/publication61512",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2014",
        "doi": "10.1002/14651858.cd000011.pub4"
      },
      {
        "title": "Developing a two‐sided intervention to facilitate shared decision‐making in haemophilia: decision boxes for clinicians and patient decision aids for patients",
        "url": "https://experts.mcmaster.ca/display/publication172885",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12495"
      },
      {
        "title": "Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly",
        "url": "https://experts.mcmaster.ca/display/publication411180",
        "journal": "European Journal of Internal Medicine",
        "year": "2014",
        "doi": "10.1016/j.ejim.2014.09.019"
      },
      {
        "title": "Non-invasive ventilation in the treatment of sleep-related breathing disorders: A review and update",
        "url": "https://experts.mcmaster.ca/display/publication411183",
        "journal": "Revista Portuguesa de Pneumologia (English Edition)",
        "year": "2014",
        "doi": "10.1016/j.rppneu.2014.03.009"
      },
      {
        "title": "Patient data meta‐analysis of Post‐Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated withrAHF‐PFM",
        "url": "https://experts.mcmaster.ca/display/publication172891",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12480"
      },
      {
        "title": "Heart failure and chronic kidney disease in a registry of internal medicine wards",
        "url": "https://experts.mcmaster.ca/display/publication995630",
        "journal": "European Geriatric Medicine",
        "year": "2014",
        "doi": "10.1016/j.eurger.2014.08.005"
      },
      {
        "title": "Multimorbidity and polypharmacy in the elderly: lessons from REPOSI",
        "url": "https://experts.mcmaster.ca/display/publication411181",
        "journal": "Internal and emergency medicine",
        "year": "2014",
        "doi": "10.1007/s11739-014-1124-1"
      },
      {
        "title": "Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey",
        "url": "https://experts.mcmaster.ca/display/publication172905",
        "journal": "American Journal of Medicine",
        "year": "2014",
        "doi": "10.1016/j.amjmed.2014.05.003"
      },
      {
        "title": "Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward",
        "url": "https://experts.mcmaster.ca/display/publication172889",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12511"
      },
      {
        "title": "Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study",
        "url": "https://experts.mcmaster.ca/display/publication411182",
        "journal": "European Journal of Internal Medicine",
        "year": "2014",
        "doi": "10.1016/j.ejim.2014.06.027"
      },
      {
        "title": "Aryl hydrocarbon receptor control of a disease tolerance defence pathway",
        "url": "https://experts.mcmaster.ca/display/publication172899",
        "journal": "Nature",
        "year": "2014",
        "doi": "10.1038/nature13323"
      },
      {
        "title": "Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa",
        "url": "https://experts.mcmaster.ca/display/publication172931",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12371"
      },
      {
        "title": "First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data fromCHARMS, the Canadian Hemophilia Assessment and Resource Management System",
        "url": "https://experts.mcmaster.ca/display/publication172897",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12477"
      },
      {
        "title": "Haemophilia Experiences, Results and Opportunities (HERO) Study: Influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication172907",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12454"
      },
      {
        "title": "Evaluation of an automated method for measuring vonWillebrand factor activity in clinical samples without ristocetin",
        "url": "https://experts.mcmaster.ca/display/publication172915",
        "journal": "International Journal of Laboratory Hematology",
        "year": "2014",
        "doi": "10.1111/ijlh.12218"
      },
      {
        "title": "JointWFH‐ISTHsession: issues in clinical trial design",
        "url": "https://experts.mcmaster.ca/display/publication172913",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12415"
      },
      {
        "title": "PSY40 Indirect Comparison Of The Efficacy Of Recombinant Factor Viii Fc Fusion Protein And Other Factor Viii Products For ProphylaxisModeling The Effect Of Compliance",
        "url": "https://experts.mcmaster.ca/display/publication3461871",
        "journal": "Value in Health",
        "year": "2014",
        "doi": "10.1016/j.jval.2014.03.1345"
      },
      {
        "title": "PSY41 Indirect Comparison Of The Efficacy Of Recombinant Factor Ix Fc Fusion Protein And Other Factor Ix Products For Prophylaxis: Simulating The Effect Of Compliance On Real-World Effectiveness",
        "url": "https://experts.mcmaster.ca/display/publication3461867",
        "journal": "Value in Health",
        "year": "2014",
        "doi": "10.1016/j.jval.2014.03.1346"
      },
      {
        "title": "Patterns of tertiary prophylaxis inCanadian adults with severe and moderately severe haemophiliaB",
        "url": "https://experts.mcmaster.ca/display/publication172927",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12391"
      },
      {
        "title": "Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B",
        "url": "https://experts.mcmaster.ca/display/publication172911",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2014",
        "doi": "10.1002/14651858.cd010561.pub2"
      },
      {
        "title": "The haemophilia certification system in Canada.",
        "url": "https://experts.mcmaster.ca/display/publication172901",
        "journal": "Blood Transfusion",
        "year": "2014",
        "doi": "10.2450/2014.0032-14s"
      },
      {
        "title": "Ruling out DVT using the Wells rule and a D-dimer test",
        "url": "https://experts.mcmaster.ca/display/publication172925",
        "journal": "The BMJ",
        "year": "2014",
        "doi": "10.1136/bmj.g1637"
      },
      {
        "title": "Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity",
        "url": "https://experts.mcmaster.ca/display/publication172929",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12283"
      },
      {
        "title": "A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol (vol 2, 113, 2013)",
        "url": "https://experts.mcmaster.ca/display/publication172939",
        "journal": "Systematic Reviews",
        "year": "2014",
        "doi": "10.1186/2046-4053-2-113"
      },
      {
        "title": "Erratum to: A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol",
        "url": "https://experts.mcmaster.ca/display/publication411199",
        "journal": "Systematic Reviews",
        "year": "2014",
        "doi": "10.1186/2046-4053-3-76"
      },
      {
        "title": "Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics",
        "url": "https://experts.mcmaster.ca/display/publication172947",
        "journal": "Haemophilia",
        "year": "2014",
        "doi": "10.1111/hae.12239"
      },
      {
        "title": "Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study",
        "url": "https://experts.mcmaster.ca/display/publication172871",
        "journal": "Systematic Reviews",
        "year": "2014",
        "doi": "10.1186/2046-4053-3-137"
      },
      {
        "title": "Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication172942",
        "journal": "Thrombosis and Haemostasis",
        "year": "2014",
        "doi": "10.1160/th13-04-0336"
      },
      {
        "title": "High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance",
        "url": "https://experts.mcmaster.ca/display/publication172945",
        "journal": "Journal of Hematology and Oncology",
        "year": "2013",
        "doi": "10.1186/1756-8722-6-63"
      },
      {
        "title": "Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation",
        "url": "https://experts.mcmaster.ca/display/publication172944",
        "journal": "European Journal of Internal Medicine",
        "year": "2013",
        "doi": "10.1016/j.ejim.2013.08.697"
      },
      {
        "title": "Drug–drug interactions in a cohort of hospitalized elderly patients",
        "url": "https://experts.mcmaster.ca/display/publication172943",
        "journal": "Pharmacoepidemiology and Drug Safety",
        "year": "2013",
        "doi": "10.1002/pds.3510"
      },
      {
        "title": "Erratum to “Small intestinal bacterial overgrowth and warfarin dose requirement variability” [Thromb. Res. 126 (1) (2010) 12–17]",
        "url": "https://experts.mcmaster.ca/display/publication995768",
        "journal": "Thrombosis Research",
        "year": "2013",
        "doi": "10.1016/j.thromres.2013.05.022"
      },
      {
        "title": "Inhibitor development in previously treated hemophilia A patients: a systematic review, meta‐analysis, and meta‐regression",
        "url": "https://experts.mcmaster.ca/display/publication172949",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013",
        "doi": "10.1111/jth.12335"
      },
      {
        "title": "Prevalence of potentially inappropriate medications in a cohort of hospitalized elderly: Results from the REPOSI study",
        "url": "https://experts.mcmaster.ca/display/publication3461870",
        "journal": "European Geriatric Medicine",
        "year": "2013",
        "doi": "10.1016/j.eurger.2013.07.018"
      },
      {
        "title": "Prophylaxis of venous thromboembolism in elderly patients with multimorbidity",
        "url": "https://experts.mcmaster.ca/display/publication172954",
        "journal": "Internal and emergency medicine",
        "year": "2013",
        "doi": "10.1007/s11739-013-0944-8"
      },
      {
        "title": "Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B",
        "url": "https://experts.mcmaster.ca/display/publication1747317",
        "journal": "Clinical Respiratory Journal",
        "year": "2013",
        "doi": "10.1002/14651858.cd010561"
      },
      {
        "title": "The Rodin (Research Of Determinants of INhibitor Development among PUPs with haemophilia) study: the clinical conundrum from the perspective of haemophilia treaters",
        "url": "https://experts.mcmaster.ca/display/publication172956",
        "journal": "Haemophilia",
        "year": "2013",
        "doi": "10.1111/hae.12149"
      },
      {
        "title": "Factor VIII Products and Inhibitors in Severe Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication411185",
        "journal": "New England Journal of Medicine",
        "year": "2013",
        "doi": "10.1056/nejmc1301995"
      },
      {
        "title": "Factor VIII Products and Inhibitors in Severe Hemophilia A REPLY",
        "url": "https://experts.mcmaster.ca/display/publication1508943",
        "journal": "New England Journal of Medicine",
        "year": "2013"
      },
      {
        "title": "Factor VIII products and inhibitors in severe hemophilia A.",
        "url": "https://experts.mcmaster.ca/display/publication172957",
        "journal": "New England Journal of Medicine",
        "year": "2013",
        "doi": "10.1056/NEJMc1301995"
      },
      {
        "title": "Adverse Clinical Events and Mortality During Hospitalization and 3 Months After Discharge in Cognitively Impaired Elderly Patients",
        "url": "https://experts.mcmaster.ca/display/publication172971",
        "journal": "The journals of gerontology. Series A, Biological sciences and medical sciences",
        "year": "2013",
        "doi": "10.1093/gerona/gls181"
      },
      {
        "title": "Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.",
        "url": "https://experts.mcmaster.ca/display/publication172959",
        "journal": "Blood Transfusion",
        "year": "2013",
        "doi": "10.2450/2012.0158-12"
      },
      {
        "title": "Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach",
        "url": "https://experts.mcmaster.ca/display/publication172962",
        "journal": "Current Treatment Options in Cardiovascular Medicine",
        "year": "2013",
        "doi": "10.1007/s11936-012-0225-2"
      },
      {
        "title": "Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences",
        "url": "https://experts.mcmaster.ca/display/publication172960",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2013",
        "doi": "10.1016/j.jclinepi.2012.08.007"
      },
      {
        "title": "Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale",
        "url": "https://experts.mcmaster.ca/display/publication172964",
        "journal": "Drugs and Aging",
        "year": "2013",
        "doi": "10.1007/s40266-012-0044-x"
      },
      {
        "title": "Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study",
        "url": "https://experts.mcmaster.ca/display/publication173027",
        "journal": "Internal and emergency medicine",
        "year": "2013",
        "doi": "10.1007/s11739-011-0581-z"
      },
      {
        "title": "Comparison of Disease Clusters in Two Elderly Populations Hospitalized in 2008 and 2010",
        "url": "https://experts.mcmaster.ca/display/publication172961",
        "journal": "Gerontology",
        "year": "2013",
        "doi": "10.1159/000346353"
      },
      {
        "title": "Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study",
        "url": "https://experts.mcmaster.ca/display/publication172941",
        "journal": "BioMed Research International",
        "year": "2013",
        "doi": "10.1155/2013/901975"
      },
      {
        "title": "Risk factors for hospital readmission of elderly patients",
        "url": "https://experts.mcmaster.ca/display/publication172967",
        "journal": "European Journal of Internal Medicine",
        "year": "2013",
        "doi": "10.1016/j.ejim.2012.10.005"
      },
      {
        "title": "Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends",
        "url": "https://experts.mcmaster.ca/display/publication1973978",
        "journal": "Blood",
        "year": "2012",
        "doi": "10.1182/blood.v120.21.1186.1186"
      },
      {
        "title": "Uncertainties in baseline risk estimates and confidence in treatment effects",
        "url": "https://experts.mcmaster.ca/display/publication172965",
        "journal": "The BMJ",
        "year": "2012",
        "doi": "10.1136/bmj.e7401"
      },
      {
        "title": "Applicability of the AGREE II Instrument in Evaluating the Development Process and Quality of Current National Academy of Clinical Biochemistry Guidelines",
        "url": "https://experts.mcmaster.ca/display/publication172972",
        "journal": "Clinical Chemistry",
        "year": "2012",
        "doi": "10.1373/clinchem.2012.185850"
      },
      {
        "title": "Summarizing the theoretical foundation for hospital communication research: a scoping review of interdisciplinary literature",
        "url": "https://experts.mcmaster.ca/display/publication1933902",
        "year": "2012"
      },
      {
        "title": "Clotting factor concentrate switching and inhibitor development in hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication172975",
        "journal": "Blood",
        "year": "2012",
        "doi": "10.1182/blood-2012-03-378927"
      },
      {
        "title": "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)",
        "url": "https://experts.mcmaster.ca/display/publication172978",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2012",
        "doi": "10.1111/j.1538-7836.2012.04735.x"
      },
      {
        "title": "Psychosocial aspects of haemophilia: a systematic review of methodologies and findings",
        "url": "https://experts.mcmaster.ca/display/publication172991",
        "journal": "Haemophilia",
        "year": "2012",
        "doi": "10.1111/j.1365-2516.2011.02683.x"
      },
      {
        "title": "Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients",
        "url": "https://experts.mcmaster.ca/display/publication172984",
        "journal": "International Psychogeriatrics",
        "year": "2012",
        "doi": "10.1017/s1041610211002353"
      },
      {
        "title": "Central nervous system bleeding in patients with rare bleeding disorders",
        "url": "https://experts.mcmaster.ca/display/publication173025",
        "journal": "Haemophilia",
        "year": "2012",
        "doi": "10.1111/j.1365-2516.2011.02545.x"
      },
      {
        "title": "Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication173020",
        "journal": "Haemophilia",
        "year": "2012",
        "doi": "10.1111/j.1365-2516.2011.02611.x"
      },
      {
        "title": "Association between clusters of diseases and polypharmacy in hospitalized elderly patients: Results from the REPOSI study",
        "url": "https://experts.mcmaster.ca/display/publication172989",
        "journal": "European Journal of Internal Medicine",
        "year": "2011",
        "doi": "10.1016/j.ejim.2011.08.029"
      },
      {
        "title": "Individual participant data meta-analyses compared with meta-analyses based on aggregate data",
        "url": "https://experts.mcmaster.ca/display/publication3461869",
        "journal": "Trials",
        "year": "2011",
        "doi": "10.1186/1745-6215-12-s1-a57"
      },
      {
        "title": "Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study",
        "url": "https://experts.mcmaster.ca/display/publication3461849",
        "journal": "Blood",
        "year": "2011",
        "doi": "10.1182/blood.v118.21.26.26"
      },
      {
        "title": "Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score",
        "url": "https://experts.mcmaster.ca/display/publication3461848",
        "journal": "Blood",
        "year": "2011",
        "doi": "10.1182/blood.v118.21.544.544"
      },
      {
        "title": "Concentrate‐related inhibitor risk: is a difference always real?",
        "url": "https://experts.mcmaster.ca/display/publication172999",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2011",
        "doi": "10.1111/j.1538-7836.2011.04480.x"
      },
      {
        "title": "Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study",
        "url": "https://experts.mcmaster.ca/display/publication172995",
        "journal": "American Journal of Hematology",
        "year": "2011",
        "doi": "10.1002/ajh.22156"
      },
      {
        "title": "Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication172982",
        "journal": "Seminars in Thrombosis and Hemostasis",
        "year": "2011",
        "doi": "10.1055/s-0031-1297171"
      },
      {
        "title": "Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B",
        "url": "https://experts.mcmaster.ca/display/publication172997",
        "journal": "Clinical Respiratory Journal",
        "year": "2011",
        "doi": "10.1002/14651858.cd003429.pub4"
      },
      {
        "title": "In‐hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study",
        "url": "https://experts.mcmaster.ca/display/publication173001",
        "journal": "International Journal of Geriatric Psychiatry",
        "year": "2011",
        "doi": "10.1002/gps.2627"
      },
      {
        "title": "The association between venous thromboembolism and physical inactivity in everyday life",
        "url": "https://experts.mcmaster.ca/display/publication173022",
        "journal": "The BMJ",
        "year": "2011",
        "doi": "10.1136/bmj.d3865"
      },
      {
        "title": "Management of Inheritedvon Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients",
        "url": "https://experts.mcmaster.ca/display/publication172987",
        "journal": "Seminars in Thrombosis and Hemostasis",
        "year": "2011",
        "doi": "10.1055/s-0031-1281037"
      },
      {
        "title": "Commentary",
        "url": "https://experts.mcmaster.ca/display/publication1747328",
        "journal": "Annals of Internal Medicine",
        "year": "2011"
      },
      {
        "title": "The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care",
        "url": "https://experts.mcmaster.ca/display/publication173023",
        "journal": "ACP journal club",
        "year": "2011",
        "doi": "10.7326/0003-4819-154-12-201106210-02013"
      },
      {
        "title": "More about optimal choices in cardioembolism prevention",
        "url": "https://experts.mcmaster.ca/display/publication995613",
        "journal": "European Journal of Internal Medicine",
        "year": "2011",
        "doi": "10.1016/j.ejim.2011.01.009"
      },
      {
        "title": "Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism",
        "url": "https://experts.mcmaster.ca/display/publication995796",
        "journal": "ACP journal club",
        "year": "2011",
        "doi": "10.7326/0003-4819-154-9-201105030-00016"
      },
      {
        "title": "Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study",
        "url": "https://experts.mcmaster.ca/display/publication173030",
        "journal": "European Journal of Clinical Pharmacology",
        "year": "2011",
        "doi": "10.1007/s00228-010-0977-0"
      },
      {
        "title": "Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly",
        "url": "https://experts.mcmaster.ca/display/publication173028",
        "journal": "European Journal of Internal Medicine",
        "year": "2011",
        "doi": "10.1016/j.ejim.2010.11.009"
      },
      {
        "title": "Referat zu: Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study",
        "url": "https://experts.mcmaster.ca/display/publication1747356",
        "journal": "Vasomed",
        "year": "2011"
      },
      {
        "title": "Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication173029",
        "journal": "The BMJ",
        "year": "2011",
        "doi": "10.1136/bmj.d813"
      },
      {
        "title": "Clinical efficacy and safety of moroctocog alfa",
        "url": "https://experts.mcmaster.ca/display/publication3461860",
        "journal": "Clinical Investigation",
        "year": "2011",
        "doi": "10.4155/cli.10.27"
      },
      {
        "title": "Recombinant Factor VIIa Concentrate versus Plasma-derived Concentrates for the Treatment of Acute Bleeding Episodes in Persons with Haemophilia and Inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication3461861",
        "journal": "European Oncology and Haematology",
        "year": "2011",
        "doi": "10.17925/eoh.2011.07.02.140"
      },
      {
        "title": "Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy.",
        "url": "https://experts.mcmaster.ca/display/publication173033",
        "journal": "Blood Transfusion",
        "year": "2011",
        "doi": "10.2450/2010.0011-10"
      },
      {
        "title": "Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards",
        "url": "https://experts.mcmaster.ca/display/publication173032",
        "journal": "European Journal of Internal Medicine",
        "year": "2010",
        "doi": "10.1016/j.ejim.2010.07.014"
      },
      {
        "title": "A Predictive Model for the Development of High-Responding Inhibitor In Children with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study",
        "url": "https://experts.mcmaster.ca/display/publication3461850",
        "journal": "Blood",
        "year": "2010",
        "doi": "10.1182/blood.v116.21.710.710"
      },
      {
        "title": "Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients",
        "url": "https://experts.mcmaster.ca/display/publication3461853",
        "journal": "Blood",
        "year": "2010",
        "doi": "10.1182/blood.v116.21.238.238"
      },
      {
        "title": "Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]",
        "url": "https://experts.mcmaster.ca/display/publication1973972",
        "journal": "Blood",
        "year": "2010",
        "doi": "10.1182/blood.v116.21.3169.3169"
      },
      {
        "title": "Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis",
        "url": "https://experts.mcmaster.ca/display/publication173040",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2010",
        "doi": "10.1111/j.1538-7836.2010.04022.x"
      },
      {
        "title": "Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor",
        "url": "https://experts.mcmaster.ca/display/publication173034",
        "journal": "JAMA Internal Medicine",
        "year": "2010",
        "doi": "10.1001/archinternmed.2010.367"
      },
      {
        "title": "A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis",
        "url": "https://experts.mcmaster.ca/display/publication173036",
        "journal": "ACP journal club",
        "year": "2010",
        "doi": "10.7326/0003-4819-153-8-201010190-02013"
      },
      {
        "title": "Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism",
        "url": "https://experts.mcmaster.ca/display/publication173035",
        "journal": "ACP journal club",
        "year": "2010",
        "doi": "10.7326/0003-4819-153-8-201010190-00009"
      },
      {
        "title": "Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication173038",
        "journal": "Current Pharmaceutical Design",
        "year": "2010",
        "doi": "10.2174/138161210793563428"
      },
      {
        "title": "Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting",
        "url": "https://experts.mcmaster.ca/display/publication173039",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2010",
        "doi": "10.1111/j.1538-7836.2010.03991.x"
      },
      {
        "title": "In-Hospital Death and Adverse Clinical Events in Elderly Patients According to Disease Clustering: The REPOSI Study",
        "url": "https://experts.mcmaster.ca/display/publication173043",
        "journal": "Rejuvenation Research",
        "year": "2010",
        "doi": "10.1089/rej.2009.1002"
      },
      {
        "title": "Small intestinal bacterial overgrowth and warfarin dose requirement variability",
        "url": "https://experts.mcmaster.ca/display/publication173056",
        "journal": "Thrombosis Research",
        "year": "2010",
        "doi": "10.1016/j.thromres.2009.11.032"
      },
      {
        "title": "Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review",
        "url": "https://experts.mcmaster.ca/display/publication173049",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2010",
        "doi": "10.1111/j.1538-7836.2010.03823.x"
      },
      {
        "title": "Mortality and causes of death in Italian persons with haemophilia, 1990–2007",
        "url": "https://experts.mcmaster.ca/display/publication173052",
        "journal": "Haemophilia",
        "year": "2010",
        "doi": "10.1111/j.1365-2516.2009.02188.x"
      },
      {
        "title": "Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children",
        "url": "https://experts.mcmaster.ca/display/publication173048",
        "journal": "Circulation",
        "year": "2010",
        "doi": "10.1161/circulationaha.109.913673"
      },
      {
        "title": "Influenza Vaccination and Vitamin K Antagonist Treatment",
        "url": "https://experts.mcmaster.ca/display/publication173047",
        "journal": "JAMA Internal Medicine",
        "year": "2010",
        "doi": "10.1001/archinternmed.2010.49"
      },
      {
        "title": "Selective outcome reporting: telling and detecting true lies. The state of the science",
        "url": "https://experts.mcmaster.ca/display/publication173050",
        "journal": "Internal and emergency medicine",
        "year": "2010",
        "doi": "10.1007/s11739-010-0371-z"
      },
      {
        "title": "Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study",
        "url": "https://experts.mcmaster.ca/display/publication173057",
        "journal": "European Journal of Vascular and Endovascular Surgery",
        "year": "2010",
        "doi": "10.1016/j.ejvs.2009.11.022"
      },
      {
        "title": "Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus",
        "url": "https://experts.mcmaster.ca/display/publication173053",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2010",
        "doi": "10.1002/14651858.cd004888.pub2"
      },
      {
        "title": "Bone mineral density in haemophilia patients",
        "url": "https://experts.mcmaster.ca/display/publication173055",
        "journal": "Thrombosis and Haemostasis",
        "year": "2010",
        "doi": "10.1160/th09-09-0629"
      },
      {
        "title": "Response: Comparing joint arthroplasties in severe hemophilia A with severe hemophilia B",
        "url": "https://experts.mcmaster.ca/display/publication995836",
        "journal": "Blood",
        "year": "2009",
        "doi": "10.1182/blood-2009-09-244566"
      },
      {
        "title": "Impact of Thrombophilia On Arterial Ischemic Stroke or Cerebral Venous Sinus Thromboses in Children: A Systematic Review & Meta-Analysis of Observational Studies.",
        "url": "https://experts.mcmaster.ca/display/publication1973969",
        "journal": "Blood",
        "year": "2009",
        "doi": "10.1182/blood.v114.22.3993.3993"
      },
      {
        "title": "Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.",
        "url": "https://experts.mcmaster.ca/display/publication3461851",
        "journal": "Blood",
        "year": "2009",
        "doi": "10.1182/blood.v114.22.3494.3494"
      },
      {
        "title": "Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature.",
        "url": "https://experts.mcmaster.ca/display/publication3461852",
        "journal": "Blood",
        "year": "2009",
        "doi": "10.1182/blood.v114.22.3154.3154"
      },
      {
        "title": "Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)",
        "url": "https://experts.mcmaster.ca/display/publication173063",
        "journal": "Thrombosis Research",
        "year": "2009",
        "doi": "10.1016/j.thromres.2009.05.014"
      },
      {
        "title": "Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus",
        "url": "https://experts.mcmaster.ca/display/publication173064",
        "journal": "American Journal of Gastroenterology",
        "year": "2009",
        "doi": "10.1038/ajg.2009.311"
      },
      {
        "title": "Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment",
        "url": "https://experts.mcmaster.ca/display/publication173061",
        "journal": "American Journal of Hematology",
        "year": "2009",
        "doi": "10.1002/ajh.21469"
      },
      {
        "title": "Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders",
        "url": "https://experts.mcmaster.ca/display/publication173069",
        "journal": "Blood",
        "year": "2009",
        "doi": "10.1182/blood-2009-01-195313"
      },
      {
        "title": "Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends?",
        "url": "https://experts.mcmaster.ca/display/publication173066",
        "journal": "Haemophilia",
        "year": "2009",
        "doi": "10.1111/j.1365-2516.2009.02031.x"
      },
      {
        "title": "Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy",
        "url": "https://experts.mcmaster.ca/display/publication1747358",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009",
        "doi": "10.1111/j.1538-7836.2009.03318.x"
      },
      {
        "title": "Performance of recalibrated ReFacto®laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one‐stage assays after infusion of recalibrated ReFacto®(B‐domain deleted recombinant factor VIII)",
        "url": "https://experts.mcmaster.ca/display/publication173071",
        "journal": "Haemophilia",
        "year": "2009",
        "doi": "10.1111/j.1365-2516.2009.01983.x"
      },
      {
        "title": "Errata",
        "url": "https://experts.mcmaster.ca/display/publication1747359",
        "journal": "Haemophilia",
        "year": "2009",
        "doi": "10.1111/j.1365-2516.2009.02014_3.x"
      },
      {
        "title": "Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis (vol 14, pg 444, 2008)",
        "url": "https://experts.mcmaster.ca/display/publication995840",
        "journal": "Haemophilia",
        "year": "2009"
      },
      {
        "title": "Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study",
        "url": "https://experts.mcmaster.ca/display/publication411187",
        "journal": "Haemophilia",
        "year": "2009",
        "doi": "10.1111/j.1365-2516.2008.01926.x"
      },
      {
        "title": "Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature",
        "url": "https://experts.mcmaster.ca/display/publication3461846",
        "journal": "Blood",
        "year": "2008",
        "doi": "10.1182/blood.v112.11.3029.3029"
      },
      {
        "title": "Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase.",
        "url": "https://experts.mcmaster.ca/display/publication173072",
        "journal": "Blood Transfusion",
        "year": "2008",
        "doi": "10.2450/2008.0042-07"
      },
      {
        "title": "Selecting references that match constructs: the difficult job of citing the parachute hyperbole",
        "url": "https://experts.mcmaster.ca/display/publication173087",
        "journal": "Internal and emergency medicine",
        "year": "2008",
        "doi": "10.1007/s11739-008-0149-8"
      },
      {
        "title": "Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis",
        "url": "https://experts.mcmaster.ca/display/publication173093",
        "journal": "Haemophilia",
        "year": "2008",
        "doi": "10.1111/j.1365-2516.2008.01679.x"
      },
      {
        "title": "Interventions for enhancing medication adherence",
        "url": "https://experts.mcmaster.ca/display/publication175104",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2008",
        "doi": "10.1002/14651858.cd000011.pub3"
      },
      {
        "title": "Iatrogenic causes of an ICH",
        "url": "https://experts.mcmaster.ca/display/publication173089",
        "journal": "European Journal of Anaesthesiology",
        "year": "2008",
        "doi": "10.1017/s0265021507003171"
      },
      {
        "title": "Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting",
        "url": "https://experts.mcmaster.ca/display/publication173097",
        "journal": "Thrombosis and Haemostasis",
        "year": "2008",
        "doi": "10.1160/th07-06-0409"
      },
      {
        "title": "The good use of plasma. A critical analysis of five international guidelines.",
        "url": "https://experts.mcmaster.ca/display/publication173077",
        "journal": "Blood Transfusion",
        "year": "2008",
        "doi": "10.2450/2008.0041-07"
      },
      {
        "title": "Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence",
        "url": "https://experts.mcmaster.ca/display/publication173103",
        "journal": "Internal and emergency medicine",
        "year": "2007",
        "doi": "10.1007/s11739-007-0058-2"
      },
      {
        "title": "RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS",
        "url": "https://experts.mcmaster.ca/display/publication3461862",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2007",
        "doi": "10.1111/j.1538-7836.2007.tb01920.x"
      },
      {
        "title": "Chronic Prostatitis",
        "url": "https://experts.mcmaster.ca/display/publication411191",
        "journal": "New England Journal of Medicine",
        "year": "2007",
        "doi": "10.1056/nejmc063135"
      },
      {
        "title": "Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients",
        "url": "https://experts.mcmaster.ca/display/publication173107",
        "journal": "Thrombosis and Haemostasis",
        "year": "2007",
        "doi": "10.1160/th07-03-0201"
      },
      {
        "title": "Thrombophilia and Cerebral Vein Thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication173101",
        "journal": "Frontiers of Neurology and Neuroscience",
        "year": "2007",
        "doi": "10.1159/000111261"
      },
      {
        "title": "Influenza vaccination in patients on long-term anticoagulant therapy",
        "url": "https://experts.mcmaster.ca/display/publication173128",
        "journal": "Vaccine",
        "year": "2006",
        "doi": "10.1016/j.vaccine.2006.05.036"
      },
      {
        "title": "d-Dimer Testing to Determine the Duration of Anticoagulation Therapy",
        "url": "https://experts.mcmaster.ca/display/publication173119",
        "journal": "New England Journal of Medicine",
        "year": "2006",
        "doi": "10.1056/nejmoa054444"
      },
      {
        "title": "Are placebo‐controlled trials ethical in areas where current guidelines recommend therapy? No",
        "url": "https://experts.mcmaster.ca/display/publication173125",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2006",
        "doi": "10.1111/j.1538-7836.2006.02133.x"
      },
      {
        "title": "High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C.",
        "url": "https://experts.mcmaster.ca/display/publication1688439",
        "journal": "Haematologica",
        "year": "2006"
      },
      {
        "title": "Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B",
        "url": "https://experts.mcmaster.ca/display/publication173131",
        "journal": "Clinical Respiratory Journal",
        "year": "2006",
        "doi": "10.1002/14651858.cd003429.pub3"
      },
      {
        "title": "Can evidence harm? Certainly not hemophilia treatment and community",
        "url": "https://experts.mcmaster.ca/display/publication173132",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2006",
        "doi": "10.1111/j.1538-7836.2006.01853.x"
      },
      {
        "title": "Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma‐derived solvent‐detergent factor VIII concentrate",
        "url": "https://experts.mcmaster.ca/display/publication411193",
        "journal": "Haemophilia",
        "year": "2006",
        "doi": "10.1111/j.1365-2516.2006.01201.x"
      },
      {
        "title": "Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments",
        "url": "https://experts.mcmaster.ca/display/publication173127",
        "journal": "Cerebrovascular Diseases",
        "year": "2006",
        "doi": "10.1159/000094604"
      },
      {
        "title": "High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.",
        "url": "https://experts.mcmaster.ca/display/publication3461845",
        "journal": "Blood",
        "year": "2005",
        "doi": "10.1182/blood.v106.11.3219.3219"
      },
      {
        "title": "Differences between patients’, physicians’ and pharmacists’ preferences for treatment products in haemophilia: a discrete choice experiment",
        "url": "https://experts.mcmaster.ca/display/publication411195",
        "journal": "Haemophilia",
        "year": "2005",
        "doi": "10.1111/j.1365-2516.2005.01159.x"
      },
      {
        "title": "Performance Comparison of Three Assay Methods Used in Fasting and Postmethionine Load Plasma Homocysteine Determinations From Patients With Vascular Disease",
        "url": "https://experts.mcmaster.ca/display/publication173137",
        "journal": "American Journal of Clinical Pathology",
        "year": "2005",
        "doi": "10.1309/0f85mtu8kl3d7jjp"
      },
      {
        "title": "Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease",
        "url": "https://experts.mcmaster.ca/display/publication995646",
        "journal": "American Journal of Clinical Pathology",
        "year": "2005",
        "doi": "10.1309/0F85MTU8KI.3D7.JJP"
      },
      {
        "title": "Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism",
        "url": "https://experts.mcmaster.ca/display/publication173135",
        "journal": "Current Pharmaceutical Design",
        "year": "2005",
        "doi": "10.2174/138161205774580534"
      },
      {
        "title": "Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves",
        "url": "https://experts.mcmaster.ca/display/publication173141",
        "journal": "International Journal of Laboratory Hematology",
        "year": "2005",
        "doi": "10.1111/j.1365-2257.2005.00713.x"
      },
      {
        "title": "Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B",
        "url": "https://experts.mcmaster.ca/display/publication173143",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2005",
        "doi": "10.1002/14651858.cd003429.pub2"
      },
      {
        "title": "Interventions to enhance medication adherence",
        "url": "https://experts.mcmaster.ca/display/publication1161503",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2005",
        "doi": "10.1002/14651858.CD000011.pub2"
      },
      {
        "title": "Corrigenda",
        "url": "https://experts.mcmaster.ca/display/publication1747345",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2004",
        "doi": "10.1111/j.1538-7836.2004.00945.x"
      },
      {
        "title": "Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents (vol 2, pg 1055, 2004)",
        "url": "https://experts.mcmaster.ca/display/publication995722",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2004"
      },
      {
        "title": "Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents",
        "url": "https://experts.mcmaster.ca/display/publication173234",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2004",
        "doi": "10.1111/j.1538-7836.2004.00753.x"
      },
      {
        "title": "Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication173238",
        "journal": "Arthritis and Rheumatism",
        "year": "2004",
        "doi": "10.1002/art.20237"
      },
      {
        "title": "Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants",
        "url": "https://experts.mcmaster.ca/display/publication173248",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2003",
        "doi": "10.1046/j.1538-7836.2003.00364.x"
      },
      {
        "title": "Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen",
        "url": "https://experts.mcmaster.ca/display/publication173252",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2003",
        "doi": "10.1046/j.1538-7836.2003.00241.x"
      },
      {
        "title": "Flow cytometric measurement of intracellular IFN-gamma induction in aged subjects before and after parenteral influenza vaccination.",
        "url": "https://experts.mcmaster.ca/display/publication1747329",
        "journal": "Developments in Biologicals",
        "year": "2003"
      },
      {
        "title": "Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months",
        "url": "https://experts.mcmaster.ca/display/publication173228",
        "journal": "Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research",
        "year": "2003",
        "doi": "10.1159/000081508"
      },
      {
        "title": "Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.",
        "url": "https://experts.mcmaster.ca/display/publication173270",
        "journal": "Haematologica",
        "year": "2002"
      },
      {
        "title": "Influenza A Virus Specific T Cell Immunity in Humans during Aging",
        "url": "https://experts.mcmaster.ca/display/publication411197",
        "journal": "Virology",
        "year": "2002",
        "doi": "10.1006/viro.2002.1491"
      },
      {
        "title": "Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication173284",
        "journal": "New England Journal of Medicine",
        "year": "2001",
        "doi": "10.1056/nejm200107193450302"
      },
      {
        "title": "Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery",
        "url": "https://experts.mcmaster.ca/display/publication173290",
        "journal": "JAMA Internal Medicine",
        "year": "2000",
        "doi": "10.1001/archinte.160.15.2327"
      },
      {
        "title": "Mesenteric-portal Vein Thrombosis in a Patient with Hyperhomocysteinemia and Heterozygous for 20210A Prothrombin Allele",
        "url": "https://experts.mcmaster.ca/display/publication173289",
        "journal": "Thrombosis and Haemostasis",
        "year": "2000",
        "doi": "10.1055/s-0037-1614025"
      },
      {
        "title": "Miconazole Oral Gel Potentiates Warfarin Anticoagulant Activity",
        "url": "https://experts.mcmaster.ca/display/publication173292",
        "journal": "Thrombosis and Haemostasis",
        "year": "2000",
        "doi": "10.1055/s-0037-1613916"
      },
      {
        "title": "Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery",
        "url": "https://experts.mcmaster.ca/display/publication3461864",
        "journal": "Investigative Urology",
        "year": "1999",
        "doi": "10.1097/00005392-199910000-00130"
      },
      {
        "title": "Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery",
        "url": "https://experts.mcmaster.ca/display/publication3461872",
        "journal": "Investigative Urology",
        "year": "1999",
        "doi": "10.1016/s0022-5347(05)68386-3"
      },
      {
        "title": "Withdrawal of warfarin after deep vein thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication173299",
        "journal": "Blood Coagulation and Fibrinolysis",
        "year": "1999",
        "doi": "10.1097/00001721-199907000-00011"
      },
      {
        "title": "Enoxaparin Plus Compression Stockings Compared With Compression Stockings Alone in the Prevention of Venous Thromboembolism After Elective Neurosurgery",
        "url": "https://experts.mcmaster.ca/display/publication3461863",
        "journal": "Obstetrical and Gynecological Survey",
        "year": "1998",
        "doi": "10.1097/00006254-199811000-00013"
      },
      {
        "title": "Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery",
        "url": "https://experts.mcmaster.ca/display/publication173307",
        "journal": "New England Journal of Medicine",
        "year": "1998",
        "doi": "10.1056/nejm199807093390204"
      },
      {
        "title": "Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism",
        "url": "https://experts.mcmaster.ca/display/publication995612",
        "journal": "Blood Coagulation and Fibrinolysis",
        "year": "1997",
        "doi": "10.1097/00001721-199706000-00002"
      },
      {
        "title": "Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.",
        "url": "https://experts.mcmaster.ca/display/publication173310",
        "journal": "Blood Coagulation and Fibrinolysis",
        "year": "1997",
        "doi": "10.1097/00001721-199706000-00002"
      },
      {
        "title": "Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication173315",
        "journal": "Clinical Pharmacokinetics",
        "year": "1997",
        "doi": "10.2165/00003088-199732020-00005"
      },
      {
        "title": "Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents",
        "url": "https://experts.mcmaster.ca/display/publication173312",
        "journal": "Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research",
        "year": "1997",
        "doi": "10.1159/000217438"
      },
      {
        "title": "Post-discharge deep-vein thrombosis after orthopaedic surgery",
        "url": "https://experts.mcmaster.ca/display/publication173317",
        "journal": "The Lancet",
        "year": "1996",
        "doi": "10.1016/s0140-6736(05)65324-x"
      },
      {
        "title": "Increased Plasma Levels of Tissue Factor Pathway Inhibitor (TFPI) after n-3 Polyunsaturated Fatty Acids Supplementation in Patients with Chronic Atherosclerotic Disease",
        "url": "https://experts.mcmaster.ca/display/publication173319",
        "journal": "Thrombosis and Haemostasis",
        "year": "1996",
        "doi": "10.1055/s-0038-1650285"
      },
      {
        "title": "Post Discharge Clinically Overt Venous Thromboembolism in Orthopaedic Surgery Patients with Negative Venography -an Overview Analysis",
        "url": "https://experts.mcmaster.ca/display/publication173316",
        "journal": "Thrombosis and Haemostasis",
        "year": "1996",
        "doi": "10.1055/s-0038-1650681"
      },
      {
        "title": "Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins",
        "url": "https://experts.mcmaster.ca/display/publication173320",
        "journal": "Circulation",
        "year": "1995",
        "doi": "10.1161/01.cir.92.10.2819"
      },
      {
        "title": "Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.",
        "url": "https://experts.mcmaster.ca/display/publication173321",
        "journal": "Translational Research",
        "year": "1995"
      },
      {
        "title": "Dermatan sulphate in heparin-induced thrombocytopenia",
        "url": "https://experts.mcmaster.ca/display/publication173322",
        "journal": "The Lancet",
        "year": "1994",
        "doi": "10.1016/s0140-6736(94)90780-3"
      },
      {
        "title": "Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications",
        "url": "https://experts.mcmaster.ca/display/publication173323",
        "journal": "Seminars in Thrombosis and Hemostasis",
        "year": "1994",
        "doi": "10.1055/s-2007-1001912"
      },
      {
        "title": "Antipyretic analgesics",
        "url": "https://experts.mcmaster.ca/display/publication1747354",
        "journal": "Side Effects of Drugs Annual",
        "year": "1994",
        "doi": "10.1016/s0378-6080(05)80253-3"
      },
      {
        "title": "Streptokinase and rt-PA activate platelets by a different way: Implications on the rethrombosis rate after their administration in myocardial infarction",
        "url": "https://experts.mcmaster.ca/display/publication3461868",
        "journal": "Fibrinolysis and Proteolysis",
        "year": "1994",
        "doi": "10.1016/0268-9499(94)90489-8"
      },
      {
        "title": "Fibrinogen degradation products generation is the major determinant of platelet inhibition induced by plasminogen activators in platelet-rich plasma",
        "url": "https://experts.mcmaster.ca/display/publication995622",
        "journal": "Fibrinolysis and Proteolysis",
        "year": "1993",
        "doi": "10.1016/0268-9499(93)90062-z"
      },
      {
        "title": "Thrombolytic and haemorrhagic effects of bolus doses of rt-PA and A hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935)",
        "url": "https://experts.mcmaster.ca/display/publication3461873",
        "journal": "Thrombosis Research",
        "year": "1993",
        "doi": "10.1016/0049-3848(93)90428-q"
      },
      {
        "title": "PB2629: LATE DIAGNOSIS OF TWO ADULT SIBLINGS WITH BERNARD SOULIER SYNDROME (BSS)",
        "url": "https://experts.mcmaster.ca/display/publication3461840",
        "journal": "HemaSphere",
        "doi": "10.1097/01.hs9.0000977204.63685.a6"
      },
      {
        "title": "PB2647: USE OF EMICIZUMAB FOR THE TREATMENT OF ACQUIRED HEMOPHILIA A: A SYSTEMATIC REVIEW",
        "url": "https://experts.mcmaster.ca/display/publication3461841",
        "journal": "HemaSphere",
        "doi": "10.1097/01.hs9.0000977272.39179.7d"
      },
      {
        "title": "Psychological interventions for people with hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication3461865",
        "journal": "Cochrane Database of Systematic Reviews",
        "doi": "10.1002/14651858.cd010215"
      },
      {
        "title": "Reflections on the Canadian Bleeding Disorders Registry: Lessons Learned and Future Perspectives",
        "url": "https://experts.mcmaster.ca/display/publication2716670",
        "journal": "Canadian Journal of Health Technologies",
        "doi": "10.51731/cjht.2022.425"
      }
    ],
    "chapters": [
      {
        "title": "Non-Anticoagulant Actions of Glycosaminoglycans",
        "url": "https://experts.mcmaster.ca/display/publication3461866",
        "year": "1996",
        "doi": "10.1007/978-1-4613-0371-8_8"
      }
    ],
    "conferences": [
      {
        "title": "Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study",
        "url": "https://experts.mcmaster.ca/display/publication995654",
        "journal": "Haemophilia",
        "year": "2024",
        "doi": "10.1111/hae.14969"
      },
      {
        "title": "Characterisation of the first global VWD cohort from the WFH world bleeding disorders registry",
        "url": "https://experts.mcmaster.ca/display/publication3513406",
        "journal": "Haemophilia",
        "year": "2024"
      },
      {
        "title": "Evolution of haemophilia care: Analysing factor VIII usage trends and the impact of novel therapies",
        "url": "https://experts.mcmaster.ca/display/publication3513404",
        "journal": "Haemophilia",
        "year": "2024"
      },
      {
        "title": "Gene therapy with the Padua variant of a codon-optimised human factor IX gene etranacogene dezaparvovec in people with haemophilia B: Effects on patient-oriented outcomes measured using the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire in the HOPE-B study",
        "url": "https://experts.mcmaster.ca/display/publication3513402",
        "journal": "Haemophilia",
        "year": "2024"
      },
      {
        "title": "Real-world effectiveness of pegylated, recombinant antihaemophilic factor (Rurioctocog alfa pegol) prophylaxis in patients with haemophilia A in Canada: A retrospective, intra-patient comparison with a before-after design",
        "url": "https://experts.mcmaster.ca/display/publication3513405",
        "journal": "Haemophilia",
        "year": "2024"
      },
      {
        "title": "Self-reflections, lessons learned and suggestions for data quality assurance from a retrospective data analysis from the Canadian Bleeding Disorders Registry",
        "url": "https://experts.mcmaster.ca/display/publication3513403",
        "journal": "Haemophilia",
        "year": "2024"
      },
      {
        "title": "Comparing inhibitor development in (plasma derived vs. recombinant) FVIII/FIX concentrates in severe haemophilia: Reporting on 1392 PUPs from EUHASS and canadian registries",
        "url": "https://experts.mcmaster.ca/display/publication3429332",
        "journal": "Haemophilia",
        "year": "2024"
      },
      {
        "title": "International data integration program of the WFH world bleeding disorders registry: bringing europe data to the global stage",
        "url": "https://experts.mcmaster.ca/display/publication3429333",
        "journal": "Haemophilia",
        "year": "2024"
      },
      {
        "title": "Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry",
        "url": "https://experts.mcmaster.ca/display/publication3403139",
        "journal": "Blood",
        "year": "2023",
        "doi": "10.1182/blood-2023-174057"
      },
      {
        "title": "A COMPARATIVE STUDY OF DIFFERENT METHODS OF HANDLING MISSING DATA IN PATIENT REPORTED OUTCOMES, BURDENS AND EXPERIENCES (PROBE) SCORE ALGORITHM AMONG PEOPLE WITH HEMOPHILIA",
        "url": "https://experts.mcmaster.ca/display/publication2980744",
        "journal": "American Journal of Hematology",
        "year": "2023"
      },
      {
        "title": "BUILDING A GLOBAL RESOURCE FOR THE LONG-TERM FOLLOW-UP OF HEMOPHILIA PATIENTS TREATED WITH GENE THERAPY: COLLABORATION BETWEEN THE WORLD FEDERATION OF HEMOPHILIA AND NATIONAL REGISTRIES",
        "url": "https://experts.mcmaster.ca/display/publication3282185",
        "journal": "Haemophilia",
        "year": "2023"
      },
      {
        "title": "COLLABORATION FOR THE LONG-TERM FOLLOW-UP OF PEOPLE WITH HEMOPHILIA TREATED WITH GENE THERAPY: WORLD FEDERATION OF HEMOPHILIA- AMERICAN THROMBOSIS AND HEMOSTASIS NETWORK",
        "url": "https://experts.mcmaster.ca/display/publication2981099",
        "journal": "American Journal of Hematology",
        "year": "2023"
      },
      {
        "title": "TEST-RETEST RELIABILITY ANALYSIS OF THE PATIENT REPORTED OUTCOMES BURDENS AND EXPERIENCES (PROBE) STUDY",
        "url": "https://experts.mcmaster.ca/display/publication3281999",
        "journal": "Haemophilia",
        "year": "2023"
      },
      {
        "title": "Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry",
        "url": "https://experts.mcmaster.ca/display/publication2922803",
        "journal": "Blood",
        "year": "2022",
        "doi": "10.1182/blood-2022-157531"
      },
      {
        "title": "COST-EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS",
        "url": "https://experts.mcmaster.ca/display/publication2424575",
        "journal": "Value in Health",
        "year": "2022"
      },
      {
        "title": "Comparison of change in number of identified people with haemophilia A and factor VIII use per patient over time",
        "url": "https://experts.mcmaster.ca/display/publication2188826",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "Empowering people with haemophilia to take control of their care and treatment through myWBDR and myPROBE-A patient-reported outcomes tool for achieving a 360-degree patient-centred evaluation",
        "url": "https://experts.mcmaster.ca/display/publication2187647",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "Feasibility of integrating PROBE (patient reported outcomes, burdens and experiences) into a clinical care pathway to facilitate transformation to a value-based health care model in haemophilia",
        "url": "https://experts.mcmaster.ca/display/publication2187650",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "Integration of the Mexican Registry of Coagulopathies (RMC) with PROBE",
        "url": "https://experts.mcmaster.ca/display/publication2187649",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "Prevalence of selected bleeding and thrombotic events in persons with congenital haemophilia versus the general non-haemophilia population",
        "url": "https://experts.mcmaster.ca/display/publication2188825",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "Using the World Federation of Haemophilia gene therapy registry for the long-term follow-up of haemophilia patients treated with gene therapy",
        "url": "https://experts.mcmaster.ca/display/publication2187651",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "WFH world bleeding disorders registry highlights gaps in haemophilia diagnosis and management",
        "url": "https://experts.mcmaster.ca/display/publication2188824",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "CANADIAN CLINICAL EXPERIENCE ON SWITCHING FROM OCTOCOG ALFA TO EXTENDED-HALF-LIFE FVIII DAMOCTOCOG ALFA PEGOL IN PATIENTS WITH SEVERE HAEMOPHILIA A",
        "url": "https://experts.mcmaster.ca/display/publication2165640",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY - A GLOBAL RESOURCE FOR THE LONG-TERM FOLLOW-UP OF HEMOPHILIA PATIENTS TREATED WITH GENE THERAPY",
        "url": "https://experts.mcmaster.ca/display/publication2165639",
        "journal": "Haemophilia",
        "year": "2022"
      },
      {
        "title": "Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry",
        "url": "https://experts.mcmaster.ca/display/publication2427707",
        "journal": "Blood",
        "year": "2021",
        "doi": "10.1182/blood-2021-147195"
      },
      {
        "title": "Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study",
        "url": "https://experts.mcmaster.ca/display/publication2428077",
        "journal": "Blood",
        "year": "2021",
        "doi": "10.1182/blood-2021-147550"
      },
      {
        "title": "ANALYSIS OF HEMOPHILIA PATIENT IDENTIFICATION IN DIFFERENT ECONOMIC SETTINGS",
        "url": "https://experts.mcmaster.ca/display/publication1962896",
        "journal": "Haemophilia",
        "year": "2021"
      },
      {
        "title": "EQUITY IN THE USE OF PROPHYLAXIS IN CHILDREN WITH SEVERE HEMOPHILIA",
        "url": "https://experts.mcmaster.ca/display/publication1962898",
        "journal": "Haemophilia",
        "year": "2021"
      },
      {
        "title": "THE WORLD FEDERATION OF HEMOPHILIA GENE THERAPY REGISTRY",
        "url": "https://experts.mcmaster.ca/display/publication1962004",
        "journal": "Haemophilia",
        "year": "2021"
      },
      {
        "title": "WORLD BLEEDING DISORDERS REGISTRY SHOWCASES DISPARITIES IN HEMOPHILIA CARE AROUND THE WORLD",
        "url": "https://experts.mcmaster.ca/display/publication1962897",
        "journal": "Haemophilia",
        "year": "2021"
      },
      {
        "title": "Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry",
        "url": "https://experts.mcmaster.ca/display/publication1963023",
        "journal": "Blood",
        "year": "2020",
        "doi": "10.1182/blood-2020-137320"
      },
      {
        "title": "Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database",
        "url": "https://experts.mcmaster.ca/display/publication3434164",
        "journal": "Blood",
        "year": "2020",
        "doi": "10.1182/blood-2020-142816"
      },
      {
        "title": "Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication3434165",
        "journal": "Blood",
        "year": "2020",
        "doi": "10.1182/blood-2020-136586"
      },
      {
        "title": "Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments",
        "url": "https://experts.mcmaster.ca/display/publication3434163",
        "journal": "Blood",
        "year": "2020",
        "doi": "10.1182/blood-2020-141801"
      },
      {
        "title": "Comparative PK evaluation of SHL vs EHL by non-compartmental and compartmental population PK analysis in patients with severe and moderate HA",
        "url": "https://experts.mcmaster.ca/display/publication1914750",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "Data is the new currency: The World Bleeding Disorders Registry Data Quality Accreditation Program",
        "url": "https://experts.mcmaster.ca/display/publication1914744",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "Education in people with Hemophilia - Insights from the PROBE Study",
        "url": "https://experts.mcmaster.ca/display/publication1914746",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "International Standard Set of Health Outcomes that matter for people living with hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1914745",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "What the future might look like-The PROBE Study",
        "url": "https://experts.mcmaster.ca/display/publication1894316",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "ASSESSING A POPULATION PHARMACOKINETIC MODEL OF A PLASMA-DERIVED, VON WILLEBRAND FACTOR-CONTAINING FVIII CONCENTRATE FOR BAYESIAN FORECASTING IN LOW DOSE SCENARIOS",
        "url": "https://experts.mcmaster.ca/display/publication1694212",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY",
        "url": "https://experts.mcmaster.ca/display/publication1692273",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "INTERNATIONAL STANDARD SET OF HEALTH OUTCOMES THAT MATTER FOR PEOPLE LIVING WITH HEMOPHILIA",
        "url": "https://experts.mcmaster.ca/display/publication1692275",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS",
        "url": "https://experts.mcmaster.ca/display/publication1694213",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "REPORT ON THE ANNUAL GLOBAL SURVEY-20 YEARS ON AND MORE INFORMATIVE",
        "url": "https://experts.mcmaster.ca/display/publication1694211",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "THE WORLD BLEEDING DISORDERS REGISTRY CELEBRATES 2 YEARS!",
        "url": "https://experts.mcmaster.ca/display/publication1694210",
        "journal": "Haemophilia",
        "year": "2020"
      },
      {
        "title": "Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1942922",
        "journal": "Blood",
        "year": "2019",
        "doi": "10.1182/blood-2019-127046"
      },
      {
        "title": "Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products",
        "url": "https://experts.mcmaster.ca/display/publication1942921",
        "journal": "Blood",
        "year": "2019",
        "doi": "10.1182/blood-2019-127946"
      },
      {
        "title": "Routine Double Filtration Plasmapheresis Affects Hemostatic Proteins and Prolongs Clotting Tests",
        "url": "https://experts.mcmaster.ca/display/publication1942080",
        "journal": "Blood",
        "year": "2019",
        "doi": "10.1182/blood-2019-127524"
      },
      {
        "title": "Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization",
        "url": "https://experts.mcmaster.ca/display/publication1500755",
        "journal": "Journal of Pharmacokinetics and Pharmacodynamics",
        "year": "2019",
        "doi": "10.1007/s10928-019-09634-7"
      },
      {
        "title": "Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients",
        "url": "https://experts.mcmaster.ca/display/publication1600586",
        "journal": "Journal of Pharmacokinetics and Pharmacodynamics",
        "year": "2019",
        "doi": "10.1007/s10928-019-09637-4"
      },
      {
        "title": "PROSPECTIVE STUDY OF THE IMMUNOLOGICAL RES PONSE TO FACTOR VIII IN SEVERE HEMOPHILIA A PATIENTS DURING IMMUNE TOLERANCE INDUCTION TREATMENT",
        "url": "https://experts.mcmaster.ca/display/publication1671698",
        "journal": "Haematologica",
        "year": "2019"
      },
      {
        "title": "coreHEM, a Multistakeholder Core Outcome Set Project for Gene Therapy in Hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1639464",
        "journal": "Molecular Therapy",
        "year": "2019"
      },
      {
        "title": "ASSESSMENT OF PHARMACOKINETIC BAYESIAN PREDICTIONS IN HEMOPHILIA B USING LIMITED SAMPLING ANALYSIS.",
        "url": "https://experts.mcmaster.ca/display/publication1632300",
        "journal": "Clinical Pharmacology and Therapeutics",
        "year": "2019"
      },
      {
        "title": "Part-time employment and early retirement in people with severe haemophilia: Insights from the PROBE study",
        "url": "https://experts.mcmaster.ca/display/publication1628469",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "Predictors for acute and chronic pain in patients with severe haemophilia in the PROBE cohort",
        "url": "https://experts.mcmaster.ca/display/publication1628470",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "The WFH world bleeding disorders registry",
        "url": "https://experts.mcmaster.ca/display/publication1629942",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "The Web-Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-HEMO) contribution to tailoring treatment in children: Examples for hemophilia A and B",
        "url": "https://experts.mcmaster.ca/display/publication1629941",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "Using individual pharmacokinetic parameters on octocog alfa to predict individual pharmacokinetic parameters on efmoroctocog alfa in persons with hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1629943",
        "journal": "Haemophilia",
        "year": "2019"
      },
      {
        "title": "Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform",
        "url": "https://experts.mcmaster.ca/display/publication1632298",
        "journal": "Blood",
        "year": "2018",
        "doi": "10.1182/blood-2018-99-115308"
      },
      {
        "title": "Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada",
        "url": "https://experts.mcmaster.ca/display/publication1632119",
        "journal": "Blood",
        "year": "2018",
        "doi": "10.1182/blood-2018-99-113858"
      },
      {
        "title": "Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study",
        "url": "https://experts.mcmaster.ca/display/publication1630926",
        "journal": "Blood",
        "year": "2018",
        "doi": "10.1182/blood-2018-99-119568"
      },
      {
        "title": "Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of anti-hemophilic factor recombinant plasma/albumin-free method (rAHF-PFM) concentrate in patients with Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1541344",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem",
        "url": "https://experts.mcmaster.ca/display/publication1581308",
        "journal": "Value in Health",
        "year": "2018",
        "doi": "10.1016/j.jval.2018.04.1439"
      },
      {
        "title": "The PROBE Data Dashboard - A new tool for real-time data visualization and analysis of patient reported outcomes",
        "url": "https://experts.mcmaster.ca/display/publication1543698",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "The PROBE Study - Global burden of bleeding from the mouth in Haemophilia - a call to action",
        "url": "https://experts.mcmaster.ca/display/publication1543701",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "The WFH World Bleeding Disorders Registry",
        "url": "https://experts.mcmaster.ca/display/publication1543700",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "coreHEM: A multi-stakeholder approach to developing a core outcome set for gene therapy in hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication1543702",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice",
        "url": "https://experts.mcmaster.ca/display/publication1543699",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of factor VIII concentrate in patients with hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication1498587",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "Occurrence and impact of pain among patients living with hemophilia: An analysis from the patient reported outcomes, burdens and experiences (PROBE) study",
        "url": "https://experts.mcmaster.ca/display/publication1498586",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice",
        "url": "https://experts.mcmaster.ca/display/publication1498585",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "Perioperative management for patients with congenital factor XI deficiency",
        "url": "https://experts.mcmaster.ca/display/publication1498588",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "The WFH world bleeding disorders registry",
        "url": "https://experts.mcmaster.ca/display/publication1498589",
        "journal": "Haemophilia",
        "year": "2018"
      },
      {
        "title": "Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study",
        "url": "https://experts.mcmaster.ca/display/publication1979440",
        "journal": "Blood",
        "year": "2017"
      },
      {
        "title": "Comparative Assessment of the Performance of Pharmacokinetic Tools for Prophylactic Dosing of Antihemophilic Factor Recombinant Plasma/Albumin-Free Method (rAHF-PFM) Concentrate in Patients with Hemophilia A",
        "url": "https://experts.mcmaster.ca/display/publication3272670",
        "journal": "Blood",
        "year": "2017"
      },
      {
        "title": "Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a",
        "url": "https://experts.mcmaster.ca/display/publication1589072",
        "journal": "Blood",
        "year": "2017"
      },
      {
        "title": "Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study",
        "url": "https://experts.mcmaster.ca/display/publication3272671",
        "journal": "Blood",
        "year": "2017"
      },
      {
        "title": "Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study",
        "url": "https://experts.mcmaster.ca/display/publication1979441",
        "journal": "Blood",
        "year": "2017"
      },
      {
        "title": "The Development of the World Bleeding Disorders Registry Pilot Phase",
        "url": "https://experts.mcmaster.ca/display/publication995663",
        "journal": "Haemophilia",
        "year": "2017"
      },
      {
        "title": "An individual participant data meta-analysis of 13 randomized trials to evaluate the impact of prophylactic use of heparin in oncological patients",
        "url": "https://experts.mcmaster.ca/display/publication1563461",
        "journal": "Blood",
        "year": "2017",
        "doi": "10.1182/blood.v130.suppl_1.626.626"
      },
      {
        "title": "Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome",
        "url": "https://experts.mcmaster.ca/display/publication1471695",
        "journal": "Arthritis & Rheumatology",
        "year": "2017"
      },
      {
        "title": "THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome",
        "url": "https://experts.mcmaster.ca/display/publication1477831",
        "journal": "Annals of the Rheumatic Diseases",
        "year": "2017",
        "doi": "10.1136/annrheumdis-2017-eular.2085"
      },
      {
        "title": "The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1563464",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2017",
        "doi": "10.1111/jth.14824"
      },
      {
        "title": "Clinical and Biological Determinants of Bleeding Manifestation in Congenital Factor XI Deficiency; A Systematic Review",
        "url": "https://experts.mcmaster.ca/display/publication995657",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.1407.1407"
      },
      {
        "title": "Installing FVIII-Specific Tolerance in Hemophilia Via Engagement of the Aryl Hydrocarbon Receptor By Tryptophan Derivatives",
        "url": "https://experts.mcmaster.ca/display/publication995659",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.2563.2563"
      },
      {
        "title": "Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)",
        "url": "https://experts.mcmaster.ca/display/publication995656",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.2593.2593"
      },
      {
        "title": "Perioperative Management for Congenital Factor XI Deficiency; A Systematic Review",
        "url": "https://experts.mcmaster.ca/display/publication995658",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.3796.3796"
      },
      {
        "title": "Perioperative Management of Von Willebrand Disease, a Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication995664",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.1408.1408"
      },
      {
        "title": "Rwd Study for Epidemiology and Characteristics of Patients with Multiple Myeloma in Italy",
        "url": "https://experts.mcmaster.ca/display/publication995652",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.5693.5693"
      },
      {
        "title": "Test-Retest Reliability Analysis of the Patient Reported Outcomes Burdens and Experiences (PROBE)",
        "url": "https://experts.mcmaster.ca/display/publication995651",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.5964.5964"
      },
      {
        "title": "The Effect of Platelet Transfusion on Death in the Intensive Care Unit",
        "url": "https://experts.mcmaster.ca/display/publication554330",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.3850.3850"
      },
      {
        "title": "Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication710721",
        "journal": "Blood",
        "year": "2016",
        "doi": "10.1182/blood.v128.22.3821.3821"
      },
      {
        "title": "NHF-MCMASTER GUIDELINE ON CARE MODELS FOR HEMOPHILIA MANAGEMENT",
        "url": "https://experts.mcmaster.ca/display/publication626825",
        "journal": "American Journal of Hematology",
        "year": "2016"
      },
      {
        "title": "Hemophilia research and clinical care needs: Regional variation in future priorities",
        "url": "https://experts.mcmaster.ca/display/publication995672",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Home therapy consensus in an under resourced hemophilia setting",
        "url": "https://experts.mcmaster.ca/display/publication995680",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Measuring the quality of hemophilia care across different settings: a set of performance indices derived from demographics data",
        "url": "https://experts.mcmaster.ca/display/publication995671",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "The patient reported outcomes burdens and experiences (PROBE) study phase 1 methodology and feasibility results",
        "url": "https://experts.mcmaster.ca/display/publication995670",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "When health care professionals express themselves: results overview of the qualitative phase of Hero initiative",
        "url": "https://experts.mcmaster.ca/display/publication995673",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "The patient reported outcome burdens and experiences (PROBE) study - phase 1 results show PROBE study methodology feasible",
        "url": "https://experts.mcmaster.ca/display/publication995693",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2016"
      },
      {
        "title": "Evidence Based Haemophilia Care - Current Status and Where to Go?",
        "url": "https://experts.mcmaster.ca/display/publication995697",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Haemophilia Research and Clinical Care Needs: Assessing Future Priorities",
        "url": "https://experts.mcmaster.ca/display/publication995701",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Health Status of Elderly Persons with Hemophilia Compared with the General Population: The Sphera Study",
        "url": "https://experts.mcmaster.ca/display/publication995683",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Nonacog Alfa as Prophylaxis in Moderately Severe to Severe (FIX:C <= 2%) Hemophilia B Patients: Identifying Clinical Predictors of Response",
        "url": "https://experts.mcmaster.ca/display/publication995700",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "The Patient Reported Outcomes, Burdens, and Experiences (Probe) Phase 1 Study Methodology and Feasibility",
        "url": "https://experts.mcmaster.ca/display/publication995689",
        "journal": "Haemophilia",
        "year": "2016"
      },
      {
        "title": "Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication440320",
        "journal": "Blood",
        "year": "2015",
        "doi": "10.1182/blood.v126.23.1120.1120"
      },
      {
        "title": "Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors",
        "url": "https://experts.mcmaster.ca/display/publication440317",
        "journal": "Blood",
        "year": "2015",
        "doi": "10.1182/blood.v126.23.428.428"
      },
      {
        "title": "Safety and Effectiveness of Desmopressin for the Management of Delivery and Major Surgery in Patients with Mild-Moderate Von Willebrand Disease: Final Analysis of the Prodeswil Study",
        "url": "https://experts.mcmaster.ca/display/publication995699",
        "journal": "Blood",
        "year": "2015",
        "doi": "10.1182/blood.v126.23.759.759"
      },
      {
        "title": "Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis",
        "url": "https://experts.mcmaster.ca/display/publication440289",
        "journal": "Blood",
        "year": "2015",
        "doi": "10.1182/blood.v126.23.430.430"
      },
      {
        "title": "Study Design: A Critical Aspect of Research",
        "url": "https://experts.mcmaster.ca/display/publication995719",
        "journal": "Haemophilia",
        "year": "2015"
      },
      {
        "title": "Web Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-Hemo): A Service for Bayesian Post Hoc Estimation",
        "url": "https://experts.mcmaster.ca/display/publication995695",
        "journal": "Journal of Pharmacokinetics and Pharmacodynamics",
        "year": "2015"
      },
      {
        "title": "A population approach to hemophilia pharmacokinetics. Wapps: a web-service for bayesian post hoc estimation",
        "url": "https://experts.mcmaster.ca/display/publication623885",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Assessing the indication and success of treatment for haemophilia patients: results from a delphi panel",
        "url": "https://experts.mcmaster.ca/display/publication995716",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Bayesian approach to the assessment of the population specific risk of inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication623879",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Determinants of inhibitor development in previously treated hemophilia A patients",
        "url": "https://experts.mcmaster.ca/display/publication771728",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Indirect comparisons of factor consumption, bleeding rates, and infusion frequencies during routine prophylaxis with recombinant factor IX FC fusion protein and other recombinant factor IX products",
        "url": "https://experts.mcmaster.ca/display/publication995704",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Indirect comparisons of factor consumption, bleeding rates, and infusion frequencies during routine prophylaxis with recombinant factor VIII FC fusion protein and other recombinant factor VIII products",
        "url": "https://experts.mcmaster.ca/display/publication995708",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Investigating potential determinants of ITI success using immune gene expression profiling: a preliminary study",
        "url": "https://experts.mcmaster.ca/display/publication995702",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "OPTIMAL DURATION OF ANTICOAGULANT THERAPY FOR THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS",
        "url": "https://experts.mcmaster.ca/display/publication995712",
        "journal": "Haematologica",
        "year": "2015"
      },
      {
        "title": "Pharmacokinetic characteristics of factor VIII and IX concentrates - a systematic review",
        "url": "https://experts.mcmaster.ca/display/publication623901",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Surveillance study of safety and efficacy of a VWF/FVIII concentrate in patients with von willebrand disease (WIL-20) - a planned interim analysis",
        "url": "https://experts.mcmaster.ca/display/publication995707",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Utilization of anti-inhibitors products and inhibitors status of severe hemophilia patients: 5 years national data from the Canadian hemophilia assessment and resource management system",
        "url": "https://experts.mcmaster.ca/display/publication995703",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2015"
      },
      {
        "title": "Population pharmacokinetics for busy clinicians and active patients: how to get the most out of it?",
        "url": "https://experts.mcmaster.ca/display/publication995737",
        "journal": "Haemophilia",
        "year": "2015"
      },
      {
        "title": "A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication623891",
        "journal": "Blood",
        "year": "2014",
        "doi": "10.1182/blood.v124.21.2821.2821"
      },
      {
        "title": "Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients",
        "url": "https://experts.mcmaster.ca/display/publication771740",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2014"
      },
      {
        "title": "Risk of inhibitor development in previously treated patients with positive inhibitor history or low titer of inhibitor at baseline: results of a survey of hemophilia experts",
        "url": "https://experts.mcmaster.ca/display/publication623977",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2014"
      },
      {
        "title": "An evaluation of whether the ankle is now the dominant site of chronic hemophilic arthropathy in young adults with severe hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication995759",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "An indirect comparison of the efficacy of prophylactic use of rFIXFc and other rFIX products and simulation of the effect of compliance on effectiveness",
        "url": "https://experts.mcmaster.ca/display/publication995755",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "An indirect comparison of the efficacy of prophylactic use of rFVIIIFc and other rFVIII products and model of the effect of compliance",
        "url": "https://experts.mcmaster.ca/display/publication995747",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Assessment of patient preferences and perceived value of the comprehensive interdisciplinary combined hemophilia and orthopedic clinic using a validated questionnaire",
        "url": "https://experts.mcmaster.ca/display/publication959070",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Cardiac risk factors in older patients with hemophilia: Report of the age related cardiovascular disease in hemophilia epidemiologic research (archer) study",
        "url": "https://experts.mcmaster.ca/display/publication995760",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Factor VII deficiency patients: 5 years factors concentrates utilization trend based on the Canadian Hemophilia Assessment and Resource Management System (CHARMS)",
        "url": "https://experts.mcmaster.ca/display/publication995752",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Factors influencing quality of life in Chinese adults with hemophilia: Results from the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995728",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Fathers' and Mothers' Perceptions and Communication on Carrier Status and Diagnosis of Congenital Haemophilia: Global Results from the Haemophilia Experiences, Results and Opportunities (HERO) Study",
        "url": "https://experts.mcmaster.ca/display/publication995725",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Investigating Attitudes and Practices of Canadian Physiotherapists on Sexual Health: A Comparison to the HERO Dataset",
        "url": "https://experts.mcmaster.ca/display/publication995726",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Physiotherapy and point of care ultrasonography in the management of hemophilia: Training phase",
        "url": "https://experts.mcmaster.ca/display/publication959071",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Safety of antihemophilic factor recombinant plasma/albumin-free method [rAHF-PFM] in hemophilia A patients with low titer inhibitors or a personal history of inhibitor: A meta-analysis of ADVATE Post-Authorization Safety Studies data",
        "url": "https://experts.mcmaster.ca/display/publication624036",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Does product type influence the development on inhibitor in PTPs and PUPs?",
        "url": "https://experts.mcmaster.ca/display/publication995756",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Does product type influence the development on inhibitor in PTPs and PUPs?",
        "url": "https://experts.mcmaster.ca/display/publication995770",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Investigating determinants of inhbitor development to factor VIII molecules in previously treated hemophilia A patients",
        "url": "https://experts.mcmaster.ca/display/publication771722",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "The use of FVIII concentrate in hemophilia A patients with low titer inhibitors or a personal history of inhibitor: a meta-analysis of advate post-authorization safety studies in different countries",
        "url": "https://experts.mcmaster.ca/display/publication624005",
        "journal": "Haemophilia",
        "year": "2014"
      },
      {
        "title": "Venous thromboembolism prophylaxis in elderly patients admitted to Italian internal medicine wards",
        "url": "https://experts.mcmaster.ca/display/publication995769",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Developing a Two-Sided Intervention To Facilitate Shared Decision Making In Haemophilia: Decision Boxes For Clinicians and Brief Patient Decision Aids For Patients",
        "url": "https://experts.mcmaster.ca/display/publication771741",
        "journal": "Blood",
        "year": "2013"
      },
      {
        "title": "Association between treatment regimen and quality of life assessed by EQ-5D-3L and pain interference in adults with haemophilia with and without inhibitors in the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995741",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Association of treatment regimen and location with bleed frequency, quality of life and comorbidities in adults and children with haemophilia from the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995749",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia A patients carrying F8 gene null mutations",
        "url": "https://experts.mcmaster.ca/display/publication995750",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Do bleed rates and haemophilia treatment centre/provider utilisation vary with physical activity risk in adults with haemophilia: An analysis from the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995746",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Do inhibitors, treatment regimen and bleed frequency impact haemophilia treatment centre and provider utilisation: an analysis of adults with haemophilia in the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995758",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Do inhibitors, treatment regimen and bleed frequency impact parent-directed haemophilia treatment centre and provider utilisation: An analysis of parents of children with haemophilia in the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995742",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Does higher risk activity change bleed frequency and haemophilia treatment center/provider utilisation in children with haemophilia: an analysis from the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995748",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Effect of type and intensity of FVIII exposure on inhibitors development in hemophilia A: first results of an individual patient data meta-analytic project",
        "url": "https://experts.mcmaster.ca/display/publication995751",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "External validation and updating of the Vienna Prediction Model for recurrent venous thromboembolism using a pooled individual patient data database",
        "url": "https://experts.mcmaster.ca/display/publication995743",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Meta-analysis of Post Authorization Safety Studies: worldwide postmarking surveillance of hemophilia A patients treated with antihemophilic factor recombinant plasma/albumin-free method rAHF-PFM",
        "url": "https://experts.mcmaster.ca/display/publication624017",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Potential relationships between negative impacts on employment or relationships and haemophilia treatment centre/provider utilisation: an analysis of adults with haemophilia from the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995754",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Potential relationships between negative impacts on employment or relationships with haemophilia centre/provider utilisation: An analysis of parents of children with haemophilia from the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995753",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Quality of life and well-being of haemophilia patients and parents in China: subgroup analysis of the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995757",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Relationship of quality of life, pain and self-reported arthritis with activity, bleed rate and haemophilia treatment centre/provider utilisation: results from the HERO study",
        "url": "https://experts.mcmaster.ca/display/publication995745",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2013"
      },
      {
        "title": "Access to haemophilia treatment centres (HTCS), treatment and information sources: european results from the hero study",
        "url": "https://experts.mcmaster.ca/display/publication995771",
        "journal": "Haemophilia",
        "year": "2013"
      },
      {
        "title": "Demographic characteristics of European respondents in the hero study",
        "url": "https://experts.mcmaster.ca/display/publication995776",
        "journal": "Haemophilia",
        "year": "2013"
      },
      {
        "title": "Effect of turoctocog alfa on quality of life of children, adolescents and adults with haemophilia A: results from two clinical trials",
        "url": "https://experts.mcmaster.ca/display/publication995765",
        "journal": "Haemophilia",
        "year": "2013"
      },
      {
        "title": "Effects of haemophilia on relationships, intimacy and family: european results from the hero study",
        "url": "https://experts.mcmaster.ca/display/publication995764",
        "journal": "Haemophilia",
        "year": "2013"
      },
      {
        "title": "Quality of life in adults with haemophilia: european results from the hero study",
        "url": "https://experts.mcmaster.ca/display/publication995767",
        "journal": "Haemophilia",
        "year": "2013"
      },
      {
        "title": "Hemophilia Experiences, Results and Opportunities (HERO) Study: US Respondent Demographics and Impact of Diagnosis On Career and Lifestyle Decisions and Quality of Life",
        "url": "https://experts.mcmaster.ca/display/publication995785",
        "journal": "Blood",
        "year": "2012",
        "doi": "10.1182/blood.v120.21.4244.4244"
      },
      {
        "title": "Assessment of treatment-related risk factors for inhibitor development in previously untreated hemophilia A patients: Different statistical approaches",
        "url": "https://experts.mcmaster.ca/display/publication995787",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Clinical presentation and management of adult patients responding to the Hemophilia Experiences Results Opportunities (HERO) study",
        "url": "https://experts.mcmaster.ca/display/publication995786",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Clinical presentation and management of pediatric hemophilia patients as reported by parents surveyed in the Haemophilia Experiences Results Opportunities (HERO) survey",
        "url": "https://experts.mcmaster.ca/display/publication995794",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Demographic characteristics of adult patient respondents in the Hemophilia Experiences Results Opportunities (HERO) study",
        "url": "https://experts.mcmaster.ca/display/publication995790",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Demographic characteristics of parents of children/adolescents with hemophilia responding in the Hemophilia Experiences Results Opportunities (HERO) study",
        "url": "https://experts.mcmaster.ca/display/publication995793",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Hemophilia knowledge and frequently used and valued information sources: Patient/parent perceptions from the Hero study",
        "url": "https://experts.mcmaster.ca/display/publication995788",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Impact of hemophilia on interpersonal relationships: Assessment of parent/caregiver respondents in the hemophilia experiences, results, opportunities (hero) study",
        "url": "https://experts.mcmaster.ca/display/publication995780",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Impact of hemophilia on relationships with partners, family, and friends: Assessment of adult patient respondents in the hemophilia experiences, results, opportunities (HERO) study",
        "url": "https://experts.mcmaster.ca/display/publication995791",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Low bone mineral density and increased fat mass in boys with severe hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication179544",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Nutritional intake and bone mineral density in boys with severe hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication179542",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Osteochondral Lesions of the Ankle Joint in Patients with Hemophilia A: A Retrospective Case Series",
        "url": "https://experts.mcmaster.ca/display/publication179516",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Predictors of success of immune tolerance induction in hemophilia A patients with high-responding inhibitors: A score from the Italian registry",
        "url": "https://experts.mcmaster.ca/display/publication995779",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Qualitative and quantitative assessment of sexual intimacy in adult patients in the hemophilia experiences results opportunities (HERO) study",
        "url": "https://experts.mcmaster.ca/display/publication995778",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Quality of life (QOL) and well-being of hemophilia patients and parents managing hemophilia: Hero study analysis",
        "url": "https://experts.mcmaster.ca/display/publication995792",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Concentrate type and dose in hemophilia A patients: is there an independent effect on risk of inhibitor formation?",
        "url": "https://experts.mcmaster.ca/display/publication995805",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "The use of the clinical trial design in Hemophilia: methodological considerations",
        "url": "https://experts.mcmaster.ca/display/publication995808",
        "journal": "Haemophilia",
        "year": "2012"
      },
      {
        "title": "Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study",
        "url": "https://experts.mcmaster.ca/display/publication995804",
        "journal": "Blood",
        "year": "2011"
      },
      {
        "title": "Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score",
        "url": "https://experts.mcmaster.ca/display/publication995810",
        "journal": "Blood",
        "year": "2011"
      },
      {
        "title": "Bioequivalence of B-domain deleted and plasma derived FVIII concentrates",
        "url": "https://experts.mcmaster.ca/display/publication995729",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2011"
      },
      {
        "title": "HERO - an international initiative exploring unmet psychosocial needs in haemophilia: results from a qualitative survey targeting 150 subjects in seven countries",
        "url": "https://experts.mcmaster.ca/display/publication995724",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2011"
      },
      {
        "title": "HERO, an international initiative exploring unmet psychosocial needs in haemophilia: characteristics of a quantitative survey targeting 1200 subjects in 12 countries",
        "url": "https://experts.mcmaster.ca/display/publication995731",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2011"
      },
      {
        "title": "Heterogeneity of the clinical, laboratory and molecular markers of VWD type 3: results from the retrospective/prospective studies on 122/52 Italian patients",
        "url": "https://experts.mcmaster.ca/display/publication995740",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2011"
      },
      {
        "title": "Impact of persistent antiphospholipid antibodies on symptomatic thromboembolism in children: a systematic review & meta-analysis [observational studies]",
        "url": "https://experts.mcmaster.ca/display/publication995736",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2011"
      },
      {
        "title": "Psychosocial aspects of living with haemophilia: the hero project and a narrative review of the published literature",
        "url": "https://experts.mcmaster.ca/display/publication995738",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2011"
      },
      {
        "title": "Predictive model to assess the risk of inhibitor development in children with severe and moderate haemophilia A - results of a multicenter cohort study",
        "url": "https://experts.mcmaster.ca/display/publication995806",
        "journal": "Haemophilia",
        "year": "2011"
      },
      {
        "title": "Predictors of inhibitor development in haemophilia A previously untreated patients: the role of factor concentrate type. An individual patient data meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication995811",
        "journal": "Haemophilia",
        "year": "2011"
      },
      {
        "title": "A Predictive Model for the Development of High-Responding Inhibitor In Children. with Severe and Moderate Hemophilia A- Results of a Multicenter Cohort Study",
        "url": "https://experts.mcmaster.ca/display/publication995803",
        "journal": "Blood",
        "year": "2010"
      },
      {
        "title": "Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients",
        "url": "https://experts.mcmaster.ca/display/publication995795",
        "journal": "Blood",
        "year": "2010"
      },
      {
        "title": "Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review & Meta-Analysis [Observational Studies]",
        "url": "https://experts.mcmaster.ca/display/publication995802",
        "journal": "Blood",
        "year": "2010"
      },
      {
        "title": "Bioequivalence of B-domain deleted and plasma derived FVIII concentrates",
        "url": "https://experts.mcmaster.ca/display/publication995814",
        "journal": "Haemophilia",
        "year": "2010"
      },
      {
        "title": "Bone mineral density in hemophilia patients: a meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication995817",
        "journal": "Haemophilia",
        "year": "2010"
      },
      {
        "title": "Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B",
        "url": "https://experts.mcmaster.ca/display/publication995821",
        "journal": "Haemophilia",
        "year": "2010"
      },
      {
        "title": "Effect of plasma-derived or recombinant factor VIII on inhibitor development: a systematic review",
        "url": "https://experts.mcmaster.ca/display/publication995823",
        "journal": "Haemophilia",
        "year": "2010"
      },
      {
        "title": "Predictors of success in immune tolerance induction (ITI) in haemophilia A patients with high-responding inhibitors: the Italian ITI registry",
        "url": "https://experts.mcmaster.ca/display/publication995830",
        "journal": "Haemophilia",
        "year": "2010"
      },
      {
        "title": "Recombinant factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication995820",
        "journal": "Haemophilia",
        "year": "2010"
      },
      {
        "title": "IDIOPATHIC VEIN THROMBOSIS: IDENTIFICATION OF POPULATIONS AT DIFFERENT RISK OF RELAPSE FOLLOWING ORAL ANTICOAGULANT TREATMENT. THE RESULTS OF THE 'EXTENDED-DACUS STUDY'",
        "url": "https://experts.mcmaster.ca/display/publication1683963",
        "journal": "Haematologica",
        "year": "2010"
      },
      {
        "title": "PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS",
        "url": "https://experts.mcmaster.ca/display/publication1683964",
        "journal": "Haematologica",
        "year": "2010"
      },
      {
        "title": "IDIOPATHIC VEIN THROMBOSIS: IDENTIFICATION OF POPULATIONS AT DIFFERENT RISK OF RELAPSE FOLLOWING ORAL ANTICOAGULANT TREATMENT. THE RESULTS OF THE 'EXTENDED-DACUS STUDY'",
        "url": "https://experts.mcmaster.ca/display/publication995826",
        "journal": "Haematologica",
        "year": "2010"
      },
      {
        "title": "PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS",
        "url": "https://experts.mcmaster.ca/display/publication995822",
        "journal": "Haematologica",
        "year": "2010"
      },
      {
        "title": "Effect of plasma-derived or recombinant factor VIII on inhibitor development. A systematic review",
        "url": "https://experts.mcmaster.ca/display/publication995833",
        "journal": "Haemophilia",
        "year": "2010"
      },
      {
        "title": "Impact of Thrombophilia On Arterial Ischemic Stroke or Cerebral Venous Sinus Thromboses in Children: A Systematic Review & Meta-Analysis of Observational Studies",
        "url": "https://experts.mcmaster.ca/display/publication995844",
        "journal": "Blood",
        "year": "2009"
      },
      {
        "title": "Prevalence and Determinants of Bleeding in Severe Von Willebrand Disease Type 3: Results of Retro/Prospective Studies in a Cohort of 105/52 Italian Patients.",
        "url": "https://experts.mcmaster.ca/display/publication995832",
        "journal": "Blood",
        "year": "2009"
      },
      {
        "title": "Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature",
        "url": "https://experts.mcmaster.ca/display/publication995839",
        "journal": "Blood",
        "year": "2009"
      },
      {
        "title": "Audit of the clinical use of fresh-frozen plasma in umbria: study design and results",
        "url": "https://experts.mcmaster.ca/display/publication3305094",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Bone mineral density in hemophilia patients: a meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication3305009",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Central nervous system (CNS) bleeding in patients with rare bleeding disorders (RBDS)",
        "url": "https://experts.mcmaster.ca/display/publication3305093",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Clinical prediction guide to predict thrombosis recurrence after a first unprovoked venous thromboembolism",
        "url": "https://experts.mcmaster.ca/display/publication3305013",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the two coagulation disorders",
        "url": "https://experts.mcmaster.ca/display/publication3305092",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Computer assisted VKA monitoring with point of care device by general practitioners",
        "url": "https://experts.mcmaster.ca/display/publication3305089",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "D-dimer to predict thrombosis recurrence after unprovoked venous thromboembolism: effect of patient- and D-dimer-related factors on recurrence prediction",
        "url": "https://experts.mcmaster.ca/display/publication3305008",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "D-dimer to predict thrombosis recurrence: comparison of aggregate data and individual patient data meta-analyses",
        "url": "https://experts.mcmaster.ca/display/publication3305007",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Does patient sex and prior hormonal therapy predict risk for thrombosis recurrence after a first venous thromboembolism?",
        "url": "https://experts.mcmaster.ca/display/publication3305010",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Does the clinical presentation of venous thromboembolism predict the risk for and type of thrombosis recurrence?",
        "url": "https://experts.mcmaster.ca/display/publication3305012",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Factor VIII gene (F8) mutations as a predictor of outcome in immune tolerance induction (ITI) in hemophilia A patients with high-responding inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication3305090",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Intracranial haemorrhage in haemophilia A and B: an italian retrospective survey",
        "url": "https://experts.mcmaster.ca/display/publication3305091",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Multicentric evaluation of current dosing practice of recombinant fix in italy",
        "url": "https://experts.mcmaster.ca/display/publication3305087",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Plasma derived (PD) and recombinant (R) factor VIII (FVIII) concentrates induce a different rate of inhibitor development in hemophilia A patients. a systematic review of the literature",
        "url": "https://experts.mcmaster.ca/display/publication3305014",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Prospective assessment of clinical endpoints of VKA treatment in a primary care computer assisted management model",
        "url": "https://experts.mcmaster.ca/display/publication3305088",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "Venous thromboembolism recurrence after a first episode of provoked venous thrombosis due to a transient risk factor. A systematic review of the literature",
        "url": "https://experts.mcmaster.ca/display/publication3305011",
        "journal": "Journal of Thrombosis and Haemostasis",
        "year": "2009"
      },
      {
        "title": "International clinical trials are the best way to improve global haemophilia care? No",
        "url": "https://experts.mcmaster.ca/display/publication995837",
        "journal": "Haemophilia",
        "year": "2009"
      },
      {
        "title": "Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature",
        "url": "https://experts.mcmaster.ca/display/publication995834",
        "journal": "Blood",
        "year": "2008"
      },
      {
        "title": "Antiviral therapy for chronic hepatitis C in haemophilia patients with human immunodeficiency virus",
        "url": "https://experts.mcmaster.ca/display/publication995632",
        "journal": "Clinical Respiratory Journal",
        "year": "2008",
        "doi": "10.1002/14651858.cd004888"
      },
      {
        "title": "Causes of death among Italian hemophiliacs: results from the Italian Association of Hemophilia Centers (AICE) Survey",
        "url": "https://experts.mcmaster.ca/display/publication995634",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Clinical audit of fresh frozen plasma usage in Umbria, Italy",
        "url": "https://experts.mcmaster.ca/display/publication995627",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Critical appraisal of five international guidelines on fresh frozen plasma clinical use",
        "url": "https://experts.mcmaster.ca/display/publication995629",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Factor IX pharmacokinetics: differences between plasma‐derived and recombinant products and the clinical and economic implications: a meeting report",
        "url": "https://experts.mcmaster.ca/display/publication995625",
        "journal": "Haemophilia",
        "year": "2008",
        "doi": "10.1111/j.1365-2516.2008.01762.x"
      },
      {
        "title": "Haemophilia A and B and other rare bleeding disorders: an Italian retrospective survey on the intracranial haemorrhagic episodes",
        "url": "https://experts.mcmaster.ca/display/publication995626",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Immune tolerance induction (ITI) in patients with hemophilia A and inhibitors: the Italian retrospective-prospective registry - the PROFIT study",
        "url": "https://experts.mcmaster.ca/display/publication995628",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger?",
        "url": "https://experts.mcmaster.ca/display/publication995633",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Pharmacokinetics of reformulated B-domain deleted recombinant factor VIII (BDD-rFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS)",
        "url": "https://experts.mcmaster.ca/display/publication995631",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Replacement therapy with recombinant FIX - multicentre evaluation of current dosing practice in Italy",
        "url": "https://experts.mcmaster.ca/display/publication995636",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "The haemophilia registry of the Italian Association of Haemophilia Centres",
        "url": "https://experts.mcmaster.ca/display/publication995635",
        "journal": "Haemophilia",
        "year": "2008"
      },
      {
        "title": "Pharmacokinetics of the reformulated B-DOMAIN deleted recombinant factor VIII (BDD-RFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS)",
        "url": "https://experts.mcmaster.ca/display/publication995644",
        "journal": "Haematologica",
        "year": "2007"
      },
      {
        "title": "Pharmacokinetics of the reformulated B-domain deleted recombinant factor VIII concentrate using chromogenicand one-stage assays with pooled normal plasma and refacto laboratory standard",
        "url": "https://experts.mcmaster.ca/display/publication995637",
        "journal": "Haematologica",
        "year": "2007"
      },
      {
        "title": "Systematic Review of Randomized Controlled Trials of Prophylactic Clotting Factor Concentrate in Hemophilia.",
        "url": "https://experts.mcmaster.ca/display/publication995640",
        "journal": "Blood",
        "year": "2005",
        "doi": "10.1182/blood.v106.11.3114.3114"
      },
      {
        "title": "Accreditation standard for surveillance center for patients undergoing oral anticoagulant therapy",
        "url": "https://experts.mcmaster.ca/display/publication1747348",
        "journal": "Rivista di Medicina di Laboratorio",
        "year": "2002"
      },
      {
        "title": "Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: A metanalysis",
        "url": "https://experts.mcmaster.ca/display/publication995829",
        "journal": "Thrombosis and Haemostasis",
        "year": "1999"
      },
      {
        "title": "Plasma homocysteine measurement: Comparison of three different assay methods in plasma from vascular patients",
        "url": "https://experts.mcmaster.ca/display/publication995825",
        "journal": "Thrombosis and Haemostasis",
        "year": "1999"
      },
      {
        "title": "Risk factors for venous thromboembolism in patients undergoing elective neurosurgery",
        "url": "https://experts.mcmaster.ca/display/publication995816",
        "journal": "Thrombosis and Haemostasis",
        "year": "1999"
      },
      {
        "title": "Serine base exchange enzyme in commercially available porcine lyophilized platelets: Different effect of unfractionated heparin and low molecular weight heparin",
        "url": "https://experts.mcmaster.ca/display/publication995824",
        "journal": "Thrombosis and Haemostasis",
        "year": "1999"
      },
      {
        "title": "The role of thrombophilic states in the bleeding tendency of patients with hemophilia",
        "url": "https://experts.mcmaster.ca/display/publication995815",
        "journal": "Thrombosis and Haemostasis",
        "year": "1999"
      },
      {
        "title": "Three-months compared with one-year of oral anticoagulant treatment after a first idiopathic deep vein thrombosis: The warfarin optimal duration Italian trial (WODIT)",
        "url": "https://experts.mcmaster.ca/display/publication995827",
        "journal": "Thrombosis and Haemostasis",
        "year": "1999"
      },
      {
        "title": "Enoxaparin plus compression stockings versus compression stockings alone in the prevention of venous thromboembolism (VTE) in neurosurgery patients: A randomised double blind venography study",
        "url": "https://experts.mcmaster.ca/display/publication995881",
        "journal": "Thrombosis and Haemostasis",
        "year": "1997"
      },
      {
        "title": "Plasma heparin level and coronary patency in patients with acute myocardial infarction treated with a double rt-PA bolus and randomised to two different heparin regimens",
        "url": "https://experts.mcmaster.ca/display/publication995866",
        "journal": "Thrombosis and Haemostasis",
        "year": "1997"
      },
      {
        "title": "Withdrawal of warfarin therapy after deep vein thrombosis: A randomised study on the effects of a very low fixed dose regimen",
        "url": "https://experts.mcmaster.ca/display/publication995872",
        "journal": "Thrombosis and Haemostasis",
        "year": "1997"
      },
      {
        "title": "EFFECTS OF DERMATAN SULFATE ON ACTIVATED PARTIAL THROMBOPLASTIN TIME DETERMINED WITH 5 DIFFERENT REAGENTS",
        "url": "https://experts.mcmaster.ca/display/publication995870",
        "journal": "Thrombosis and Haemostasis",
        "year": "1995"
      },
      {
        "title": "FIBRINOGENOLYSIS AND THROMBIN ACTIVATION AFTER ACCELERATED WEIGHT-ADJUSTED OR CONVENTIONAL ADMINISTRATION OF RT-PA FOR PULMONARY-EMBOLISM",
        "url": "https://experts.mcmaster.ca/display/publication995877",
        "journal": "Thrombosis and Haemostasis",
        "year": "1995"
      },
      {
        "title": "POSTDISCHARGE CLINICALLY OVERT THROMBOEMBOLIC EVENTS IN ORTHOPEDIC-SURGERY PATIENTS WITH NEGATIVE VENOGRAPHY",
        "url": "https://experts.mcmaster.ca/display/publication995874",
        "journal": "Thrombosis and Haemostasis",
        "year": "1995"
      },
      {
        "title": "THE DISPLACEMENT OF NONSPECIFICALLY BOUND UNFRACTIONATED HEPARIN FROM PLASMA-PROTEINS PRODUCES AN ANTITHROMBOTIC EFFECT",
        "url": "https://experts.mcmaster.ca/display/publication995883",
        "journal": "Thrombosis and Haemostasis",
        "year": "1995"
      },
      {
        "title": "EX-VIVO COMPARISON OF THE NONSPECIFIC-BINDING OF UNFRACTIONATED HEPARIN AND ENOXAPARIN TO PLASMA-PROTEINS",
        "url": "https://experts.mcmaster.ca/display/publication821713",
        "journal": "Thrombosis and Haemostasis",
        "year": "1993"
      },
      {
        "title": "INHIBITION OF FLUID-PHASE AND CLOT-BOUND THROMBIN - EFFECTS OF HEPARIN, HIRUDIN AND A THROMBIN-INHIBITING DECAPEPTIDE (LU-58463)",
        "url": "https://experts.mcmaster.ca/display/publication995867",
        "journal": "Thrombosis and Haemostasis",
        "year": "1993"
      },
      {
        "title": "KINETICS OF PLASMA THROMBIN NEUTRALIZING ACTIVITY IN PATIENTS WITH DEEP-VEIN THROMBOSIS TREATED WITH SUBCUTANEOUS HEPARIN TWICE A DAY",
        "url": "https://experts.mcmaster.ca/display/publication995871",
        "journal": "Thrombosis and Haemostasis",
        "year": "1993"
      },
      {
        "title": "PLASMA HALF-LIFE OF THE ANTI-IIA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARINS ASSESSED WITH A SENSITIVE TEST (PTNA)",
        "url": "https://experts.mcmaster.ca/display/publication821717",
        "journal": "Thrombosis and Haemostasis",
        "year": "1993"
      },
      {
        "title": "PLATELET INHIBITION INDUCED BY PLASMINOGEN ACTIVATORS - ROLE OF FIBRINOGEN DEGRADATION PRODUCTS",
        "url": "https://experts.mcmaster.ca/display/publication995879",
        "journal": "Thrombosis and Haemostasis",
        "year": "1993"
      },
      {
        "title": "SELECTIVE-INHIBITION OF ALLOGRAFT-RESPONSE BY MURINE VIRUS",
        "url": "https://experts.mcmaster.ca/display/publication3520895",
        "journal": "Annali Sclavo. Collana monografica",
        "year": "1975"
      },
      {
        "title": "EVIDENCE FOR VIRAL NATURE OF AN IMMUNODEPRESSIVE FACTOR (IDF) ASSOCIATED WITH VARIOUS TRANSPLANTABLE TUMORS",
        "url": "https://experts.mcmaster.ca/display/publication3520896",
        "journal": "The FASEB Journal",
        "year": "1974"
      }
    ],
    "other": [],
    "preprints": [
      {
        "title": "Attitudes and Perceptions of University Students and Postdoctoral Fellows in the Medical and Life Sciences Towards the Use of Artificial Intelligence Chatbots in the Educational Process: A Large-Scale, International Cross-Sectional Survey",
        "url": "https://experts.mcmaster.ca/display/publication3607070",
        "year": "2025",
        "doi": "10.1101/2025.06.25.25328523"
      },
      {
        "title": "Policies on Artificial Intelligence Chatbots Among Academic Publishers: A Cross-Sectional Audit",
        "url": "https://experts.mcmaster.ca/display/publication3441879",
        "year": "2024",
        "doi": "10.1101/2024.06.19.24309148"
      },
      {
        "title": "The McMaster Health Information Research Unit: Over a Quarter-Century of Health Informatics Supporting Evidence-Based Medicine (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3413012",
        "year": "2024",
        "doi": "10.2196/preprints.58764"
      },
      {
        "title": "Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Large-Scale, International Cross-Sectional Survey",
        "url": "https://experts.mcmaster.ca/display/publication3402622",
        "year": "2024",
        "doi": "10.1101/2024.02.27.24303462"
      },
      {
        "title": "Researcher and Clinician Preferences for a Journal Transparency Tool: A Mixed-Methods Survey and Focus Group Study",
        "url": "https://experts.mcmaster.ca/display/publication3490130",
        "year": "2024",
        "doi": "10.1101/2024.05.28.24307345"
      },
      {
        "title": "Attitudes and Perceptions of Medical Researchers Towards the Use of Artificial Intelligence Chatbots in the Scientific Process: A Protocol for a Cross-Sectional Survey",
        "url": "https://experts.mcmaster.ca/display/publication3282107",
        "year": "2023",
        "doi": "10.1101/2023.07.26.23293211"
      },
      {
        "title": "Machine learning to increase the efficiency of a literature surveillance system: a performance evaluation",
        "url": "https://experts.mcmaster.ca/display/publication3267865",
        "year": "2023",
        "doi": "10.1101/2023.06.18.23291567"
      },
      {
        "title": "Selective serotonin reuptake inhibitors for children with Autism Spectrum Disorder: a systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication3437457",
        "year": "2023",
        "doi": "10.21203/rs.3.rs-2757603/v1"
      },
      {
        "title": "Machine learning to increase the efficiency of a literature surveillance system: a performance evaluation (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3236693",
        "year": "2022",
        "doi": "10.2196/preprints.42982"
      },
      {
        "title": "User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3285816",
        "year": "2021",
        "doi": "10.2196/preprints.30797"
      },
      {
        "title": "Machine Learning Approaches to Retrieve High-Quality, Clinically Relevant Evidence From the Biomedical Literature: Systematic Review (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3401692",
        "year": "2021",
        "doi": "10.2196/preprints.30401"
      },
      {
        "title": "A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3236696",
        "year": "2021",
        "doi": "10.2196/preprints.29398"
      },
      {
        "title": "A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3461855",
        "doi": "10.2196/preprints.10281"
      },
      {
        "title": "Attitudes and Perceptions of Biomedical Journal Editors-in-Chief Towards the Use of Artificial Intelligence Chatbots in the Scholarly Publishing Process: A Cross-Sectional Survey",
        "url": "https://experts.mcmaster.ca/display/publication3593236",
        "doi": "10.1101/2025.05.26.25328101"
      },
      {
        "title": "Effects of Electronic Prescribing on Adherence to Prescribed Medications in Community Settings: A Systematic Review (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3582039",
        "doi": "10.2196/preprints.73599"
      },
      {
        "title": "Fine-Tuning and Benchmarking Transformer Models for Multiclass Classification of Clinical Research Articles: Modeling Study (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3587738",
        "doi": "10.2196/preprints.77311"
      },
      {
        "title": "Knowledge translation strategies for sharing evidence-based health information with older adults and their caregivers: Findings from a co-design study",
        "url": "https://experts.mcmaster.ca/display/publication3461844",
        "doi": "10.21203/rs.3.rs-373549/v1"
      },
      {
        "title": "Recommendations and Guidelines for Creating Scholarly Journals: A Scoping Review",
        "url": "https://experts.mcmaster.ca/display/publication3461843",
        "doi": "10.31219/osf.io/5d72z"
      },
      {
        "title": "Translating Clinical Questions by Physicians Into Searchable Queries: Analytical Survey Study (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3461847",
        "doi": "10.2196/preprints.16777"
      }
    ]
  },
  "filename": "Alfonso_Iorio.json",
  "file_created": "2025-07-27T15:08:22.972310"
}